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Abstract  
Decidualisation of human endometrial stromal cells (hESC) is essential for embryo 
implantation. As ethical barriers prevent investigation of human implantation in vivo, this 
project aimed to develop convenient/reliable co-culture models to evaluate the activity of 
platelet-derived growth factors (PDGF) and the anti-inflammatory/anti-oxidant haem-
oxygenase-1 (HO-1) in hESC–trophoblast interactions. The St-T1b cell line and primary hESC 
were decidualised in vitro and HTR-8 trophoblast line grown as spheroids and used to develop 
trophoblast-spheroid expansion and invasion/sprouting assays. Fluorescence cell-labelling 
coupled with ImageJ/trainable weka plugin facilitated monitoring/analysis of assays over 72 h. 
Decidualisation of hESC reduced their migration in scratch-wound assays, inhibited trophoblast 
sprouting and promoted trophoblast-spheroid spreading. PDGF-AA was down-regulated whilst 
PDGF-α/-β receptor expression increased with hESC decidualisation. PDGF-BB increased 
hESC migration and HTR-8 trophoblast spheroid expansion and invasion in the presence of 
decidual hESC. HO-1 was upregulated during hESC decidualisation in a forkhead box-O1-
dependent manner. Induction of HO-1 inhibited hESC migration and increased HTR-8-spheroid 
invasion. VEGF secretion increased, whereas sFlt-1 levels reduced with hESC decidualisation. 
Surprisingly, HO-1 induction enhanced sFlt-1 and VEGF expression in hESC and HTR-8 cells. 
Collectively, the results support use of these in vitro models as a platform to evaluate hESC 
decidualisation and other factors on trophoblast expansion/invasion and identify decidual 
regulation of HO-1 and PDGF activity in hESC. As defective hESC decidualisation causes 
infertility and pregnancy disorders, further investigation of HO-1 up-regulation and PDGF 
responsiveness in decidual hESC may identify new pathways underpinning these conditions.  
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1.1. Introduction 
The use of assisted reproductive techniques (ART) is still a promising and hopeful solution for 
both clinicians and infertile patients. However, it is a costly procedure that adds an extra burden 
to NHS in the UK and health services in most countries. Furthermore, the chance of a live birth 
following ART is only 29% in women less than 35 years (2018), compared to 84% of couples 
conceiving naturally within a year if they have regular unprotected sex  (NHS, 18). One of the 
main limiting steps in ART is embryo implantation (Spandorfer and Rosenwaks, 1999, 
Kreyenfeld and Konietzka, 2017). Accordingly, research to increase the rate of success, 
particularly improving embryo implantation rates, is demanded.  
Successful implantation requires the presence of a correctly developed blastocyst stage embryo 
and a synchronous receptive endometrium leading to a maternal-fetal interaction which 
comprises maternal decidua and invading trophoblast (Simón et al., 2000). Perturbations of this 
dialogue can lead to infertility, pregnancy loss (miscarriage), growth restriction of the fetus or 
maternal pregnancy disorders, including pre-eclampsia (Gellersen et al., 2007a).   
 1.2. The human endometrium  
                            The human uterus composed of perimetrium, myometrium and endometrium (Hermes et al., 
2000) ( 
Figure 1.1 and Figure 1.2). The endometrium is the mucosal lining of the uterine endometrial cavity. Its basic 
function is to offer a proper place for embryo implantation and growth support. If no 
implantation occurs, most of the endometrium will be sloughed off. The result will be menstrual 
flow, followed by endometrial regeneration next cycle (Lessey, 2000). Cyclical endometrial 
shedding and regeneration are regulated by ovarian oestrogen (E2) and progesterone (P) 
hormones with a typical 28 day menstrual cycle that occurs approximately 400 times during the 
Chapter 1 – General introduction 
3 
 
human female reproductive lifespan (Teklenburg et al., 2010a, Somasundaram, 2016). The 
endometrium is subdivided into two layers. The outer thinner layer lies next to the myometrium 
and is called the stratum basalis. This layer is relatively fixed and does not change during the 
menstrual cycles (Ham and Cormack, 1987, Ayachit and Kulkarni, 2017). The inner layer is 
the stratum functionalis which lines the endometrial cavity. It is thicker, extremely sensitive to 
ovarian hormonal changes, completely shed during menstruation, and regenerated again from 
progenitors cells in the stratum basalis (Lindenberg, 1994, Ayachit and Kulkarni, 2017). In the 
presence of conceptus, the stratum functionalis is maintained and forms the decidua. 
Histologically, the endometrium is composed of glandular and luminal epithelia, stromal 
fibroblasts, endothelial cells, vascular smooth muscle cells and leukocytes (Chan et al., 2004). 
The uterine blood supply is mainly through uterine arteries which pass through the myometrium 
and divide to give the basal arteries (Ferris et al., 1972, Moore et al., 2013). The basal arteries 
are short straight arteries, which enter the endometrium and supply the stratum basalis. Spiral 
arterioles arise from basal arteries and supply stratum functionalis (Kurup, 2008). They form 
thick and long tortuous vessels, which are very sensitive to ovarian hormone fluctuation and 
become more prominent with endometrial secretory changes (Smith, 2018). These arterioles 
anastomose with each other forming an extensive vascular network invading the stroma 
(Rogers, 1996) as shown in  
Figure 1.1. In the first trimester of pregnancy, remodelling of spiral arterioles occurs through 
the loss of maternal vascular smooth muscle and endothelial cells and replacement by extra 
villus trophoblasts embedded into a fibrinous matrix (Smith et al., 2009). Thus, vessels will be 
changed from narrow elastic to relaxed channel-like structures. Thereby, they can permit a high 
volume and low resistance blood flow to the fetus. This blood flow maintains healthy fetal 
growth and successful pregnancy (Burton et al., 2009). 
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Figure 1.1: The human female reproductive and endometrium structures. The upper figure 
showing the ovary and uterus. The lower figure shows the uterine layers. In the endometrium, the 
functional layer is the innermost one that contains the epithelial layer, glands, and stroma. This 
layer receives blood supply from the spiral arteries. The second layer is the basal layer which is 
the progenitor of the functional layer. Adapted from Pijnenborg et al  (2006) 
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1.3. Human endometrial cyclical changes 
The cyclical endometrial changes are regulated by E2 and P (Salker, 2013). Ovarian steroids 
are regulated by hypothalamic-pituitary hormones. The hypothalamus secretes gonadotropin-
releasing hormone (GnRH) which stimulates the pituitary to secrete the glycoproteins 
luteinizing hormone (LH) and follicle-stimulating hormone (FSH) (Figure 1.2).  
FSH and LH hormones induce the ovary to secrete P, E2, activins, and inhibin. Prominent 
feedback control is operated throughout the axis  (Silberstein and Merriam, 2000, Mikhael et 
al., 2019). FSH and LH release is depending on positive and negative feedback of ovarian 
hormone. During the luteal phase, E2 regulates LH while P and inhibin B regulate FSH. Both 
E2 and P regulate FSH and LH during the luteal phase while inhibin A affects FSH. E2 is the 
main positive feedback sensitiser of the pituitary to the gonadotrophin releasing hormone 
(Messinis, 2006) 
Morphologically, the cyclical endometrial changes can be divided into three phases: follicular, 
secretory, and menstruation (Ferenczy and Guralnick, 1983, Murray and Orr, 2020). 
Menstruation spans days 1-5 of the cycle, early to a mid-proliferative phase spans from 6-11 
days; late proliferative phase, which extends from days 12-14, early secretory phase, which 
spans days 15-19. Finally, the mid-late secretory phase extends beyond 20th day until the 
initiation of menses  (Sakamoto, 1985, Reed and Carr, 2018). 
1.4. The proliferative phase of the endometrial cycle 
This phase is under the influence of E2 secreted from growing follicles in the ovary (Reed and 
Carr, 2018). Regeneration of the endometrium starts from the basal layer in the early 
proliferative phase, the endometrium is thin with sparse narrow short glands (Figure 1.1 and 
Figure 1.2).  
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Figure 1.2: Schematic representation of events in the endometrium regulated by pituitary 
gonadotropins and ovarian steroids during the menstrual cycle. FSH hormone from the anterior 
pituitary gland stimulates ovarian follicle growth. The growing follicles release E2, which induces 
proliferation of the endometrium. Increased release of LH from the anterior pituitary (LH surge) 
stimulates ovulation of the dominant follicle. Post ovulatory P release induces secretory changes and 
decidualisation in the endometrium to prepare for embryo implantation. The failure of pregnancy 
causes endometrial sloughing and menstruation begins. Adapted from Hatcher and Namnoum (2004). 
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From day three of the cycle, proliferation increases both in the glands and stroma and active 
mitosis is evident. The epithelial cells proliferate to replace the sloughed surface of the 
endometrium (Mihm et al., 2011). The glands grow in size and become elongated. Finally, the 
spiral arterioles extend in the regenerating endometrium due to the proliferation of their 
vascular endothelial cells (Gellersen et al., 2007b). The progressive production of E2 by the 
dominant follicle in the ovary induces a rise in LH production – the LH surge (Clarke, 1995). 
Ovulation occurs approximately on day 14, 24-36 h following this surge, (Miller and Soules, 
1996). The remnant of the ovulated follicle in the ovary becomes the corpus luteum, which 
secretes post-ovulatory P (Niswender et al., 2000) 
1.5. The secretory phase  
The secretory phase occurs as a result of P secretion from the corpus luteum, which inhibits 
proliferation and induces differentiation of E2-primed endometrial cells (Bentley, 1998, Binder 
et al., 2015). During this phase, the glands become coiled and filled with glycogen-rich 
secretory product. The spiral arterioles become coiled. The stromal cell enlarges in size with 
dramatic changes in the extracellular matrix and are transformed into decidual cells in a process 
called decidualisation (Pan-Castillo et al., 2018). In the absence of pregnancy, E2 and P 
secretion fall as the corpus lutetium ages and undergoes fibrosis (Alam, 2006). 
1.6. Menstruation 
 Following the decline in P secretion (Figure 1.2), an influx of leukocytes, VEGF release, and 
spiral vessel constriction occur in the endometrium (Irwin et al., 1996, Reavey et al., 2019). 
This constriction is triggered by the production of prostaglandin from stromal cell lysosome 
and cause ischemia of stratum functionalis (Reavey et al., 2019). Later, the process becomes 
progesterone-independent, due to the secretion of matrix metalloprotease from the leukocytes, 
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which causes cell membrane lysis and degradation of the extracellular matrix (ECM) (Irwin et 
al., 1996). This leads to the shedding of the stratum functionalis of the endometrium and 
bleeding. Menstrual bleeding occurs from day 1-5 of the menstrual cycle and aids with the 
fibrinolytic activity. However, thrombin production from the basal layer secures homeostasis 
(Mihm et al., 2011). Synchronised regeneration under the influence of E2 occurs from the 
stratum basalis layer (Mihm et al., 2011). 
1.7. Decidualisation and implantation window 
Decidualisation can be defined broadly as postovulatory uterine remodelling in preparing for 
embryo implantation and pregnancy that involves all the endometrium and the inner third of 
the myometrium, which is called the junctional zone (Gellersen et al., 2007b). Thus, it leads to 
the coiling of the spiral arterioles, the entrance of uterine natural killer (uNK) leukocytes, 
maturation of secretory glands, and stromal fibroblast decidual transformation (Gellersen and 
Brosens, 2003a). Consequently, decidualising stromal cells attain the unique capability to 
control trophoblast invasion, to cope with oxidative and inflammatory injuries, and to prevent 
rejecting maternal immune reactions (Gellersen et al., 2007a). A more restricted definition is 
the morphological and biochemical transformation of ESC to secretory cells, which support 
immune-privileged and invigorating environments crucial for implantation and success of 
pregnancy (Gellersen et al., 2007b). Typically, menstruating animals undergo spontaneous 
decidualisation after ovulation, while in non-menstruating species, decidualisation require 
signals from an implanting embryo (Emera et al., 2012). Decidualisation occurs mainly in 
haemochorial placentation where the fetal chorion achieves direct contact with maternal blood 
for nutrient and gas exchange in species such as the human, mouse, rabbit, and guinea pig 
(Brosens et al., 2002). In humans, decidualisation is initially visible in the area surrounding the 
spiral arterioles around the 23rd day of the menstrual cycle (Figure 1.2). Decidualisation 
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continues until the 28th day of the cycle (Brosens and Gellersen, 2006). It later migrates evenly 
throughout the endometrium during pregnancy. 
The programmed remodelling of uterine endometrium during decidualisation occurs via rising 
postovulatory P acting on E2-primed endometrial stromal cells leading to the stimulation of the 
cyclic adenosine monophosphate (cAMP) system (Telgmann et al., 1997). Various paracrine 
or autocrine regulators operate beside hormonal control (Carson et al., 2000). During early 
pregnancy, decidualisation is maintained by blastocyst-derived human chorionic gonadotropin 
(hCG), which preserves the corpus luteum to maintain P production (Berndt et al., 2006) 
leading to the formation of pregnancy decidua. 
 Decidualisation indicates the end of a restricted time of endometrial receptivity known as the 
implantation window (IW) (Brosens and Gellersen, 2006). The IW refers to the time during 
which a competent blastocyst can attach to a receptive endometrium and usually spans the 20th 
to 24th day of a regular menstrual cycle (Quinn and Casper, 2008, Wilcox et al., 1999). Embryo 
implantation out of this period is likely to be unsuccessful (Brosens and Gellersen, 2006). A 
restricted time for implantation receptivity allows for the recruitment of a competent embryo 
more than abnormally developed but highly invasive embryos as in the study of Wilcox et al 
(1999), who found that implantation out of the IW is associated with early pregnancy loss. 
Approximately 50% of embryo implantation failure in ART is due to defective endometrial 
receptivity (Salamonsen, 2009). Some authors consider the establishment of a receptive 
phenotype is synchronised with decidualisation of the endometrial stroma. This notion is based 
on the idea that the receptivity of the endometrial epithelia, which is the primary barrier of 
implantation, is achieved by a substance secreted from the endometrial stromal cell under P 
control. E.g. morphogen Indian hedgehog in murine uterine epithelium which is essential for 
normal P effect on the uterus depends on the P receptor in the stromal cells (Simon et al., 2009, 
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Salker et al., 2010). During the IW, the endometrium expresses proteins that enable critical 
modulations to occur in a sequence starting with a fundal localisation of the embryo and ending 
with trophoblast invasion into the uterine stroma  (Kimber, 2008, Wang and Dey, 2006). 
1.7.1. Morphological changes in stromal cells 
During decidualisation, endometrial stromal cells (ESC) undergo differentiation into active 
secretory cells associated with characteristic morphological changes. They transform from 
elongated stellate fibroblasts to large rounded polygonal epithelioid secretory cells with an 
enlarged rounded active nucleus, well developed Golgi cisternae and rough endoplasmic 
reticulum, and cytoplasmic deposition of lipid and glycogen droplets (Fazleabas et al., 2004). 
Decidualised ESC are structurally close to myofibroblasts expressing desmin, α-smooth muscle 
actin (α-SMA), and vimentin (Oliver et al., 1999). During decidualisation, re-arrangement of 
the cyto-skeleton occurs regulated by the activation of myosin light chain and α-SMA 
dynamics. There is down-regulation of  α-SMA (Fazleabas et al., 2004) and polymerisation of 
filamentous actin combined by stress fibre formation (Teklenburg et al., 2010a). 
1.7.2. Biochemical changes in stromal cells 
The biochemical transformation of the decidual cells is manifested through the expression of 
products such as insulin-like growth factor binding protein-1 (IGFBP-1), decidual prolactin 
(dPRL), Forkhead box O-1 (FOXO1), tetraspanin CD82 (KAI1), (Gonzalez et al., 2011),  
interferon regulatory factor 4 (IRF4), Promyelocytic leukaemia zinc finger (PLZF), and 
superoxide dismutase-2 (SOD2) (Sugino et al., 2000). Additionally, the decidualised 
endometrial cells express chemoattractant factors such as cytokines and growth factors, which 
attract an influx into the decidua of specialised uterine natural killers leukocytes (uNK), which 
represent 90% of resident lymphocytes in the early conception (Brosens and Gellersen, 2006). 
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The uNKs have a primary action in the formation of both angiogenic factors and cytokines 
(Demir et al., 2010, Li et al., 2008), the regulation of trophoblast invasion, uterine vascular 
remodelling (Cartwright et al., 2010), and additional cytotoxic effects (Dosiou and Giudice, 
2005). An important role of decidual cells is their regulatory role in the trophoblastic invasion 
through a not fully understood involvement of the cytokine/chemokine environment (Loke and 
King, 1995, Menkhorst et al., 2019) with various expressions of regulatory factors such as 
metalloproteinase, cell adhesion molecules, and immune complex (Lunghi et al., 2007). 
1.7.2.1 dPRL 
Prolactin (PRL) is a hormone produced by lactotroph cells of the anterior pituitary, dermal 
fibroblasts (Richards and Hartman, 1996), hematopoietic cells (De Bellis et al., 2005), and 
decidual endometrial cells when it is known as decidual prolactin (dPRL). The secretion of 
dPRL needs cAMP stimulation (Telgmann et al., 1997). Progesterone has no noticeable effect 
on dPRL secretion (Telgmann and Gellersen, 1998). dPRL secretion is increased by insulin and 
relaxin (Li et al., 1993). In contrast,  dPRL secretion by hESC is reduced by platelet-derived 
growth factor (PDGF), epidermal growth factor (EGF), tumour necrosis factor- α (TNF-α), and 
interleukin (IL)  (Ben-Jonathan et al., 1996).  
The initiation of dPRL secretion by the decidual cell is synchronised with the histological 
decidualisation and  increases with decidualisation. dPRL can act locally or on the corpus 
luteum (Maslar and Riddick, 1979, Marano and Ben-Jonathan, 2014). The PRL function in the 
endometrium depends on the Janus Kinase (JAK) 2/ Signal transducer and activation of 
transcription protein (STAT) pathway. Upon stimulation with dPRL, the phosphorylation of the 
pathway occurs, and functions are initiated (Jabbour et al., 1998). dPRL plays a crucial role 
during embryo implantation by affecting the growth and differentiation of trophoblast cells, 
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enhancing the endometrial gland’s secretory function that promotes the trophoblastic invasion, 
regulation of angiogenesis, immunological role through antiapoptotic effect, and stimulation of 
immune cells proliferation (Jabbour and Critchley, 2001). 
1.7.2.2. IGFBP-1  
IGFBP-1 belongs to the insulin-like growth factor (IGF) family. IGF-I and II are hormone 
modulators as well as major binding proteins at the time of the secretory changes of the 
endometrium. IGF binding to IGFBP-1 increases its half-life and modulating its interaction 
with the cell surface receptor. The IGF family plays a crucial role in cell metabolism and 
proliferation. The IGFBP-1 expression is stimulated by glucocorticoids and cAMP in the 
presence of low insulin concentrations (Suwanichkul et al., 1993), relaxin, and P via 
glucocorticoid response element (Gao et al., 1994). Both IGF and insulin both have an 
inhibitory effect on IGFBP-1 production (Lewitt et al., 1991). 
IGFBP-1 is not only a marker of decidualisation, but it also promotes trophoblast invasion and 
migration (Chakraborty et al., 2002). Excess production of IGFBP-1 is associated with 
intrauterine growth restriction (Crossey et al., 2002),  while low levels are found in polycystic 
ovarian disease (Apter et al., 1995). 
1.7.2.3. FOXO1  
The FOXO subfamily includes FOXO1, FOXO3a, FOXO4, and FOXO6 (Hannenhalli and 
Kaestner, 2009). FOXO1 is not constitutively expressed by the uterine stromal cells and is 
induced during decidualisation while FOXO3a is reported to be suppressed (Christian et al., 
2002, Labied et al., 2006). FOXO4 is not expressed by endometrium (Labied et al., 2006). The 
FOXO1 protein is encoded in humans by the FOXO1 gene (Galili et al., 1993), which is induced 
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on the first day of decidualisation (Gellersen et al., 2007b) by the increase in the cAMP activity. 
FOXO1 is a master transcriptional regulator involved in the diverse cellular functions such as 
apoptosis, cell death, immune cells haemostasis, DNA repair, and coping with oxidative stress. 
All of these are critical features of decidualisation in hESC (Kajihara et al., 2006). These 
functions are regulated by post-translation modifications of FOXO1 protein by 
phosphorylation, acetylation, deacetylation, and proteolytic degradation. These modifications 
guide the localisation of FOXO1 either to the nucleus leading to transcriptional activity or the 
cytoplasm and exposure to proteasomal degradation (Vogt et al., 2005) (Figure 1.3). Growth 
factors such as EGF activate the phosphatidylinositol/AKT signalling pathway leading to 
transcriptional inhibition of FOXO1 through its phosphorylation and transport out of the 
nucleus to the cytoplasm (Kops et al., 1999, Brunet et al., 1999). Nuclear localisation of 
FOXO1 upon phosphorylation of alternative residues by the mitogen-activated protein kinase 
(MAPK) family member, JUN N-terminal kinase (JNK) stimulates FOXO1 transcriptional 
activity as the production of SOD2 and oxidative stress resistance (Essers et al., 2004, Wang et 
al., 2005). FOXO1 controls a number of genes involved in decidualisation like IGFPB-1, dPRL,  
and tissue inhibitors of matrix metalloproteinases (TIMP) (Buzzio et al., 2006). Using a 
luciferase reporter assay, FOXO1 was shown to be a transcriptional coregulator of homeobox-
A (HOXA) 11 and CEBP-β leading to the activation of PRL (Lynch et al., 2009, Christian et 
al., 2002)  and IGFBP-1 promotors (Kim et al., 2005).  
The promotors of dPRL and IGFBP-1 are stimulated by a FOXO1 transcription complex 
regulated by the interaction of P and cAMP signals (Gellersen and Brosens, 2003b) in addition 
to FOXO1 regulation by the PKA pathway and the nuclear P receptor (PGR).  
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Figure 1.3: Schematic representation of FOXO1 transcriptional activity regulation by 
P/cAMP in ESCs. Left panel: In the late luteal phase, elevated intracellular cAMP is synergized 
with P to enhance FOXO1 transcription. However, it causes release of a small nuclear fraction 
into the cytoplasm to serve as a latent reservoir. The remaining large fraction of nuclear FOXO1 
induces the expression of decidualisation genes like IGFBP-1 and dPRL. Right panel: P4 
withdrawal before menstruation. Re-entrance of cytoplasmic FOXO1 into the nucleus. The 
plentiful amount of active nuclear FOXO1 binds to its direct receptor and activates cycle arrest 
and apoptotic genes. Adapted from Brosens and Gellersen (2006). 
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A few days following treatment with cAMP, cultured endometrial stromal cells accumulate 
FOXO1 and this further increases in the presence of P. However, treatment with P alone does 
not induce FOXO1 expression (Labied et al., 2006). FOXO1 knockdown in hESC resulted in a 
more than 50% inhibition of IGFBP-1, dPRL, TIMP3, and somatostatin mRNAs (however, 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and actin were unaffected). 
Collectively, these results robustly suggest a vital role for FOXO1 in inducing the process of 
decidualisation (Grinius et al., 2006). 
1.7.2.4. KAI1 
KAI1 is a cell surface protein; it is also called cluster differentiation 82 (CD82). It is classified 
according to function as a tumour suppressor while it is categorised structurally within the 
tetraspanin family (Vogt et al., 2002) with two extracellular domains and four transmembrane 
domains (Stipp et al., 2003). Tetraspanins regulate diverse functions such as cell motility, 
proliferation (Tohami et al., 2007), and immunity (Toyo-oka et al., 1999). By 
immunohistochemistry, Gellersen et al (2007a) reported the expression of KAI1 by decidual 
endometrial cells and absence of its expression by the trophoblast cells. Upon KAI1 
knockdown, there was a loss of the decidual product decorin, which is involved in limiting 
trophoblast invasion (Gellersen et al., 2007a).  
1.7.2.5. PLZF 
PLZF was first recognised in promyelocytic leukaemia (Xue et al., 2000). It is a member of the 
Krüppel-like zinc finger family that is essential for limb development, myeloid cell 
differentiation, and nervous system formation  (Fahnenstich et al., 2003). It inhibits 
transcription by recruiting suppressor proteins like histone deacetylase I, nuclear receptor 
corepressor, silencing mediators for retinoid and thyroid hormone receptors, and Sin3 (Costoya 
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and Pandolfi, 2001, Melnick et al., 2000). PLZF can offer resistance to apoptosis by inhibiting 
the transcription of the pro-apoptotic protein (Parrado et al., 2004). PLZF is anti-proliferative 
through the transcriptional repression of genes regulating the cell cycle such as cyclin A (Yeyati 
et al., 1999). However, during the early phase of decidualisation before the transformation of 
ESC into decidualised cells, PLZF may promote proliferation (Gellersen and Brosens, 2014). 
PLZF is directly induced by P stimulation of endometrial cells, and it is crucial in their 
progesterone-mediated decidualisation (Kommagani et al., 2016). In vivo, PLZF is found in the 
nuclei of ESC at the mid to late secretory phase (Fahnenstich et al., 2003). Brosens and 
Gellersen (2006) reported that PLZF mRNA is induced rapidly upon P stimulation of hESCs 
while cAMP cannot induce it. It is reported that PLZF knockdown in hESC abolishes 
morphological changes associated with decidualisation, attenuation of the expression of the 
PRL and IGFBP1 decidual markers, and the reduction of hESC motility (Szwarc et al., 2017).  
1.7.2.6. IRF4 
IRF4 is an important decidualisation regulator in hESC and a genomic target of both P and 
FOXO1 (Vasquez et al., 2015). It was found that the knockdown of FOXO1 led to the removal 
of P from its DNA binding site in IRF4 and decreased the transcription of IRF4 with the 
reduction of decidualisation. IRF4 regulates the production of interleukin-10 (IL-10) (Lee et 
al., 2011a), which is predominantly detected in the decidual site (Viganò et al., 2002).  
1.7.2.7. SOD2 
SOD2 (a.k.a Mn-SOD) belongs to the ubiquitous enzyme family that catalyses the dismutation 
of superoxide ions. Other family members are SOD1 (CuZn-SOD), which is mostly 
intracellular, while SOD3 has a particular extracellular localisation (Zelko et al., 2002). In the 
female reproductive system, embryo implantation and placentation can be considered as 
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inflammatory processes and changes in oxygen tension can produce an oxidative stress 
environment (Burton, 2009);  decidual cells express SOD2 which contribute to their oxidative 
stress resistance (Sugino et al., 1996, Storz, 2011). FOXO1 is the transcription factor regulating  
SOD2 expression during decidualisation (Brosens and Gellersen, 2006). 
1.8. Decidualisation signalling 
1.8.1. Progesterone  
Progesterone binds to acts via two dominant PGRs produced by alternative mRNA splicing. 
PGR-A is a truncated version of PGR-B lacking 164 amino acids (Kastner et al., 1990, 
Gellersen and Brosens, 2014). PGRs display cyclical and cell type-dependent expression in the 
human endometrium. PGR-A is the predominant receptors in hESC (Mote et al., 1999) and is 
a more powerful transactivator role of dPRL and IGFBP-1promotor (Gao et al., 2000). PGR-A 
is abundantly expressed by hESC along the menstrual cycle and gestation, whereas its epithelial 
cell expression subsides following ovulation. In contrast, PGR-B's stromal and epithelial cell 
expression peaks in the mid proliferative phase, followed by a gradual decline afterwards 
(Jabbour and Critchley, 2001). Selective ablation of PGR receptors in mice revealed that PGR-
A is essential for ovarian and endometrial function, while PGR-B is indispensable for mammary 
development (Mulac-Jericevic and Conneely, 2004). Progesterone is a lipophilic hormone and 
can pass freely through the cell membrane (Georget et al., 1997)  to exert its effects via PGR-
A which is located mainly in the nucleus, whilst PGR-B shuttles between the nucleus and 
cytoplasm (Boonyaratanakornkit and Edwards, 2007). Progesterone binding induces structural 
changes in PGRs leading to dissociation from their chaperone proteins and dimerization 
(Rekawiecki et al., 2017). Subsequently, the PGR binds to specific response elements in target 
genes and interacts with steroid receptor co-activators to enable transcription. Post-translation 
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modifications such as sumoylation modulate PGR activity. Reduced PGR sumoylation is partly 
responsible for increased hESC progesterone sensitivity (Jones et al., 2006a). 
1.8.2. cAMP  
cAMP is a ubiquitous second messenger generated by stimulation of G protein-coupled 
receptors (GPCR)  from ATP upon activation of adenylate cyclase (Hur and Kim, 2002). 
Adenylate cyclase and cAMP levels are higher during the secretory phase of the cycle (Tanaka 
et al., 1993). The main target of cAMP is the protein kinase A pathway (PKA). In its inactive 
state PKA is a dimer of two catalytic submits linked to two regulatory units. Upon binding of 
cAMP the catalytic units dissociates,  facilitating diffusion into the nucleus and phosphorylation 
of the cAMP response binding protein (CREB) and cAMP modulating protein (CREM) leading 
to transcription of target genes such as dPRL and IGFBP-1 (Gellersen and Brosens, 2014). hCG 
signals via this cAMP pathway to maintain decidualisation in early pregnancy (Weedon-Fekjær 
and Taskén, 2012). Cyclic AMP levels are regulated by the rate of production as well as 
degradation by cyclic nucleotide phosphodiesterase (PDEs), and the inhibition of PDE can 
induce the expression of decidual markers (Bartsch et al., 2004). Another mechanism 
controlling cAMP activity is catabolism of PKA catalytic subunits and upregulation of 
regulatory subunits decreasing cAMP levels (Kopperud et al., 2003).  
 1.9. The convergence of cAMP and P activity during decidualisation  
Historically, P was considered as the only inducer of hESC decidualisation. Now, other vital 
factors have been identified, including cAMP.  Progesterone induces modest decidual changes 
over ten days in hESC in vitro which can proceed. In contrast, treatment with 8-Br-cAMP can 
induce strong decidualisation, which is not maintained in long-term culture (Brosens et al., 
1999). 
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Cyclic AMP sensitises hESC to P primarily through stimulation of the PKA pathway alters the 
interaction of PGRs with the nuclear receptor corepressor and silencing mediator of retinoid 
thyroid receptors (Wagner et al., 1998). This promotes the selection of the steroid receptor co-
activators (Rowan et al., 2000). The further mechanism by stimulation of different subsidiary 
transcription factors like FOXO1, SV40 promoter binding protein 1 (SP1), C/EBP-ß, and signal 
transducer and activators of transcription 3 and 5 (STAT3 and STAT5) (Christian et al., 2002, 
Mak et al., 2002). All these transcription factors share the ability to interact with PGRs. 
Thereby, the generation of multimeric transcription complexes gives PGR regulatory activity 
over gene transcription without the involvement of the PGR element (PGRE) binding (Salker, 
2013). 
1.10. Functions of decidualisation  
1.10.1. Trophoblast invasion and embryo encapsulation and selection  
The process of embryo implantation is analogous to tumour invasion with the decidua 
controlling embryo invasion. The decidua should limit extensive pathological invasion and 
prevent placenta accreta by modulating the local cytokine environment. It should also promote 
the growth of an embryo and prevent growth retardation. This means that the decidua both 
accommodates and promotes trophoblast invasion to an equal extent which has been called 
"cooperation and conflict in the placental bed" (Haig, 2010). Trophoblast invasion requires the 
remodelling and degradation of the extracellular matrix by matrix metalloproteinases (MMP) 
produced by trophoblasts. MMPs proteolytic action is counteracted by TIMPs, which are 
secreted from both decidual cells and trophoblasts (Lambert et al., 2004). Transforming growth 
factor β (TGFβ) is another inhibitor of MMPs produced by decidual cells as well as its storage 
proteoglycan, which is called decorin (Jones et al., 2006c). The decidua also produces plasmin 
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which is activated by the membrane-anchored receptor (uPAR) binding with urokinase-type 
plasminogen activator (uPA). This pathway is inhibited by plasminogen activator inhibitor 
type-1  (Wu et al., 1995, Jones et al., 2006c). 
Recently, it has been shown that the decidual endometrial cells are motile and invasive and can 
encapsulate the embryo (Weimar et al., 2013). Grewal et al  (2008, 2010) demonstrated that 
decidualised ESC motility is crucial for trophoblast invasion during implantation. Continuous 
in vitro observation using time-lapse microscopy demonstrates that the decidualised ESC 
moves around the implanting embryo to enhance its expansion. Additionally, decidualised cells 
moved towards the excellent embryo that gives them embryo selection ability.  Failure of this 
endometrial discrimination can result in recurrent miscarriage (Weimar et al., 2012). Dramatic 
upregulation of important implantation genes was observed in murine uteri treated with 
conditioned media from competent blastocysts that were compared with incompetent 
blastocysts (Brosens et al., 2014).  
 Massive desmosomal cell-cell contact is seen between trophoblasts and decidual cells. These 
cells do not display signs of degeneration which ensures embryonic invasion is controlled to 
avoid disturbance of the feto-maternal interface (Babawale et al., 2002). Collectively, it is 
evident that the decidua not only controls trophoblast invasion but also actively participates in 
embryo encapsulation and selection. 
1.11. Oxidative stress responses  
The occlusion of spiral arterioles by trophoblasts limits the vulnerability of the fetus and 
placenta to blood flow and oxygen from the maternal side and consequently, oxidative stress. 
Later on, dislodging of this trophoblastic plug permits blood flow to the inter-villus space and 
accordingly, massive fluctuations in oxygen concentrations ensues at the feto-maternal area. 
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Thereby, partial oxygen pressure rises from 20 mmHg at 7-10 week to 50 mmHg at 14 weeks 
of gestation. This fluctuation induces a flare-up of reactive oxygen species (ROS) (Wu et al., 
1995, Burton et al., 2009).  In the lack of potent defence mechanism, ROS such as hydrogen 
peroxide, superoxide anion, and hydroxyl radicals result in non-selective destruction of protein, 
nucleic acids, and lipids. The cells constitutively produce neutralising enzymes to fight 
oxidative stress and reverse the resulting damage by ROS (Sies, 1997, Lee et al., 2019). 
Furthermore, an adaptive response manifested by upregulation of antioxidant enzymes as 
peroxidase, superoxide dismutase, glutathione S-transferase, and activation of repair genes such 
as growth arrest proteins and heat shock proteins (Barnouin et al., 2002, Tran et al., 2002). 
It is still envisaged that oxidative damage at the maternal-fetal interface can result in a spectrum 
of pathological pregnancy ranging from miscarriage to pre-eclampsia and growth restriction. 
Even though the primary pathology of miscarriage or pre-eclampsia such as focal bleeding, 
necrosis, or spiral artery pathology is located on the maternal side of decidua, however, the 
decidual contribution in oxidative stress defence has been primarily skipped (Gellersen et al., 
2007a). Decidualisation is associated with the extraordinary ability of OS coping revealed by 
the induction of ROS scavenger such as Monoamine oxidase  A and B, SOD2, glutarerdoxin, 
thioredoxin, and peroxiredoxin 2 (Maruyama et al., 1997, Riesewijk et al., 2003). Moreover, 
glutathione peroxidase 3 (GPx3), which considered a powerful extracellular neutraliser of 
hydrogen peroxide and fatty acid hydroperoxide (Gellersen et al., 2007a). Expressing GPx3 
permits the decidual cell involvement in trophoblasts defence against ROS. In contrast to 
undifferentiated cells which on exposure to ROS express the pro-apoptotic FOXO3A, the 
decidual cell does not exhibit this. Therefore, oxidative-stress induced cell death is selectively 
disabled in decidualised cells (Kajihara et al., 2006).  
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1.12. Immune responses  
The decidualisation process plays an essential role in securing the immuno-tolerant 
environment around the allogenic feto-placental unit, whereas keeping the fetus and mother 
protected from pathogens. This role may be attributed to recruitment of CD56bright/CD16-ve uNK 
cells which express immune-modulatory particles as glycodelin A (placental protein 14) and 
galectins (Koopman et al., 2003). The latter inhibits T-cell survival, proliferation and pro-
inflammatory cytokine expression. Likewise, glycodelin A strongly inhibits T-cell activation. 
Recurrent miscarriage is associated with reduced serum levels of glycodelin A in the secretory 
phase of the cycle in fertile couples (Tulppala et al., 1995). There is compelling evidence that 
decidual cells can inhibit the T-cell proliferation-inducing activity of tryptophan through the 
expression of indoleamine 2 3-dioxygenase (IDO) as IDO inhibitors result in massive 
inflammation and fetal resorption in mice (Munn et al., 1998). Lastly, induction of activated-T 
cell apoptosis by decidualised cells is promoted through expression of Fas ligands and c-FLIP, 
which inhibit the auto-activation of cell death pathways (Kajihara et al., 2006). 
In conclusion, decidualisation of the human endometrium is primarily considered as a critical 
component in immunological tolerance of pregnancy (Ringden et al., 2013). Accordingly, 
transplant pathologists explored the utilisation of decidual stromal cells in the treatment of 
steroid-refractory acute transplant rejection (Ringden et al., 2013). 
1.13. Clinical perspective of aberrant decidualisation 
1.13.1. Infertility 
The steroid hormone effect on the endometrium is profoundly changing and dependant on a 
programmed cells regeneration, and because of this, the human endometrium has an 
endogenous potential for modulating its function to a secure successful conception (Gellersen 
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and Brosens, 2014). The perturbation of such programmed cell changes during decidualisation 
can result in reproduction failure as in, polycystic ovarian syndrome (Younas et al., 2019), 
recurrent pregnancy loss (Salker et al., 2010), and endometriosis (Klemmt et al., 2006). 
1.13.2. Endometriosis 
Endometriosis is a common gynaecological problem and affects approximately 10% of women 
of reproductive age (Benaglia et al., 2009). It is diagnosed in up to 30% of women with 
infertility problems (Bulletti et al., 2010) and is a major cause of low pregnancy success 
following IVF (Barnhart et al., 2002). Endometriosis is characterised by ectopic endometrial 
tissue outside the uterine cavity and it is frequently accompanied by pelvic pain. One of the 
oldest theories to explain endometriosis is menstrual blood retrograde deposition which is 
called Sampson’s theory (Sampson, 1927). An alternative theory attributes endometriosis to the 
metaplasia of Mullerian epithelia into an endometrial tissue (Fujii, 1991). Despite these 
theories, it is still difficult to explain why some women develop endometriosis while others not.  
To find effective treatments for endometriosis demands a clear understanding of the underlying 
cellular and molecular pathology. There is clear evidence of poor endometrial decidualisation 
of both ectopic and eutopic endometrial tissue which leads to endometrial shedding (Klemmt 
et al., 2006, McCluggage and Kirk, 2000, Aghajanova et al., 2010, Yang et al., 2012). This 
appears related to P resistance in eutopic endometrial tissue due to the abnormal expression of 
PGRs mainly PGR-B. Progesterone resistance leads to reduced 17-hydroxysteroid 
dehydrogenase type 2 (17-HSD-2) enzyme expression in the epithelium resulting in the 
accumulation of biologically active E2, which stimulates endometrial tissue growth (Bulun et 
al., 2006).  
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1.13.3. Miscarriage 
Miscarriage (early pregnancy loss/spontaneous abortion) is defined as loss of pregnancy before 
the conceptus gains the ability to live independently and usually occurs before the 24th week of 
gestation. Miscarriage is classified according to the week of gestation at which it occurs. It is 
categorised as pre-clinical if occurring before five weeks, or clinical from the 6th-20th week of 
pregnancy (Bienstock et al., 2015). Miscarriage can affect 10-40% of pregnancies (Bienstock 
et al., 2015). Increased the risk of miscarriage is recorded in teenagers and the over 40s. 
Miscarriage is associated with emotional trauma, anxiety and depression (Klier et al., 2000, 
Brier, 2004), which predispose to obstetric problems such as prematurity in the future 
pregnancies (Bhattacharya and Bhattacharya, 2009) and increased risk of maternal 
cardiovascular problems (Oliver-Williams et al., 2013). 
Recurrent pregnancy loss (RPL) or habitual abortion is another significant obstetric 
complication that may be the result of abnormal decidualisation. RPL is defined as two 
(American definition) or three or more consecutive miscarriages (European definition)  (Stirrat, 
1990, Medicine, 2012b). Half of these cases are due to chromosomal abnormality (Bienstock 
et al., 2015). Most cases of RPL are treated empirically using aspirin and heparin based 
management to reduce immunological rejection of the fetus, which results in improved 
pregnancy rates (Heuser and Branch, 2019). 
A new understanding of the role of decidualised ESC in embryo selection may explain RPL. 
This selectivity is demonstrated by the ability of the decidualising cells to accept the 
implantation of a good embryo and reject the implantation of a suboptimal embryo (Brosens et 
al., 2014, Teklenburg et al., 2010b, Salker et al., 2010, Macklon and Brosens, 2014). The 
response in RPL endometrium is more pro-inflammatory. It exhibits a prolonged receptive 
phase and expression of the powerful pro-inflammatory factor IL-33 and attenuated expression 
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of auto-inflammatory decoy receptor, sST2, resulting in bleeding and fetal resorption (Macklon 
and Brosens, 2014). In contrast, this hESC response is attenuated in endometriosis (Salker et 
al., 2012).  
Recently it has been found that defective decidualisation leads to a reduction of brain and 
muscle aryl hydrocarbon receptor nuclear translocator-like 1 transcriptional factor expression, 
which controls trophoblast invasion by regulating TIMP levels increasing an individual’s risk 
of RPL (Lv et al., 2019). Additionally, impaired decidualisation in women with RPL may be 
attributed to premature cellular senescence, which is an essential mechanism for healthy tissue 
remodelling to prevent uterine fibrosis (Lucas et al., 2016). Due to fluctuating P levels, the 
growth of embryos that lack fitness may also fail due to their low hCG production (Delcour et 
al., 2019) leading to low/fluctuating P levels or through the OS challenge on the transition from 
the histiotrophic phase to active maternal blood perfusion at the feto-maternal interface at the 
end of the first trimester  (Azizi et al., 2019). 
1.14. Pre-eclampsia  
Pre-eclampsia is a  disorder that complicates 2-8% of pregnancies(Ghulmiyyah and Sibai, 2012, 
Rana and Hameed, 2019), resulting in global maternal morbidity of  29750 deaths/year (Conti-
Ramsden et al., 2019). It is characterised by the development of hypertension and high 
proteinuria at or following 20th week of gestation in previously fit women (Magee et al., 2014). 
Symptoms can start with sudden weight gain, oedema, headaches, and visual disturbances. 
However, some women may be asymptomatic. Pre-eclampsia can result in a serious sequelae 
as impaired placental blood flow and intrauterine growth restriction (IUGR), eclampsia, 
placental abruption, acute renal failure, HELLP (haemolysis, elevated liver enzymes and low 
platelet count) syndrome, disseminated intravascular coagulation, pulmonary oedema, future 
cardiovascular disease (Boniface et al., 2019, Magee et al., 2014). Pre-eclampsia can be 
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classified as early-onset if it occurs before the 34th week of gestation or late-onset (Raymond 
and Peterson, 2011, Burton et al., 2019). The early-onset form can be described as of fetal origin 
due to a malfunctioned placenta. This type results in an adverse effect on the fetus, mother, 
small placenta, IUGR, and multi-organ failure (Burton et al., 2019). Late-onset pre-eclampsia 
is thought to be of maternal origin and has a more favourable prognosis, with larger placenta, 
and higher average birth weight (Raymond and Peterson, 2011). The leading risk factors of pre-
eclampsia are a history of hypertension, diabetes mellitus, obesity, null parity, and 
immunological factors as antiphospholipid syndrome, renal problems, IVF, and family history. 
These factors can predispose to placental malfunction, consequently result in the release of 
inflammatory mediators and antiangiogenic factors as soluble endoglin (sENG) and soluble 
fms-like tyrosine kinase-1 (sFlt-1), which induce preeclampsia (Rana et al., 2019). 
Furthermore, the chorionic villus transcriptional profile showed poor decidualisation in cases 
of severe pre-eclampsia (Rabaglino et al., 2015). The transcriptional profile of decidual cells of 
severe pre-eclamptic pregnancies showed genetic abnormalities. These cells were unable to 
decidualise in vitro, and their conditioned medium cannot support trophoblastic invasion 
(Garrido-Gomez et al., 2017). The histological examination of pre-eclamptic placenta showed 
shallow placental invasion (Stanek, 2019).   
1.15. Implantation overview  
Implantation is a highly complicated developmental process, which is pivotal in the progression 
of embryonic development inside the mother’s uterus (Das, 2009). Implantation extends from 
the time of blastocyst hatching to the generation of primitive placental circulation. It is initiated 
on the contact of the blastocyst to the endometrium. 
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1.15.1. Pre-implantation embryo development 
Pre-implantation development leads to the generation of an attachment-competent embryo. The 
pre-implantation period spans 6 days from the time of fertilisation to implantation (Vassena et 
al., 2011). In humans, fertilisation occurs 24-48 h after ovulation in the ampulla region of the 
Fallopian tube (Gwatkin, 2012) (Figure 1.4). The fertilised oocyte undergoes cleavage, 
activation of embryonic genome, compaction, blastocyst formation or cavitation, and finally 
zona pellucida hatching (Kidder, 1992). The hallmark result of the pre-implantation period is 
the formation of a fluid-filled structure called the blastocyst at the time of entering the uterus 
(Krüssel et al., 2003). The blastocyst consists of an outer epithelial layer of extra-embryonic 
trophectoderm (TE), which will form the placenta. The inner cell mass (ICM), which forms the 
embryo, and a fluid-filled space called the blastocoel (Larsen, 1998).  
The activation of the embryonic genome and gradual degradation of maternal genome begins 
at the 2-cell stage (Duranthon et al., 2008). At the 8-cell stage compaction occurs with 
increasing intracellular communication between individual blastomeres due to the formation of 
adherence junctions (Telford et al., 1990) leading to a 16-cell morula formation with an inner 
cell mass (ICM) surrounded by the progenitor TE (Johnson and McConnell, 2004). On the 3rd 
to 4th day after ovulation, the morula enters the uterine cavity (Croxatto, 2002). Cavitation leads 
to the formation of the blastocyst which achieves polarity by adopting a specific orientation 
towards the uterus (Diedrich et al., 2007) followed by hatching from the zona pellucida (ZP) 
~72 h after entering the uterine cavity (Watson and Barcroft, 2001). The TE cells are the origin 
of trophoblasts, which are paramount in the process of implantation as they are the first cells 
achieving contact with and subsequent invasion into the endometrium (Duc-Goiran et al., 
1999).  
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Figure 1.4: The journey of a blastocyst during the post fertilisation period. Schematic illustration 
of blastocyst differentiation from fertilisation time till implantation in the uterine endometrium. The 
fertilised oocyte undergoes cleavage, activation of embryonic genome, compaction, 
blastocyst formation or cavitation, and finally zona pellucida hatching. Adapted from  
www.drgpbiology.com. 2017.  
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The trophoblasts secrete a number of growth factors and cytokines such as tumour necrosis 
factor alpha (TNF-α), interleukins, MMPs, and hCG. These factors work in a paracrine or 
autocrine manner to communicate with the endometrium and support implantation (Merviel et 
al., 2001) 
1.15.2. Implantation 
Implantation usually takes place between six to seven days post fertilisation (Vigano et al., 
2003). In humans, implantation occurs in three stages (Error! Reference source not found.A): 
The initial unstable stage is the contact between the blastocyst and the endometrial epithelia 
and is called apposition (Modi et al., 2012). During this stage, there is interdigitation between 
microvilli on the trophectoderm and pinopodes on the endometrial epithelia with marked 
oedema and increased vascular permeability at the attachment point (Cha et al., 2012). 
Apposition is followed by firm adhesion to the endometrium (Johnson, 2015). In the adhesion 
stage, an active interaction between blastocyst and endometrium exists.  
The trophoblast differentiates into well defined, proliferating cytotrophoblasts in the inner part, 
and the fused multinucleated syncytiotrophoblast layer on the outer part (Anin et al., 2004). 
The final step of implantation is the invasion stage when the syncytiotrophoblast invades the 
endometrium by lytic activity that weakens the adjacent endometrial cells (Denker, 2012).  On 
the tenth-day post fertilisation, the embryo becomes entirely buried in the uterus, and the uterine 
epithelia rebuild over it (Glasser et al., 2002). The syncytiotrophoblast (Error! Reference 
source not found.B) is responsible for oxygen and nutrient support of the fetus and located at 
the free surface of the chorionic villi, while the villus cytotrophoblast is located underneath the 
syncytiotrophoblast (Norwitz et al., 2001). Extra villus trophoblasts (EVT) (Anin et al., 2004) 
invade the decidua as endovascular or intestinal EVT. 
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Figure 1.5: Stages of embryo implantation. Schematic representation of embryo 
implantation and spiral artery remodelling. (A) Embryo implantation has three distinct 
stages as apposition, attachment, and invasion. Implantation requires receptive endometrium 
represented by decidualisation with the influx of uNK and microphage. (B) Trophoblastic 
invasion as endovascular invasion and interstitial invasion. uNK = uterine natural killer 
cells, EVT = extra villous trophoblast. Amended from Lounghi et al (2007a).  
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The interstitial EVT anchor the placenta to decidua leading to the development of the utero-
placental circulation (Pijnenborg, 1988). The endovascular trophoblasts invade into uterine 
spiral arteries and replace their endothelial and muscle tissue to form a high capacitance and 
low resistance vessels in the fetal-maternal interface in the process of spiral arteriole 
remodelling (Goldman-Wohl and Yagel, 2002). By the end of the first trimester, the EVT 
invade the endometrium and the inner third of myometrium (Kaufmann et al., 1996, Staun-Ram 
and Shalev, 2005).  
1.15.3. Trophoblast cell function during embryo implantation 
Implantation and successful pregnancy are dependent on the proliferative, migratory, adhesive, 
and invasive potential of the trophoblast (Chakraborty et al., 2002, Ferretti et al., 2007). Despite 
intensive research, the regulatory mechanisms are still not fully understood. Trophoblast 
function is regulated by paracrine and autocrine mechanisms involving the trophoblasts and the 
uterine microenvironment (Lunghi et al., 2007). The importance of embryo-uterine crosstalk is 
highlighted here. For example, during the uterine invasion, the trophoblast secretes a wide range 
of protease enzymes, the MMPs for degrading the ECM barrier. In turn, MMP activity is widely 
influenced by the uterine microenvironment through the opposing action of TIMP. Further 
contributors could also be involved in this crosstalk such as IGFBP-1, cytokines, LIF, TNF-α, 
P, and hCG (Staun-Ram and Shalev, 2005). The decidualised endometrial stroma produces an 
ECM, which forms a cytokine-controlled environment controlling trophoblast invasion 
(Kliman, 2000) 
1.16. Growth factors, interleukins and cytokines  of the fetal-maternal interface 
Decidualised hESC produced a lot of cytokines and growth factors that further engage in 
stromal differentiation. Additionally, the surrounding immune cells, epithelial cells, and 
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endometrial vasculature further secrete signal factors that might influence decidualisation and 
embryo implantation. These factors include ILs, the TGFβ superfamily, and growth factors such 
as EGF, PDGF, VEGF, and PlGF. They are involved in the fetal-maternal interface to regulate 
the proliferative, adhesive and invasive ability of trophoblasts (Bischoff et al., 2000, Lala and 
Chakraborty, 2003). 
1.16.1. Interleukins 
Differentiating hESC secrete IL-11 in a coincident manner to IGFBP-1 and PRL (Dimitriadis 
et al., 2000). IL-11 is a pleiotropic cytokine which has a heterodimeric receptor complex 
consisting of the signalling component gp130 and IL-11 receptor α chain (IL-11Rα). IL-11 is a 
mandatory factor for the process of implantation and mice lacking IL-11, or its receptors are 
infertile due to inefficient endometrial decidualisation (Bilinski, 2010, Robb et al., 1998). A 
reduction of IGFBP-1 and PRL accompanies the inhibition of IL-11 (Dimitriadis et al., 2005, 
Karpovich et al., 2005). 
IL-1β is an essential pro-inflammatory cytokine that is produced in the embryo as well as the 
endometrium, especially in the peri-implantation period. It plays a crucial role in 
decidualisation and embryo implantation. It is proposed that IL-1β intervenes in the 
endometrial-blastocyst cross-talk during implantation through the induction of integrin αvβ3, 
which is critical for implantation (Simón et al., 1997). This ligand binds to a number of 
substances in the ECM, including laminin and fibronectin (Fazleabas et al., 1997). IL-1β 
enhances the cAMP accumulation and the expression of prostaglandin E2 through upregulation 
of cyclo-oxygenase 2 (Tamura et al., 2002). Additionally, IL-1β stimulates the action of MMP-
3 in the degradation of ECM  during implantation (Fazleabas et al., 2004). 
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1.16.2. LIF 
LIF is a glycoprotein of the IL-6 family that is highly expressed in mouse endometrial glands 
before implantation at day 4 of pregnancy (Bhatt et al., 1991). In human, its secretion is limited 
to endometrial epithelia during the luteal phase (Stewart et al., 1992). There is growing 
evidence that refers LIF as one of the entities that participate in human implantation and uterine 
receptivity (Munro, 2019). Hence,  its inhibition results in implantation failure in mice (Song 
et al., 2000). However, the administration of LIF to women with RPL in IVF did not improve 
their pregnancy outcomes (Brinsden et al., 2009). 
1.16.3. EGF 
EGF is 53 amino acid protein that is expressed by trophoblastic and decidual cells (Hofmann et 
al., 1991). It binds the epidermal growth factor receptor (EGFR) in humans ErbB-1and HER1. 
EGF and its receptor expression increase with endometrial stromal decidualisation. It is released 
at the uterine wound site and enhances epithelial, but not stromal cell proliferation at the edge 
of the wound (Alsat et al., 1993). In pregnancy, EGF improves embryonic development and 
trophoblastic differentiation through phosphatidylinositol 3-kinase (PI3K) 
and MAPK  pathways activation, trophoblast invasion (Bass et al., 1994) and proliferation (Li 
and Zhuang, 1997, Qiu et al., 2004). It promotes the function of PAI-1, MMP-2 and 9, and uPA 
in trophoblast cells (Anteby et al., 2004) and this stimulates trophoblast invasion. Therefore, 
EGF is considered as a chief regulator of embryo implantation. The placenta of IUGR 
pregnancies showed a low expression of EGFR (Evain-Brion and Alsat, 1994). EGFR increases 
the expression of IL-8, VEGF, and MMP-1  in decidual cells as well as increases wound healing 
(Goto et al., 2019). EGF is involved in regulating cell growth, laminin, PRL, and fibronectin 
expression in hESC (Irwin et al., 1991). 
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1.16.4. Heparin-binding epidermal growth factor (HB-EGF)  
HB-EGF is a pleiotropic growth factor that plays a vital role in fertility (Raab and Klagsbrun, 
1997). It belongs to the EGF family and can be found as a soluble form (Iwamoto and Mekada, 
2000). It binds to both EGFR and ErbB4 (HER4) (Elenius et al., 1997). It is expressed in uterine 
epithelial and stromal cells, and its highest expression by epithelial cells coincides with the mid-
secretory phase of the endometrial cycle (Simón et al., 2000). The deletion of HB-EGF in 
mouse uterus delays embryo implantation (Xie et al., 2007, Lim and Dey, 2009). It has been 
found that HB-EGF transcription is under the control of E2 and P (Gechtman et al., 1999). 
Decidualisation through cAMP enhances the expression of both forms of HB-EGF as well as 
one or both receptors (Chobotova et al., 2005, Schwenke et al., 2013). However, EGFR 
expression was reported to be more highly expressed in decidual cells in spontaneous abortion 
specimens (Balci and Özdemir, 2019). Chobotova et al (2005) indicate that HB-EGF may play 
a role in the differentiation of endometrium and abolishing TNF-α-induced apoptosis of hESC, 
as well as inhibition of HB-EGF, can reduce IGFBP-1 and PRL production. HB-EGF has 
powerful cytoprotective activity and is an essential signalling protein that control trophoblast 
invasion during early placentation. Reduced level of HB-EGF has been detected in pre-
eclamptic pregnancies (Leach et al., 2002).  
1.16.5. Activin, Inhibin, and Follistatin 
Activin, inhibin and follistatin also belong to the TGF-β family that have crucial roles in the 
decidualisation of the endometrium (Jones et al., 2006b). Activin enhances the decidual MMP-
2 production (Jones et al., 2006c) and is upregulated in parallel with PRL upon cAMP 
stimulation of hESC. It also stimulates decidual marker expression while activin function 
inhibited by follistatin (Jones et al., 2002). 
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1.16.6. Tumour necrosis factor (TNF-α).  
TNF-α is a pleiotropic cytokine that is found in trophoblasts as well as in the endometrium 
(Staun-Ram and Shalev, 2005). It is produced by activated macrophages, monocytes, as well 
as T-lymphocytes (Vassalli, 1992). TNF-α has a broad range of activities extending between 
two extreme borders of tissue regeneration and apoptosis. This is shown in its different 
physiological and pathological roles. Physiologically, it is speculated that TNF-α is involved in 
cell survival, migration, and differentiation functions (Haider and Knöfler, 2009). In women 
with regular cycles, TNF-α is upregulated in the late luteal phase indicating that it might be 
involved in the shedding of the endometrium (Hunt et al., 1996). Clear discrimination between 
the physiological and pathological function of TNF-α has not yet been established; although, 
its concentration is assumed to be a determiner of its harmful or helpful role (Haider and 
Knöfler, 2009). TNF-α may affect both the endometrium and trophoblasts (Haider and Knöfler, 
2009) as activated macrophages produce TNF-α that might alter trophoblastic invasion by 
enhancing apoptosis (Renaud et al., 2005) or activation of the plasminogen activator inhibitor 
pathway (Huber et al., 2006). Inoue et al (1994) and a number of other researchers have tried 
to explain the role of inflammation and TNF-α on implantation through exploring its role in the 
decidualisation and production of dPRL which was found to be inhibited (Inoue et al., 1994). 
Additionally, the robust reactive superoxide inducer activity of this cytokine in leukocytes, 
which massively infiltrate the endometrium during decidualisation, has drawn attention to link 
its effect on implantation with exerting an OS environment (Agarwal et al., 2005a, Vassalli, 
1992). Sugino et al (2002) indicated that TNF-α induces SOD2 through protein kinase-C (PKC) 
mediated phosphorylation and involvement of nuclear factor-κB (NF- κB).  
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1.16.7. Platelet-derived growth factor (PDGF) 
PDGF was purified in the late 1970s as a platelet-derived component that enhanced the 
proliferation of mesenchymal cells (Heldin et al., 1979). Further studies showed that there were 
two PDGF genes, which encode two polypeptides – the PDGF A and B chains.  These produce 
AA, BB and AB proteins through homo and hetero-dimerisation of the A and B chains (Heldin 
et al., 1985) (Figure 1.5). In 2000 and 2001, two additional genes were identified that encode 
PDGF-CC (Tsai et al., 2000b) (Li et al., 2000) and PDGF-DD (Bergsten et al., 2001).  
The PDGF A- and B-chains are produced as prototype molecules that undergo proteolytic 
processing in the NH2 and COOH termini respectively (Ostman et al., 1991). PDGF expression 
increases due to different stimuli such as hypoxia (Kourembanas et al., 1997), thrombin (Harlan 
et al., 1986), pregnancy, cytokines and growth factors (Betsholtz, 1992), resulting in 
chemotaxis, cell growth, survival, and actin reorganisation (Heldin and Westermark, 1990, 
Xiong et al., 2019).  
1.17. PDGF receptors 
PDGFs exerts their action through two tyrosine kinase receptors, PDGFR-α (Matsui et al., 
1989) and PDGFR-β with molecular weights of  170 kDa and 180 kDa respectively (Yarden et 
al., 1986a). Ligand binding leads to receptor homo and heterodimerisation in αα, ββ, and αβ 
combinations. 
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Figure 1.5:  Receptor binding specificity of the PDGF isoforms. A diagram showing the binding 
of PDGF to their receptors as indicated by solid arrows. PDGFR-α binds PDGF-AA, BB, AB, and 
PDGF-CC. PDGFR-β can bind PDGF-BB and PDGF DD. The extracellular receptor region contains 
five immunoglobulin-like (Ig-like) domains. The ligands bind to the first three Ig-like domains. The 
intracellular region contains a tyrosine kinase domain. Dashed arrows indicated that the receptors 
may be activated. Adapted from Sadiq et al  (2016) 
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 PDGFR-α binds PDGF-AA, BB, AB (Heldin et al., 1988, Seifert et al., 1989) and PDGF-CC 
(Tallquist and Kazlauskas, 2004), while PDGFR-β binds PDGF-BB (Heldin et al., 1988) and 
PDGF-DD (Seifert et al., 1989, Tallquist and Kazlauskas, 2004). PDGFR-β has a higher 
binding affinity towards PDGF-BB (Heldin et al., 1988) (Figure 1.5). The extracellular region 
of the receptors contains five immunoglobulin-like (Ig-like) domains and ligands bind to the 
first three Ig-like domains.  
The fourth Ig-like domain is involved in direct receptor-receptor interactions and the 
intracellular region has a tyrosine kinase domain (Claesson-Welsh et al., 1989, Yarden et al., 
1986a). The difference in mitogen potency between the A and B isoforms may be explained in 
part by the relative receptor expression with the PDGFR-α less prevalent than the PDGFR-β in 
most cell types. This makes PDGF-BB and PDGF-AB more potent mitogens for fibroblasts 
than PDGF-AA (Schatteman et al., 1992). 
1.17.1. PDGFR signal transduction  
When the ligand binds the PDGFRs, they dimerise and transactivate the tyrosine kinase 
domains in the cytoplasm. A number of downstream cell signalling pathways are activated, 
including PI3K, MAPK and the Src tyrosine kinase family (Heldin and Westermark, 1999). 
1.17.2. The role of PDGF in decidualisation and embryo implantation 
PDGF is essential for embryonic development (Yarden et al., 1986b). It directly enhances 
epithelial-mesenchymal transformation (EMT) by lowering E-cadherin and increasing vimentin 
expression (Chen et al., 2017). PDGF plays an essential role in wound healing, promotes 
angiogenesis, tumour progression, and enhances ESC motility during decidualisation  
(Schwenke et al., 2013). PDGF-AA, PDGFR-α, and PDGFR-β mRNAs were expressed whilst 
PDGF-BB was absent in human (Österlund et al., 1996) and mouse blastocysts as identified by 
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reverse transcriptase polymerase chain reaction (RT-PCR) (Palmieri et al., 1992). In mouse 
embryos, Hellstrom et al (1999) identified high PDGF-BB and PDGFR-β expression in the 
sprouting artery endothelium and PDGF-BB knock-out mice die in the perinatal period due to 
cardiovascular and renal problems (Leveen et al., 1994). 
1.18. Endosialin (CD248)  
Endosialin (a.k.a. CD248, TEM1) is an 80.9 kDa cell surface glycoprotein (type 1). Although 
it was first described as a tumour-endothelial marker (Rettig et al., 1992, Croix et al., 2000), 
the endosialin expression is limited to perivascular cells, e.g. pericytes and smooth muscle cells 
in the vascular bed (Lax et al., 2007). Endosialin is mostly expressed during development and 
down-regulated in the adult (MacFadyen et al., 2007).  
Stromal fibroblasts are the predominant source of endosialin, which has been used as a selective 
marker for the isolation of fibroblast subsets (MacFadyen et al., 2005). Endosialin can stimulate 
mesenchymal cell proliferation through its enhancing PDGF signalling via PDGFR-β 
(Tomkowicz et al., 2010, Wilhelm et al., 2016). Endosialin knockout mice lack a proliferative 
response towards PDGF-BB (Wilhelm et al., 2016) and reduced growth, invasion and 
angiogenesis in human tumour xenografts (Tomkowicz et al., 2007).  
1.19. VEGF  
VEGF is a potent angiogenic factor that stimulates endothelial cell migration and proliferation 
and survival. It was initially identified as a vascular permeability factor secreted by tumours 
(Simons et al., 2016). VEGF undergoes alternative mRNA splicing at the C-terminal leading 
to the formation of different VEGF isoforms, which are recognised by having or lacking exons 
6, 7 and 8a/8b sequences with specific roles in haemostasis and vasculogenesis (Simons et al., 
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2016, Ali et al., 2019). In humans, there are five VEGF family members: VEGF-A (VEGF), -
B, -C, -D, and placenta growth factor (PlGF). VEGF ligands bind to three receptor tyrosine 
kinases: Flt-1 (VEGFR-1) (De Vries et al., 1992), KDR (VEGFR-2) (Terman et al., 1992) and 
Flt-4 (VEGFR-3) (see Figure 1.6). The receptors are composed of an extracellular region of 
seven immunoglobulin-like domains, a transmembrane region, and the intracellular region. 
Furthermore, the kinase domain area is broken by kinase-domain insert leading to a C-terminal 
sequence (Pechan et al., 2019). Despite the high binding affinity of VEGFR1 to VEGF, 
however, KDR mediates most of the VEGF biological activity in endothelial cells (Simons et 
al., 2016). Flt-1 is considered as the major VEGF receptor in placental trophoblasts, whereas 
KDR regulates the majority of VEGF-mediated activities in vascular endothelial cells (Li et al., 
2016) (Figure 1.6A & B). The third structurally related receptor is Flt-4 (VEGFR-3), which 
mediates the action of VEGF-C and VEGF-D in lymphatic and endothelial cells (Secker and 
Harvey, 2015). Additionally, VEGF  co-receptors (neuropilins) enhance the binding of VEGF 
to its receptors (Mercurio, 2019). Most of the VEGF isoforms and receptors are found in the 
endometrium. However, the prevailing isoforms are VEGF121 and VEGF165 (Smith, 1995). 
VEGF expression is markedly upregulated upon hypoxia (Goteri et al., 2009) as well as many 
growth factors and cytokines, including PDGF and TNF-α (Yoshino et al., 2006).  
Several authors have reported the upregulation of VEGF expression in the blastocyst (Kapiteijn 
et al., 2006) as well as human decidua as in  ESC (Matsui et al., 2004), macrophage, epithelial 
cells and trophoblasts (Cooper et al., 1995). It is speculated that VEGF has important roles in 
implantation. Firstly, by stimulating angiogenesis and spiral artery remodelling (Ancelin et al., 
2002). Secondly, by being an autocrine trophoblast mitogen as well as influencing their 
migratory and invasive potential (Yoshino et al., 2006).  
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Figure 1.6: VEGF signalling system. (A) The binding preference of different VEGF family 
members and their receptors. The VEGF family composed of seven ligands for different genes 
transcript; VEGF-A, -B, -C, -D, and -E, placenta growth factor (PIGF) -1 and -2. VEGF isoforms 
have certain binding affinities to the VEGF receptor (VEGFR) -1, VEGFR-2 and VEGFR-3 tyrosine 
kinase receptors as shown. In addition, co-receptors, which are neuropilin (NRP)-1 and NRP-2 that 
enhance the binding affinity of these ligands to their respective receptors. (B) Flt-1 and sFlt-1 protein 
structure illustration. sFlt-1 protein lacks the cytoplasmic and transmembrane domains. Adapted from  
Shibuya (2011). 
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Sharma et al (2016) reported that VEGF increases trophoblast invasion, whereas Lash et al 
(1999) reported a reduced trophoblast invasion and increased motility with VEGF treatment. It 
has been found by Krüssel et al (2003) that VEGF is one of the first active genes during the 
pre-implantation period. The paramount role of VEGF and its receptor in gestational vascular 
remodelling has been highlighted by the finding that single VEGF allelic deletion results in 
intrauterine death (Carmeliet et al., 1996). Fong et al (1995) found that VEGF receptor deletion 
leads to abnormal vasculature development. Additionally, Danastas et al (2019) have reported 
reduced VEGF and its receptor expression in the receptive phase in the ovarian hyper-
stimulated rat. Varas-Godoy et al (2019) found impaired angiogenic potential and reduced 
expression of VEGF in menstrual stem cells obtained from women with a history of pre-
eclampsia. Furthermore, Zhou et al (2010) found that VEGF circulating levels are low in 
women with pre-eclampsia with endothelial dysfunction. 
1.20. sFlt-1 
Alternative mRNA splicing of the Flt-1 gene generates sFlt-1, the soluble truncated form of the 
receptor (Kendall and Thomas, 1993, Kendall et al., 1996). sFlt-1 possesses only the 
extracellular region (first six Ig-like domains containing the ligand-binding domains) and lacks 
the transmembrane and intracellular domains (Figure 1.6B). Thereby, it is a freely soluble 
secreted form of the receptor (Kendall et al., 1996). sFlt-1 works as potent anti-angiogenic 
through the sequestration of free VEGF and antagonising PlGF (Kendall and Thomas, 1993). 
The placenta is the predominant source of gestational sFlt-1 as proved by the dramatic reduction 
in maternal circulatory levels following placenta delivery (Maynard et al., 2003). VEGF can 
increase alternative Flt-1 splicing and sFlt-1 release (Fan et al., 2014).  
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Four alternatively spliced variants have been identified which differ only in their C-terminal 
regions. Two main variants of sFlt-1 have been implicated in infertility complications and pre-
eclampsia: sFlt-i13 and sFlt-e15a (a.k.a sFlt-1 v2 or sFlt-1 14) sFlt-i13 is produced in the 
placenta, kidney, brain, heart, and endothelium (Palmer et al., 2015).  sFlt-e15 is a human and 
simian primate-specific variant that is the predominant sFlt-1 isoform expressed in the placenta 
(Jebbink et al., 2011, Thomas et al., 2009). Cottrell et al  (2017) have reported that increased 
sFlt-1 is negatively correlated with dPRL and VEGF expression in endometrial cells and sFlt-
1  appears to suppress trophoblast invasion in humans (McMahon et al., 2014).                                       
1.21. Antioxidants and reproduction 
In a normal physiological state, ROS and their scavenger antioxidants are in balance. However, 
imbalance occurs in the presence of excess ROS or depletion of antioxidants (Agarwal et al., 
2005b). OS is not only seen in pathological processes but has a normal physiological role in 
pregnancy (Myatt and Cui, 2004) and labour (Fainaru et al., 2002). ROS can exert their effects 
through their role in protein expression, DNA damage, and abnormal pathways in energy 
production (Ray et al., 2004).  
ROS are a group of small molecules formed as a by-product of molecular oxygen metabolism, 
e.g. the superoxide radical (O2), which forms within the respiratory chain in the mitochondria, 
hydroxyl radicals and hydrogen peroxide (H2O2) (Chen et al., 2010). Specific metallic ions, like 
iron (Fe2+/3+) and copper (Cu) may lead to extensive ROS generation. In contrast, chelators such 
as transferrin and ethylene diamine tetra-acetic acid (EDTA), can bind these cations and 
neutralise their effects (Halliwell and Gutteridge, 1990). Antioxidants are one of the basic 
defence mechanisms in aerobic life and can be enzymes such as superoxide dismutase (SOD), 
glutathione catalase, and other peroxidases (Sies, 1991, Budni et al., 2013) and heme 
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oxygenase-1 (HO-1). The non-enzymatic types include vitamins E, C, and resveratrol. 
Oxidative stress both male and female fertility through increased ROS production due to 
infection, defective antioxidant defence mechanisms,  toxin exposure (Sikka, 2001) and poor 
endometrial decidualisation (Gupta et al., 2010). This can lead to implantation failure, reduced 
placental invasion (Wu et al., 2016), spontaneous abortion, unexplained infertility, recurrent 
pregnancy loss (Gupta et al., 2007), endometriosis, preeclampsia, and polycystic ovarian 
syndrome (Murri et al., 2013). 
1.22. HO-1 
There are three heme oxygenase (HO) isoforms: HO-1, which is inducible and found mainly in 
the liver and spleen; HO-2, which is constitutively expressed and presents mainly in the testis 
and brain (Maines et al., 1986),  and HO-3 is the inactive form and can be found in the brain 
(Shaman et al., 2013). HO-1 was firstly characterised in 1968 by Tenhunen  (1969). It is a 
critical microsomal rate-limiting catalyst in the breakdown of heme to form carbon monoxide 
(CO), biliverdin, and free iron (Ghio et al., 2018). It is considered a protective mechanism in 
many diseases (Maines, 1997, McDaid et al., 2005) as HO-1 metabolites protect against 
hypoxia, cytotoxicity, inflammation, and other cellular stresses (Soares and Bach, 2009). 
Different factors that can induce HO-1 production include heme compounds, drugs such as 
cimetidine, chemical solvents such as bromobenzene, hormones as insulin and adrenaline, 
metals as Cobalt, bacterial toxins, oxidative stress, fever and heat shock, skin injury, alkylating 
agents, neoplasms, and partial hepatectomy (Maines, 1988), inflammatory cytokines, and 
ultraviolet radiation (Terry et al., 1999).  
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The critical role of HO-1 in cell function has been identified through the use of HO inhibitors. 
For instance, administration of HO-1 inhibitors to pregnant rats resulted in fetal resorption 
(Alexandreanu and Lawson, 2002). 
 1.21.1. The role of HO-1 in reproduction and pregnancy 
 In reproduction, HO-1 and its iron metabolism by-products are involved in the regulation of 
anti-inflammatory and anti-apoptotic mechanisms in the trophoblast and maintenance of the 
balance of oxidant-antioxidants in the placenta (Bainbridge and Smith, 2005). It was found that 
HO-1 increased the successful pregnancy outcomes by enhancing the function of regulatory T-
Cells (TReg) and keeping dendritic cells at an immature stage (Schumacher et al., 2012). HO-
1 might affect cytokine and chemokine production in trophoblasts and lymphocytes through the 
production of CO, and the alteration of this delicate balance can affect placental angiogenesis 
(Wong et al., 2012). Zhao et al (2008) showed that in heterozygote mice HO-1+/- had low weight 
offspring and low placental HO-1 RNA expression with a regular HO-1 placental activity and 
high expression of endothelial nitric oxide (NO) synthase (eNOS) and inducible NO synthase 
(iNOS). HO-1 induction shifts macrophage polarisation towards the anti-inflammatory M2 
subtypes and this gives HO-1 a potential immune-modulating therapeutic approach for different 
diseases (Naito et al., 2014). Many transcriptional pathways are involved in HO-1 upregulation, 
including the nuclear factor erythroid-2-related factor 2 (Nrf2)/Batch1 system (Naito et al., 
2014). The HO-1 immune modulating (Zenclussen et al., 2007) effect has been considered in 
respect of the assumption that shifting towards type-TH2 cytokine expression (IL4 and IL10) 
favours successful pregnancy (Piccinni et al., 2001) while shifting towards the TH1 type 
cytokines (IL-2, IL-6, TNF-α, and interferon-ƴ) favours an inflammatory state, immune 
rejection and miscarriage (Kwak-Kim et al., 2005). The over-expression of HO-1 in a pregnant 
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mouse model increased the percentage of successful pregnancy outcomes (Zenclussen et al., 
2006).   
Serum HO-1 measurements show a strong inverse correlation with both systolic and diastolic 
blood pressures in hypertensive mothers 24 h before delivery. Therefore, HO-1 is considered 
as a biomarker for pregnancy-induced hypertension (Anderson et al., 2018). Reduced HO-1 
levels lead to decreased CO levels and excess free heme, which binds to NO, leading to 
vasoconstriction – a prominent finding in preeclampsia (Hansson et al., 2015). 
Using HTR-8 cells, it has been demonstrated that HO-1 reduces the migration of trophoblastic 
cells due to the stimulation of peroxisome proliferator-activated receptor–gamma (PPAR-γ) 
system signalling (Bilban et al., 2009). CO inhalation can minimise the development of IUGR 
and results in situ uNK cell proliferation (Zenclussen et al., 2015) whilst excess free heme 
application can cause fetal death in mouse models. This could be similar to the effect of 
inhibition of HO-1 action in pregnancy (Zenclussen et al., 2011).  Uterine HO-1 mRNA 
expression was found to be higher in the estrus phase of the cycle where the P is highly 
expressed. Treatment of murine uterine cells with a combination of  E2 and P caused increased 
HO-1 expression (Zenclussen et al., 2014). Ahmed et al (2000) found that two hours heme pre-
treatment of the human villous explant tissue results in elevated HO-1 protein expression and 
reduced TNF-α toxicity, indicating a cyto-protective role of HO-1. Reduced HO-1 levels were 
detected with elevated levels of sFlt-1 and soluble endoglin in pre-eclamptic patient villous 
explants (Cudmore et al., 2007). Treatment with statins was found to increase levels of HO-1 
and reduce sFlt1 and soluble endoglin secretion which led to the suggestion that statins could 
be used in the treatment of preeclampsia (Cudmore et al., 2007). 
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1.23. Modelling of human embryo implantation 
A clear understanding of implantation failure and defective placental development is hindered 
by the limited availability of the human tissue and embryos for research purposes, as well as 
tight ethical constraints and the failure of animal models to fully recapitulate human 
implantation. Therefore, the use of cell lines provides an alternative approach to those working 
in this area. Cell lines offer the convenience of being able to be sub-cultured many times without 
changes in phenotype. However, cell immortalisation carries the risk of an abnormal karyotype 
and a loss of key characteristics of the primary parent cell leading to atypical function. Krikun 
et al. (2009) have partially solved this problem by introducing the human telomerase enzyme 
into primary hESC to produce an immortal stromal cell line (St-T1b) with a classical decidual 
response to progestational stimulants during in vitro work. Endometrial adenocarcinoma is the 
primary source for the majority of the epithelial cell lines used in embryo implantation e.g. 
HEC1 cells which are often used to represent a hostile endometrium as they have low adhesive 
potential and RL95-2 cells, which are used to represent the receptive endometrium in 
implantation model duo to their excellent adhesiveness. A range of immortalised trophoblasts 
has been used to represent the trophoblast. The HTR-8 trophoblast cell line (HTR-8/SVneo) 
was selected to simulate villus and EVT. The cells have matrix invading activity and express a 
range of different cytokine and growth factor receptors (Hannan et al., 2010), which makes 
them an appropriate choice for studying the role of the trophoblast in embryo implantation 
(Table 1.1 & Table 1.2). 
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Table 1.1: The expression of trophoblast subpopulation markers in human trophoblast cell lines. 
Adapted from Hannan et al (2010). 
 
General markersb KRT7 hCG CGR HLAG CD9 
Trophoblast subtypes, in vivo 
Trophectoderm + + +   
Villous cytotrophoblast + + + - - 
Syncytiotrophoblast + + + - - 
Cell column + +distal + - - 
Extra Villous Trophoblast + +c + + + 
Primary trophoblast in vitro + + + +d +d 
CELL LINES 
 
HTR-8/Svneo + + + +d  
AC1M-88 + +  + + 
AC1M-32 + +  + + 
JEG-3 + + + +  
JAR + +  _  
BeWo + +  ± + 
SGHPL-4 + +  + + 
a Presence or absence of selected phenotypic characteristics represented as follows: present (+) 
symbol; absent, (-); conflicting data, plus/minus (±). Blanks spaces represent the absence of data. 
bKRT7 = cytokeratin 7; hCG, human chorionic gonadotrophic hormone; CGR, human chorionic 
gonadotrophic hormone receptor; HLAG, human leucocyte antigen-G; CD9, cluster of differentiation 
antigen 9. c Hyper-glycosylated CG. d If grown on Matrigel. 
 
Table 1.2: Trophoblast cell line characteristics with respect to implantation/placentation. Adapted 
from Hannan et al (2010). 
 
Cell line Origin Function Phenotype 
HTR-8/Svneo First trimester villus explants Adhesion Migration 
Invasion Proliferation 
EVT, VT 
AC1M-88 Fusion of JEG-3 and term 
trophoblast 
Adhesion Migration EVT 
JEG-3 Choriocarcinoma explant Invasion EVT 
JAR Gestational Choriocarcinoma Invasion VT/EVT 
BeWo Choriocarcinoma Syncitialisation 
invasion 
EVT 
SGHPL-4 Primary extra-villus trophoblast Adhesion Migration 
Invasion Proliferation 
EVT 
EVT, extra villus trophoblast; VT, villus cytotrophoblast. 
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1.24. Aims and objectives  
The interaction between the trophoblast and endometrium requires coordinated cross-talk 
between an invasive competent blastocyst and a receptive endometrium. As it is not possible to 
study these interactions in women due to ethical constraints as well as practical difficulties, we 
aimed to develop robust and reproducible in vitro models based on cell lines that would allow 
the investigation of hESC decidualisation and growth factors on trophoblast activity. We 
hypothesised that PDGFs and HO-1 are regulated during hESC decidualisation, lead to changes 
in VEGF activity and affect trophoblast function. 
The specific objectives of this project were:   
1.  To establish three-dimensional in vitro models of implantation to investigate the role of the 
decidualised endometrium, growth factors, and cytokines on hESC interaction with the 
trophoblast.  
2.  To determine the effect of hESC decidualisation on trophoblast migration, spreading, and 
invasion.  
3. To investigate the impact of decidualisation of hESC on PDGF expression and activity on 
hESC and trophoblasts. 
4.  To determine whether decidualisation leads to changes in HO-1 expression in hESC and if 
these account for shift in VEGF activity that accompanies implantation. 
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2.1. Materials 
All chemicals and reagents are supplied from Sigma-Aldrich (Dorset, UK) unless stated 
otherwise.  
2.2. Cells and growth medium  
2.2.1. HTR-8/ SVneo cells  
HTR-8/ SVneo cells were derived from first trimester human trophoblasts immortalised by 
transduction with SV40 large T antigen and kindly provided by Dr Charles Graham 
(Sunnybrook Health Science Centre, Toronto, Ontario, Canada) (Graham et al., 1993). Cells 
were maintained in Roswell Park Memorial Institute 1640 (RPMI-1640) medium (Gibco – 
Fischer Scientific, Wilmington, UK) containing 5% (v/v) fetal bovine serum (FBS) with 200 
M L-glutamine (Weber et al., 2013, Graham et al., 1993). 
2.2.2. The human endometrial St-T1b stromal cell line 
St-T1b cell line was a kind gift from Dr Birgit Gellersen, Endokrinologikum Hamburg (B.G.) 
Hamburg, Germany. St-T1b cells were immortalised by retroviral transduction of human 
telomerase reverse transcriptase (hTERT) under the control of the SV40 promoter (Samalecos 
et al., 2009b). St-T1b cells were cultured in phenol red-free Dulbecco’s modified Eagle medium 
(DMEM/Ham F12) (Gibco, Paisley, UK) and supplemented with 10% (v/v) FBS, 100 U/ml 
Penicillin, 100 µg/ml Streptomycin (Pen/Strep), 1 µg/ml insulin (Invitrogen), and 1 nM E2 
(Inoue et al., 1994). This medium will be called E2 medium in the project. 
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2.2.3. Primary human endometrial stromal cells (hESC) 
Endometrial tissue was obtained under informed consent from premenopausal women 
undergoing routine biopsy procedures at the Birmingham Women’s Hospital in accordance 
with the University of Birmingham Biobank ethical approval (10-014).  Primary hESC were 
isolated based on the modification of previous methods (Zhang et al., 1995; Chen and Roan, 
2015) and kindly provided by Dr Ling Ting. The primary hESC were maintained in the growth 
medium used for St-T1b Cells. Primary cells in the experiments were not used beyond 15 
passages to avoid phenotypic changes. 
2.2.4. The human dermal microvascular endothelial cell line (HMEC-1) 
The HMEC-1 cell line was purchased from ATCC (CRL-3243). These cells were immortalised 
through the retroviral mediated integration of the SV40 large T-antigen (Ades et al., 1992). The 
cells were maintained in MCDB131 containing 10% FBS (V/V) and Penicillin /Streptomycin  
2.2.5. Human umbilical vein endothelial cells (HUVEC)  
HUVEC were purchased from Promo Cell as donor pools. They were grown on flasks coated 
with 0.2% (w/v) gelatin in PBS for 20-30 min and maintained in endothelial growth medium-2 
(EGM-2) (Promo Cell, Heidelberg, Germany).  
2.3. Maintenance of cell growth 
All cells were cultured under sterile conditions using a class II biological safety cabinet (type 
A2) (Holten laminar air). Cells were cultured at 37oC in a humidified atmosphere with 5% 
carbon dioxide (CO2) incubator. The culture medium was replaced with fresh medium every 2-
3 days. Once cells had reached 80% - 90% confluence, the medium was aspirated, and they 
were washed with calcium and magnesium-free Dulbecco’s modified phosphate-buffered saline 
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(PBS), and ~1ml of 0.25% -Trypsin-/1 mM EDTA (Gibco) added for 1-2 min at 37oC. Fresh 
growth medium was added as required for seeding the cells into tissue culture flasks. All cell 
types were passaged at a ratio of 1:3 except HTR-8, which was 1:10.  
2.4. Cryopreservation of cells  
The cells were washed with PBS and detached with a trypsin-EDTA solution as described above 
and centrifuged at 200 x g for 5 min. The cell pellet was resuspended in 10% (v/v) dimethyl 
sulphoxide (DMSO) in their respective complete growth medium. The cells in ~1.5 ml of 
medium was dispensed into cryovials and frozen down to -80oC in a Mr Frosty overnight. For 
long-term storage, the cells were transferred to liquid nitrogen. When required, frozen cells 
were thawed rapidly in a 37oC water bath and added to ~10 ml of fresh medium and spun at 
200g for 5 min. The pellet was resuspended in a fresh complete growth medium in a T-75 flask. 
2.5. Mycoplasma test  
To ensure the absence of Mycoplasma contamination, which would adversely affect the results, 
the cells were checked by EZ-PCR Mycoplasma test kit following the manufacturer's protocol. 
Briefly, the cells were grown over 72 h and the supernatant collected. The supernatant was 
centrifuged at 16,000g to precipitate mycoplasma. A 50 µl of buffer was added to the pellet 
followed by heating to 95oC for three minutes. PCR was performed according to the 
manufacturer's conditions, and the products separated on 2% agarose gels. The cycling 
conditions were as follows: denaturation 30 sec, 94oC, followed by 35 cycles of amplification, 
30 sec at 94oC, annealing for 2 min at 60oC, and 60 sec at 72oC. 
Chapter 2 – Materials and methods 
54 
 
2.6. Decidualisation of hESC 
The St-T1b cells and primary hESC were grown to confluence in 6-well plates at a seeding 
density of 3x105 cell/well. In order to induce differentiation, the cells were stimulated in 
decidualisation medium consisting of DMEM/Ham F12 (with HEPES) supplemented with 2% 
(v/v) charcoal-stripped FBS (Biosera, C/O Labtech International Ltd,/UK), 100 U/ml penicillin 
and 100 µg/ml streptomycin, 1 µM medroxyprogesterone (MPA), and 0.5 mM 8-
Bromoadenosine 3',5'-cyclic adenosine monophosphate  (8-Br-cAMP) (Enzo Life Sciences, 
Exeter, UK). This medium is subsequently referred to as MPC medium throughout this thesis. 
The medium was replaced every 48 or 72 h and 24 h prior to harvesting the culture supernatants 
and cells (Figure 2.1). Morphological changes following stimulation of the cells were observed 
using 10x objective of a phase-contrast microscope (Evos XL, Fischer Scientific).  
2.7. Phalloidin staining  
To show changes in the actin cytoskeleton of decidualisation in hESC, the cells were stained 
with Phalloidin-iFluor 488 (Abcam, Cambridge, UK) and counterstained with Hoechst 33342 
(AAT Bioquest, Sunnyvale, UK). The cells were plated at 6x105 cells/well in E2 medium in 8-
well culture slides. After 24 h, the cells were stimulated to decidualise. The cells were washed 
with PBS and fixed with 3.7% formaldehyde for 30 min. Each well was washed twice with 
PBS, and the cells permeabilised with 0.1% Triton-X100 in PBS for 3 min. The cells were 
washed with PBS and stained with 100 µl of 1x Phalloidin-iFluor 488. The dye was prepared 
by mixing 1 µl of the Phalloidin conjugate stock solution in 1 ml of PBS + 1% (w/v) bovine 
serum albumin (BSA) with Hoechst stain (5 µg/ml) for 30 min in the dark in a fume hood. The 
cells were washed and immediately mounted using a drop of mounting medium (Invitrogen), 
and a coverslip applied.  
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Figure 2.1: Decidualisation of St-T1b cells. A diagram illustrating the stimulation of hESC with 
MPA (1 µM) and 8-Br-cAMP (0.5 mM) on day 0, 3, and 6. At time points 4 and 7 days, supernatant, 
RNA, and protein were collected. 
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The cells were examined using the 10 x objective of a microscope (Olympus, Tokyo, Japan) 
equipped with epifluorescence at 493/517 nm for Phalloidin, and ultraviolet fluorescence 
(545/546 nm) for Hoechst staining.  
2.8. Collection of cell lysate for RNA purification 
hESC lysates for each sample/condition were harvested and pooled from three wells of a 6-
well plate. The medium was aspirated, followed by a wash with 1 ml of PBS before175 µl of 
cell lysis buffer was added to each well. The plate was gently swirled to lyse the cells and the 
lysate harvested within 5 min. Total RNA was purified immediately, or the cell lysate stored 
at -20oC, or -80oC for future purification. 
2.9. Total RNA purification 
Total RNA extraction was performed using the Norgen total RNA plus kit according to the 
manufacturer’s instructions (Norgen Biotek Corp., Thorold, Canada). Cell lysates were first 
passed through genomic DNA removal spin columns and spun at 14,000g. The flow-through 
was retained and molecular grade ethanol added (60 µl ethanol/100 µl of flow-through) and 
passed through RNA purification spin columns. The column was washed three times with the 
wash solution. The RNA was eluted from the column by adding 50 µl of elution buffer and 
spinning at 200g for 2 min, followed by 1 min at 14000g at 4oC. Immediately, purified RNA 
was chilled on ice to prevent degradation and then stored at -80oC  
2.10. Reverse transcription  
A Tetro cDNA Synthesis Kit (Bioline, London, UK) was used to prepare single-stranded 
complementary DNA (cDNA) from 1-2 µg of total RNA according to the manufacturer's 
instructions. The RNA concentration was measured with a NanoDrop spectrophotometer 
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(Labtech, East Sussex, UK). The same amount of RNA was added for a given set of samples. 
A Master mix was prepared as described in Table 2.1. 
Table 2.1: Master Mix components used in reverse 
transcription reactions. 
Reagent 
Amount for one 
sample (µl) 
Primer: oligo (dt) 18 1 
10 mM dNTP mix 1 
5 x RT buffer 4 
Ribosafe RNase inhibitor (10 U/l) 1 
Tetro Reverse Transcriptase (200 
U/l) 
1 
 
A total volume of 20 µl was placed in each sample tube. This comprised 1-2 µg of total RNA 
in a total volume of 12 µl molecular grade and 8 µl of master mix. The amplification conditions 
were as followings; 42oC for 30 min, 50oC for 30 min, and 55oC for 30 min. The resulting 
cDNA samples were stored at -20oC. 
2.11. Reverse transcription-polymerase chain reaction (RT-PCR) 
The RT-PCR involved the preparation of reagents and primer master mix followed by running 
the prepared sample with the master mix on an agarose gel as follows; A master mix was 
prepared as follows: 0.3 µl of 100 mM dNTP mix, 4.0 µl of 5x reaction buffer, 12.1 µl of 
molecular grade water H2O, 2.0 µl of 50 mM MgCl2 solution, 0.1 µl of primers, and 0.3 µl 
Mango Taq DNA polymerase (5U/ µl) (Bioline). Sample amplification was performed in a 
SensoQuest lab thermal cycler machine (SensoQuest, Gottingen, Germany) according to the 
specific cycling conditions of each primer (see Table 2.2 and Table 2.3). 
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Table 2.2: Standard temperature and timing of each stage of RT-PCR run in a thermal cycler.  
 
Stage Temperature (0C) Time   
 
 
 
 
         Cycle number is target dependent 
Denaturation  95 5 min 
Denaturation  95 30 sec 
Annealing According to primer 30 sec 
Polymerisation  72 30 sec 
Polymerisation  72 10 min 
 
 
 
 
Table 2.3: Oligonucleotide primer sequences, amplicon sizes, and cycling conditions used for RT-
PCR. 
Gene 
Cycling 
conditions 
Amplicon 
size (bp) 
Oligonucleotide sequence Reference 
dPRL 
25 -30 cycles  
94°C, 45 sec; 
57°C, 45 sec; 
72°C, 45 sec. 
416 
 
5’-
GAGACACCAAGAAGAATCGGAACATACA
GG-3’ 
5’-TCGGGGGTGGCAAGGGAAGAA-3’ 
(Samalecos 
et al., 
2009a) 
GAPDH 
35 cycles : 
95°C, 30 sec; 
65°C, 30 sec; 
72°C, 30 sec;  
159 
 
5’-CAATGACCCCTTCATTAGCC-3’ 
5’-TTGATTTTGGAGGGATCTCG-3’ 
In house  
IGFPB-1 
25 cycles 
95°C, 30 sec; 
63°C, 30 sec; 
72°C, 90 sec.  
378 
5’-TGCTGCAGAGGCAGGGAGCCC-3’ 
5’-AAGGATCCTCTTCCCATTCCA-3’ 
(Samalecos 
et al., 
2009a) 
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2.11.1. Agarose gel electrophoresis 
Agarose gel electrophoresis was employed to separate PCR products by size. The gel 
percentage used varied from 1%, in the case of dPRL and IGFPB-1, to 2% for GAPDH. Gels 
were prepared using the molecular biology grade agarose powder (Bioline) in 1 x Tris-Acetate 
EDTA (TAE;1 mM EDTA, 20 mM acetic acid, and 40 mM Tris) buffer by heating in a 
microwave oven until dissolved. The gel was cooled to around 50oC, then 5 µl/100 ml of Midori 
green safe DNA stain (Geneflow, Staffordshire, UK) was added. The gels poured in appropriate 
casting trays and allowed to cool. The gels were immersed in 1x TAE buffer. Samples of ~15 
µl/well were then loaded along with 10 µl of the Hyperladder 100 base pair (bp) gel DNA 
marker (Bioline). A DNA separation was performed over 30-40 min at 80-120 V. The gels were 
imaged using a Gene Genius Bio-Imaging system with Genesnap analysis software (Synagen, 
Cambridge, UK).  
2.12. Quantitative real-time PCR (qPCR) 
The qPCR was performed to quantify the expression of genes of interest using the SensiMix 
SYBR Kit (Bioline). cDNAs (Section 2. 10) were diluted within molecular grade H2O 1:3. Each 
reaction mix contained 7.5 µl from 2x SensiMix, 1 µl of diluted, 0.1 µl primer of primer mix 
(each primer at 50 pmol/µl) made up to a total volume of 15 µl with molecular grade water. β-
actin was used as a housekeeping gene. Samples were amplified using a Rotor-gene Q (Qiagen) 
cycler. The relative target gene expression was calculated by the normalisation of the expression 
in comparison to the β-actin endogenous control using the ΔΔCT method (ΔΔCT = ΔCT sample 
- ΔCT housekeeping gene) (Mane et al., 2008, Pfaffl et al., 2004). The sequences of primers 
used in qPCR and the assay conditions are shown in Table 2.4. 
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Table 2.4: The forward and reverse primer sequences, annealing temperatures and references for genes 
involved in qPCR. 
 
Primer Forward sequence (5’ – 3’) Reverse sequence (5’ – 3’) 
o
C Reference 
Β-actin 
TCACCCACACTGTGCCC
ATCTACGA 
CAGCGGAACCGCTCATTG
CCAATGG 
58 (Mälarstig et al., 2003) 
Endosialin 
ACCTCGGAGATGAGTTG 
CTG 
TTCCAGGCCTCGTCTTCA 58 (Wilhelm et al., 2016) 
hFOXO1 
TTGAATTCACCCAGCCC
AAACT 
GCTACCCCAGGATCAACT
GGTG 
58 (Tanaka et al., 2009) 
IRF4 
ACCCGGAAATCCCGTAC
CA 
GGCAACCATTTTCACAAG
CTG 
58 (Vasquez et al., 2015) 
KAI1 
CGGCACAAGCAGATGG
ACAGG 
CGGCAACAGGACCCAGA
GTG 
62 (Zhang et al., 2014) 
LTBR 
AGATGAAGTTGGGAAG
GGTAACA  
GCAGTGGCTCTAATGGAT
TTTTG 
57 (Rajput et al., 2013) 
OGG1 
GTGGACTCCCACTTCCA
AGA 
GAGATGAGCCTCCACCTC
TG 
56 (Radak et al., 2011) 
PDGF-A 
TACTGAATTTCGCCGCC
ACA 
CCAAAGAATCCTCACTCC
CTACG 
57 (Juliachs et al., 2014) 
PDGF-B 
TGTGCGGAAGAAGCCA
ATCT 
AATAACCCTGCCCACACA
CTC 
57 (Juliachs et al., 2014) 
PDGFR-α 
AGTTCCTTCATCCATTCT
GGACT 
CCGTCTGTCCCCCAGTT  (Juliachs et al., 2014) 
PDGFR-β 
CATCACCGTGGTTGAGA
GC 
AATTGTAGTGTGCCCACC
TCTC 
 (Juliachs et al., 2014) 
PLZF 
TAGGGTGCACACAGGTG
AGA  
GTGCAGATGGTGCACTGG
TA 
58 
(Kommagani et al., 
2016) 
sFlt-1- 15e 
CTCCTGCGAAACCTCAG
TG- 
GACGATGGTGACGTTGAT
GT 
54 
(Whitehead et al., 
2011) 
sFlt-i13 
ACAATCAGAGGTGAGC
ACTGCAA 
TCCGAGCCTGAAAGTTAG
CAA 
56 
(Whitehead et al., 
2011) 
Flt-1 
 
TGGCAGCGAGAAACATT
CTTTTATC 
CAGCAATACTCCGTAAGA
CCACAC 
58 In house 
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SOD2 
TCAGCGGTAGCACCAGC
ACT  
ATCTGCGCGTTGATGTGA
GG  
64 (Araujo et al., 2011) 
 
2.13. Assessing PCR primer efficacy  
The efficacy of each qPCR primer set was tested before performing PCR. Primers were either 
designed using Primer BLAST (https://www.ncbi.nlm.nih.gov/tools/primer-blast/) or selected 
from publications and analysed using this programme to check for specificity, complementarity, 
and annealing temperature. After performing qPCR, melt curves were checked and the products 
separated on agarose gels to confirm the correct product/amplicon size. The efficiency of the 
primers was checked using a standard generated with ten-fold dilution series of the PCR product 
from 1:100 to 1:100,000,000 dilution.  
2.14. In vitro cell migration assays 
 Scratch-wound cell migration assays based on the methods of Jovanović and Vićovac ( 2009), 
were performed with hESC (both primary and St-T1b cells) and HTR-8 to determine their 
migratory activity. The cells were passaged using Trypsin/EDTA and plated in 6-well plates at 
a seeding density of 3x105 cells/well for primary hESC and 2.8x105 cells/well for St-T1b cells. 
Control proliferative cells were seeded at the same density in a separate plate and maintained 
in a complete hESC growth medium. The next day scratches were made in the confluent cell 
monolayers using 100 µl pipette tips. The cells were washed twice with complete PBS to 
remove any cell debris and to ensure smooth wound edges (Liang et al., 2007). DMEM/Ham 
F12 medium supplemented with 1% FBS (v/v) (2 ml/well) was then added. 
 Images were assigned at ten reference points (Figure 2.2) along with the scratch initially at 
time zero and after 18 h incubation using the 10 x objective of an EVOS XL inverted-phase 
microscope (Fisher Scientific, Loughborough, UK) or 4 x objective (Olympus, Tokyo, Japan). 
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 The degree of migration was determined based on the percentage of the scratch area remaining:  
% of migration = [(initial scratch area – scratch area at 18 h) / initial scratch area)]*100.The 
scratch-wounded areas were determined using the ImageJ Trainable-Weka segmentation 
plugin. The results calculated using the Voxel counter plugin, which is applying to count the 
pixels of an image stack (Arganda-Carreras et al., 2017). Essentially, the same procedure was 
performed using HTR-8 cells. HTR-8 cells were plated at 3x105 cells/well in the complete 
HTR-8 growth medium, which was replaced with 2 ml of DMEM/Ham F12 medium 
supplemented with 1% FBS following scratch-wounding the cell monolayer. 
2.15. Trophoblast spheroid production 
HTR-8 cells were used to generate trophoblast spheroids according to the method of Korff and 
Augustin (Korff and Augustin, 1998). A 0.25% (w/v) stock of methylcellulose solution was 
produced by dissolving 3 g of autoclaved methylcellulose (4000 centipoise (cP)) in 125 ml of 
pre-heated RPMI-1640 at 60oC for 20 min on a magnetic stirrer. A further 125 ml of RPMI-
1640 was added and the solution kept on a magnetic stirrer overnight at 4°C in a cold room. 
The solution was then centrifuged at 2500g for 4 h and the supernatant removed and stored at 
4°C.  Spheroids were formed in 96-well non-adherent round bottom plates (Sarstedt, Newton, 
USA) using either 3000 or 750 cells/well (Korff et al., 2004).  
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Figure 2.2: The in vitro scratch-wound assay plate template. Confluent monolayers of 
cells were scratched wounded according to reference template points using 100 µl pipette 
tips. 
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2.16. Spheroid expansion assay 
Spheroid expansion assays were performed based on the method of  Gonzalez et al (Gonzalez 
et al., 2011) with modifications. HTR-8 trophoblast cells were used to prepare 3000 cell 
spheroids using the methylcellulose method (Korff and Augustin, 1998). After 24 h, the 
spheroids were harvested using a 100 µl pipette and collected in a petri dish containing 2 ml of 
fresh medium. The spheroids were labelled with 10 µM Vybrant green Carboxyfluorescein 
diacetate succinimidyl ester (CFDA-SE) cell tracer dye (Invitrogen) in PBS for 15 min at 37oC 
and 5% CO2 in a humidified incubator. Decidualised or proliferative stromal cells were seeded 
at a density of 9x104 cells/well in a 24-well plate. Once confluent, hESC were labelled with 10 
µM Syto64 dye (Invitrogen) for 2 h in 0.5 ml of DMEM/Ham F12 containing 1% FBS. Three 
spheroids were then added to each well. Ten spheroids per treatment were monitored. 
Fluorescent and brightfield images captured at 0, 48 and 72 h time points using the 4x objective. 
The total area occupied by the HTR-8 cells from each spheroid was measured using ImageJ 
software at 0 h, 24 h and 48 h.  
2.17. Spheroid invasion assay 
Trophoblast spheroid invasion assays were performed essentially as described by Gellersen et 
al (2010). HTR-8 cells were used to generate trophoblast spheroids as described above (Section 
2.15), with each spheroid consisting of ~750 cells (Korff et al., 2004). After 24 h, the spheroids 
were harvested using a 100 µl pipette and collected in a Petri dish containing 2 ml of a fresh 
medium. The spheroids were labelled with 10 µM Vybrant green CFDA SE cell tracer dye 
(Invitrogen) in PBS for 15 min at 37oC and 5% CO2 in a humidified incubator. A further 
washing step was then carried out in a separate Petri dish.  
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A 24-well plate was seeded with St-T1b cells that when confluent was stimulated to decidualise 
or maintained in a proliferative state.  To each well, fibrinogen (3 mg/ml) in DMEM/Ham F12 
medium was mixed with thrombin (4 U/ml). 200 µl/well added immediately either to overlay 
the cell monolayers or to empty wells of a 24-well plate and incubated at 37oC CO2 incubator 
for 15 min to allow the gel to set. This basal layer prevented spheroids from attaching directly 
to the bottom of the well. The spheroids (3-4/well) were then added in 300 µl of fibrinogen 
solution to each well. Thrombin (4 U/ml) was added and the plate gently rocked to allow even 
distribution of spheroids in the gel as it set. The plate was incubated at 37oC in a 5% CO2 
incubator for 30 min to ensure uniform gel setting. Finally, 0.5 ml DMEM/Ham F12 medium 
containing 1% FBS and any treatment was added, and the plate incubated overnight at 37oC. 
The next day, 3 mg/ml /well of Tranexamic acid was added to prevent gel degradation by 
proteolytic enzymes. Fluorescence imaging was performed at 490/20 nm wavelength (4 x 
magnification) at 48 h and 72 h. 
2.18. Image analysis 
Computer-Based image analysis was performed using ImageJ software on images captured for 
the migration, expansion and sprouting assays. Initially, the acquired images for each 
experimental condition were loaded individually into ImageJ then grouped into a single image 
stack. The acquisition noise was eliminated with a median filter. The image contrast was 
enhanced to achieve maximum discrimination between image background and foreground. An 
automatic image segmentation process was applied to identify scratch (Appendix 1), expansion 
(Appendix 2), and spheroid core (Appendix 3) using the Trainable Weka plugin (Jaccard et al., 
2017) as shown in Figure 2.3. The plugin is primarily designed to segment objects into different 
colours. An automatic threshold was then applied to produce binary images with a black 
background and white foreground for quantification.  
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Figure 2.3: Image analysis of migration, expansion, and sprouting assays using ImageJ. The 
original images were segmented using the Trainable Weka segmentation plugin then binarised to 
calculate scratch, expansion, and sprout white areas. Scale bars = 400 µm for migration images, 
and 250 µm for expansion and sprouting images. 
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The degree of spheroid sprouting was analysed on captured images. The core was subtracted 
from the original image leaving only the spheroid sprouts. This novel approach readily 
facilitated the measurement of spheroid sprouting densities. The longest sprout in each spheroid 
quadrant was measured with an ImageJ vertical scale according to the previously established 
protocol used by Korff and Augustin (1999). An automatic threshold was then applied to 
quantify the whole sprout density (Figure 2.3). 
2.19. MTT assay 
The MTT (3-(4, 5-dimethylthiazol-2-y1) 2, 5-diphenyl tetrazolium bromide) assay was 
performed based on the method of Wan et al  (1994). Briefly, St-T1b and HTR-8 cells were 
seeded at 3x104 cells/well in a 96-well plate in 100 µl of complete growth medium and 
incubated overnight (Yu et al., 2017). After 24 h, the test treatments were applied in 
DMEM/Ham F12 containing 1% (v/v) FBS in triplicate and the plate incubated for 72 h. The 
MTT solution (~10 µg/well) was added for 4 h (Table 2.5). The precipitated MTT was then 
dissolved in 150 µl/well of MTT solvent for 2 h at room temperature with mild agitation in the 
dark.  
Table 2.5: Solutions used in the MTT test 
Reagent Components 
MTT solution 
1x PBS 
5 mg/ml MTT (w/v) 
MTT solvent 
4 mM HCl, 10% (v/v) Nondet P-40 (NP40) in 
Isopropanol 
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The absorbance at 570 nm and background at 670 nm was measured using a microplate reader 
(VersaMaxtm ELISA, Molecular Devices, California, USA). Following the subtraction of the 
background at 670 nm, cell viability was calculated as a percentage of the untreated controls, 
which were set as 100%. 
2.20. Collection of whole cell protein lysate 
Cells were plated according to the required experimental protocol into 6-well plates. Three 
wells were used per treatment condition. The wells were washed with cold PBS, then with cold 
Radioimmunoprecipitation Assay (RIPA) lysis buffer (Pierce-Thermo scientific, 
Leicestershire, UK) containing Roche mini EDTA-free protease inhibitor cocktail (1 tablet per 
10 ml) (Roche, Mannheim, Germany). The amount of RIPA buffer was determined according 
to the cell count with 125µl/well was routinely used. The plate was kept on ice for 3 min before 
protein lysates were collected using a cell scraper and incubated on ice for 15 min. The clearing 
of insoluble cellular debris was performed by centrifugation at 14000 g at 4oC for 10-15 min. 
The supernatant was collected carefully and decanted into new Eppendorf tubes and stored at -
20oC or -80oC. 
2.21. Measurement of protein concentration  
The Bicinchoninic acid (BCA) kit was used to measure protein concentration. This assay 
estimates the reduction of Cu+2 into Cu+1 ion (Smith, 1989). The number of ions liberated is 
proportional to the protein concentration through the formation of a stable purple product, 
which allows the calculation of protein concentration depending on the absorbance at 562 nm 
in a spectrophotometric plate reader.  
Protein samples were diluted with PBS at 1:1, 1:2, and 1:4 ratios in order to ensure that at least 
one would fall within the range of the standard curve. BSA protein standards were set up in 
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PBS at the following concentrations: 1000, 800, 600, 400, 200, and 0 µg/ml. 10 µl of each 
standard and samples were added in triplicate to a flat-bottomed 96-well plate. 200 µl of BCA 
solution consisting of reagent A and reagent B mixed in a 1:50 ratio, was added to each well. 
The plate was incubated in the dark at 37oC for 30 min, followed by measurement of the 
absorbance at 562 nm using a spectrophotometric plate reader. The average concentration of 
each protein sample was calculated from a standard curve following the subtraction of the 
background.   
2.22. Preparation of protein samples for sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE) 
Following protein concentration measurement, the volume of protein sample required for a total 
of 20 µg was calculated and the total volume adjusted to 15 µl with RIPA buffer. The protein 
samples separated under reducing conditions; therefore 9% (v/v) of 2-mercaptoethanol was 
added to the 4 x loading buffer (Invitrogen). Loading buffer 5 µl (4x) was added to 15 µl of 
each protein sample and heated to 95-100oC for 5 min. On cooling to room temperature, 
samples were centrifuged at 12,000g for 5 min to remove any precipitated material. 
2.22.1. Preparation of SDS-PAGE gel 
SDS-PAGE gels were cast using 1 mm thickness disposable gel cassettes (Novex-life 
technologies, Nupage, Fischer Scientific, Loughborough, UK). Ten to 15% SDS-PAGE was 
used to separate protein samples depending on the molecular weight of the protein of interest. 
The recipe for the preparation of buffer solutions used to prepare SDS-PAGE gels is shown in 
Table 2.6.  
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Table 2.6: The recipes for SDS gel preparation. 
 
Buffer Contents 
10%-15% Resolving 
SDS gel 
0.1% (v/v) SDS 
375 mM Tris pH 8.8 
10%-15% (w/v) acrylamide; 0.26% (w/v) bis-acrylamide 
0.1% (v/v) Tetramethyl ethylenediamine (TEMED) 
0.1% (w/v) ammonium persulphate (APS) 
Stacking SDS gel 
0.1%(v/v) SDS 
125 mM Tris; pH 6.8 
5% (w/v) acrylamide; 0.13% (w/v) bis-acrylamide 
0.1% (v/v) TEMED 
0.1% (w/v) (APS) 
 
The resolving gel was poured into the gel cassette to about ¾ full. Immediately, butanol or 
isopropanol was dropped on the upper margin of the poured gel to achieve a smooth upper edge 
and to prevent further gel oxygenation, which could interfere with polymerisation. Once the 
resolving gel had set, the stacking gel was poured, and an appropriate comb inserted. 
2.22.2. Separation of protein by molecular weight 
Prior to assembling the cassette in the electrophoresis tank (Geneflow), the inserted comb was 
removed gently and 1x running buffer (prepared from commercially available 10 x 
Tris/Glycine/SDS, Geneflow) poured to cover the wells of the gel cassette. Then, 5 µl of protein 
marker was added to a well (CSL-BBL pre-stained protein ladder, Geneflow), while the protein 
sample was loaded as 15 µl/well into the stacking gel. The gel then runs at 100 mV for 45- 60 
min or until the bromophenol blue dye had arrived at the bottom of the gel to ensure a good 
protein separation. 
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2.22.3. Transfer of protein from SDS-PAGE gel to PVDF membrane 
The separated proteins were transferred to the polyvinylidene difluoride (PVDF) membrane 
(Merck-Millipore, Darmstadt, Germany) using a wet gel transfer apparatus (Geneflow) as 
follows: The PVDF membrane was activated with methanol for 30 sec, washed with ultrapure 
water (3 min), then equilibrated with 1x transfer buffer for 5 min (Table 2.7). 
Table 2.7: Buffer solutions used in the protein transfer to PVDF membrane. 
Transfer solution Components 
10 x Western blot 
transfer buffer 
142.60 g/l of 190 mM glycine, 30.31 g/l of 25 mM tris base, 
made up to 1 L in ultrapure water 
1x Western blot 
transfer buffer 
100 ml 10 x transfer buffer, 200 ml methanol, 700 ml ddH2O 
 
The stacking gel was removed from the resolving gel. A transfer module was prepared from 
sequential layers, including; sponges and filter paper pre-soaked in transfer buffer, SDS-gel, 
and PVDF membrane assembled closest to the positive plate of the module and another layer 
of pre-soaked sponge and filter paper. Protein transfer performed at constant voltage (100 V) 
for 2 h at 4oC. Successful protein transfer was determined by soaking the membrane briefly in 
0.1% Ponceau stain. 
2.22.4. Western Blotting 
To prevent non-specific protein binding, the membrane was blocked with 20% (w/v) skimmed 
milk powder (Marvel) in PBS and 0.1% Tween-20 (PBS-T) for 2 h at room temperature with 
gentle agitation. The membrane was washed three times (10 min each) with 1 x PBS-T with 
mild agitation followed by incubation with the appropriate dilution of the primary antibody in 
5% BSA and 0.02% sodium azide in PBS-T at 4oC overnight (Table 2.8). The membrane was 
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washed three times in PBS-T and then incubated with horseradish peroxidase (HRP)-
conjugated secondary antibody (Table 2.9) in 5% (w/v) skimmed milk in PBS-T for 1h at room 
temperature. The membrane was washed three times in PBST and blotted to remove the excess 
buffer and soaked in enhanced chemiluminescence (ECL) Western blotting detection solution 
(Biological Industries, Beit Haemek, Israel) for 1 min. Excess ECL was removed by touching 
the edge of the membrane onto a dry tissue paper prior to wrapping with SaranWrap. An 
exposure to ECL film (Amersham Hyper film ECL, Fisher-scientific) was performed in the 
dark room at various exposure times, starting at 30 sec to develop the chemiluminescent signal. 
When required, the membrane was stripped in a mild stripping buffer to remove the bound 
antibody and re-probed with a different antibody (Table 2.10). 
Table 2.8: Primary antibodies used.  
Antibody Manufacturer and catalogue 
number 
Species raised 
in 
dilution 
HO-1 monoclonal Abcam (ab13324)  
Cell Signaling Technology (5853) 
Rabbit 1:3000 
PDGF-AA monoclonal Santa Cruz Biotech. (sc-9974) Mouse 1:500 
PDGF-BB monoclonal Santa Cruz Biotech. (sc-365805) Mouse 1:1000 
PDGFR- monoclonal Santa Cruz Biotech. (sc-398206) Mouse 1:500 
PDGFR-B monoclonal  Santa Cruz Biotech. (sc-374573) Mouse 1:500 
FOXO1 monoclonal Cell Signaling Technology 
(C29H4) 
Rabbit 1:1000 
 and -tubulin 
polyclonal 
Cell Signaling Technology 
(2148S) 
Rabbit 1:1000 
sFlt-1 monoclonal Sigma-Aldrich (101M4800) Mouse 1:1000 
Endosialin monoclonal Santa Cruz (sc-377221) Mouse 1:500 
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Table 2.9: Secondary antibodies used. 
Antibody Manufacturer and catalogue number dilution 
Anti-mouse IgG HRP-linked 
antibody 
Cell Signaling Technology (7076S) 1:5000 
Anti-rabbit IgG HRP-linked 
antibody 
Cell Signaling Technology (7074S) 1:5000 
 
Table 2.10: Mild stripping buffer. 
Item Ingredient 
Mild stripping 
buffer  
15 g glycine, 1 g SDS,10 ml Tween-20, and 1 L ultrapure water with pH 
adjustment to 2.2 
 
2.23. ELISA 
Enzyme-linked immunosorbent assays (ELISA) were employed to determine changes in human 
VEGF and sFlt-1 production in cell supernatants. The human VEGF and VEGF-R1 DuoSet 
ELISA kits were used according to manufacturers' protocol (R&D Systems, Minnesota, USA). 
ELISA plates were prepared by coating 96-well Nunc Immunosorb strip-well plates 
(ImmunoTM-Nunc) with 100 µl of a capture antibody at the recommended concentration in PBS 
overnight at room temperature. The capture antibody was aspirated, followed by three washes 
with 400 µl/well of the wash buffer, 0.05% (v/v) TWEEN-20 in PBS. The final wash was 
followed by tapping the plate over a clean tissue to remove the excess buffer. Blocking of non-
specific binding was achieved using 300 µl/well of reagent diluent (1% BSA in PBS (w/v 0.22 
µm-filtered) for 1 h. The wells were then washed three times with wash buffer as described 
above. The standards and samples were then added to the plate (100 µl/well) in duplicate and 
incubated for 2 h at room temperature then aspirated and the washing steps were repeated. 
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Subsequently, 100 µl of biotinylated kit-specific secondary antibody was added to each well 
and the plate incubated for 2 h. After further washing steps, the wells were incubated with 100 
µl of Streptavidin-horseradish peroxidase conjugate in the reagent diluent for 20 min. The plates 
were washed and 100 µl of freshly prepared substrate solution added and incubated in the dark 
for 20 min. The reaction was stopped with 50 µl of 2 N sulphuric acid (H2SO4). Immediately, 
the optical density was measured at 450 nm with wavelength correction at 540 nm using a 
spectrophotometric plate reader. The concentration of the samples was calculated from the 
standard curve using Microsoft Excel. 
2.24. siRNA-mediated knockdown in hESC 
The Viromer
® 
BLUE transfection kit was used to knockdown FOXO1 and HO-1 in hESC 
according to manufacturer's guidelines (Lipocalyx, Weinberger, Germany). The cells were 
plated at 2.2x105 cells/ml in a 6-well plate to reach 65- 85% confluency over 24 h. Transfection 
was performed with 200 µl of siRNA complex/1.5ml of the complete growth medium/well. 
This transfection complex contained 37.5 nM siRNA in 2 µl Viromer blue. After 24 h, the cells 
were either stimulated to decidualise or maintained as proliferative for 24 h prior to the 
harvesting cell supernatants and protein or RNA lysates. The siRNA sequences used are shown 
in Table 2.11. 
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Table 2.11: siRNA duplex used in the current project. 
Target  Forward sequence Reverse sequence Reference 
FOXO1 
5’-
GAGCGUGCCCUACUUCA
AGTT-3’ 
5’-
UCUCCUAGGAGAAGAGCUGT
T-3’ 
(Potente et 
al., 2005) 
HO-1 
5’-
GGCAGAGGGUGAUAGAA
GATT-3’ 
 
5’-
UCUUCUAUCACCCUCUGCCTT 
-3’ 
 
(Cudmore 
et al., 2007) 
 
2.25. Cell conditioned medium 
2.25.1. hESC conditioned medium  
St-T1b cells were plated at 10x105 cells in 12 ml of E2 medium in a T-75 flask. Once confluent, 
they were stimulated to decidualise for 5 days with the MPC medium changed at 3 days. The 
cells were harvested and re-plated in 6-well plates and stimulated with MPC medium for a 
further 24 h.  The conditioned medium was then collected. The same procedure was performed 
with proliferating cells in E2 medium. The conditioned medium was centrifuged at 200g for 10 
min to remove any cells present and the supernatant stored at -20oC. 
2.25.2. HTR-8 cell conditioned medium 
 HTR-8 cells (1x106) were plated in 12 ml of the growth medium in a T-75 flask. The next day 
when the cells had reached confluence, fresh medium was added. After 24 h, the conditioned 
medium was harvested, centrifuged at 200g for 10 min and the supernatant stored at -20oC.  
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2.26. Statistical analysis 
Data were analysed using the SPSS statistics software package version 24. The Schapiro-Wilk 
test was applied to show whether the data are normally distributed. Two-tailed Student’s T-
Tests were used to compare the differences between two data sets when appropriate. For 
multiple comparisons, one-way or two-way ANOVA was used to find any significant difference 
among groups with post hoc tests, including the least significant difference (LSD) or Dunnet, 
as appropriate. For the abnormal (non-parametric) distribution of the data, the Mann-Whitney 
test was applied to calculate the significant difference. The levels of significance were set at 
*p< 0.05 **p< 0.001   in all comparisons. 
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3.1 Introduction 
Successful human embryo implantation depends on a highly synchronised interaction of a 
competent blastocyst with a receptive endometrium. The molecular mechanisms that underpin 
this dialogue are still poorly understood. One key component is endometrial decidualisation 
which occurs spontaneously under the influence of the post ovulatory increase in P and local 
cAMP elevation even in the absence of an embryo (2012). Two typical decidual products, 
namely, dPRL and IGBP-1 are considered to be key molecular markers of decidualisation 
(Gellersen and Brosens, 2003b). The major regulator/driver of decidualisation of hESC is  
FOXO1, which is a transcription factor that induced with decidualisation and its inhibition can 
result in IGFBP-1 and PRL inhibition (Grinius et al., 2006). Decidual cells expressed can 
express other genes such as KAI1, PLZF, IRF4, and SOD2 (Kajihara et al., 2011). 
The perturbation of  endometrial decidualisation can result in abnormal trophoblastic invasion 
(Lei et al., 2007, Godbole et al., 2011, Suman et al., 2012), embryo implantation failure (Paria 
et al., 2002), recurrent miscarriage (Salker et al., 2010), pre-eclampsia, IUGR (Garrido-Gomez 
et al., 2017), and infertility problems such as endometriosis (Brosens et al., 2013). There is also 
an increased risk of cardiovascular problems in both mothers and offspring in later life (Ros et 
al., 2001, Smith et al., 2001).  
Some studies suggest that decidualisation causes a physical barrier that inhibits trophoblastic 
invasion depending on the fact that trophoblastic invasion does not extend beyond the inner 
layer of the myometrium. Some studies suggest that the decidua inhibits invasion through 
secreting factors that increase trophoblast adhesion (Graham et al., 1992), as well as tissue 
factor that neutralises the proteolytic activity of trophoblastic metalloprotease (Lala and 
Graham, 1990). Menkhorst (2019) found that decidualisation significantly reduced the MMP 
production from ESC. Paiva et al (2009) found that the decidual limiting of trophoblast invasion 
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is due to the effect of IL-11 through its effect on STAT3. According to these findings, the 
decidua can be considered as a chemical barrier for invasion (Sharma et al., 2016). Other studies 
agree that the decidua has a regulating role on trophoblastic invasion through a fine balance 
between invasion activating and inhibitory substances (Kliman, 2000). Godbole et al (2011) 
found that the decidual conditioned medium enhances trophoblastic invasion through 
increasing the production of MMPs and the reduction of TIMMPs in trophoblast cell lines. 
Despite all these studies, the role of hESC decidualisation in trophoblasts invasion is still not 
definitely elucidated so far. Investigation of the role of decidualisation in the process of human 
blastocyst invasion is often hampered due to various constraints. For instance, difficulties in 
obtaining a primary endometrial tissue due to ethical and practical limitations, as well as the 
inability to passage primary cells in vitro for a long time (Krikun et al., 2004). Human embryos 
are relatively inaccessible and only a few labs in the world have access to donated embryos for 
research purposes (Brosens and Gellersen, 2010). This has necessitated the development of in 
vitro models to mimic human stromal cell trophoblast interactions. Consequently, immortalised 
endometrial and trophoblast cell lines have been utilised. Different types of endometrial stromal 
and trophoblastic cell lines have been introduced to date. Telomerase immortalised endometrial 
stromal cells have been developed and called St-T1b cells (Rinehart et al., 1993, Samalecos et 
al., 2009c). These cells have been used in the current in vitro models of embryo implantation 
as the endometrial side of maternal-trophoblast interface. To represent the trophoblast part of 
the interface, Gonzales et al (2011) used the AC-IM88 cell line. These cells might not be 
representative of embryo implantation or early pregnancy as it is a fusion of term placental cells 
with mutant JEG-3 choriocarcinoma, which has a tumour-like invasive behaviour more than 
the expected in a normal embryo implantation. Therefore, in the current study, another 
trophoblastic cell line, HTR-8/SVneo cells, were chosen. These cells are immortalised cells 
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derived from first trimester villus explants. The cells show adhesion, invasion, migration, and 
proliferative abilities, and the expression of KRT7, chorionic gonadotrophin receptor, and 
HLAG marker. These criteria enable them to be used as implantation and EVT models (Hannan 
et al., 2010). Grewal et al (2010) developed a heterologous two dimensional co-culture model 
composed of a mouse embryo over a layer of hESC with the modulation of hESC Rho GTPases 
expression to explore the role of endometrial stromal motility on spreading of the embryo over 
endometrium during implantation. Gonzalez et al (2011) developed an expansion co-culture 
model composed of T-hESC and AC-IM88 trophoblastic cell lines to evaluate the role of 
decidualisation in trophoblastic invasion. An essential requirement in model development is the 
establishing of accurate analysis protocol and preferably easy and automated and this what I 
was aiming during the project course. 
3.1.1. Aim and objectives 
The aim of this chapter was to develop suitable in vitro models to facilitate the investigation of 
the role of endometrial decidualisation, growth factors, and cytokines in trophoblast-
endometrial interactions. Trophoblast invasion has been shown to be influenced by various 
cytokines and growth factors such as TNF-α, interleukins, LIF, and EGF in a paracrine or 
autocrine manner (Staun-Ram and Shalev, 2005).  
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3.2. Results 
3.2.1. In vitro characterisation of human endometrial stromal cell line (St-T1b) 
decidualisation 
The human St-T1b endometrial stromal cell line (Samalecos et al., 2009) was used to 
investigate the effect of decidualisation on growth factor expression and cell function.  Initially 
the ability of St-T1b to decidualise was confirmed to validate their use as a suitable alternative 
to primary hESC. The in vitro decidualisation of the cells was achieved using a decidualisation 
protocol based on that described by Samalecos et al  (2009c) for 4 to 7 days.  In order to induce 
differentiation, the cells were stimulated in decidualisation medium (MPC medium). The 
medium was replaced every 48 – 72 h and 24 h prior to harvesting the culture supernatants and 
cells (Figure 2.1). 
3.2.2. Morphological characterisation of St-T1b cells and primary hESC 
decidualisation 
St-T1b cells and primary hESC were plated at a seeding density of 3x105cell/well in a six-well 
plate and induced for differentiation at 4 and 7 days. Differentiation was judged by the 
morphological reorganisation of elongated spindle shape St-T1b fibroblasts in the proliferative 
stage into epithelioid-like, enlarged, more cuboidal decidualised cells (Figure 3.1A), which 
continue to proliferate and appear elongated and more densely packed on day 7 of the 
experiments. The cells were stained with Phalloidin-iFluor 488 and counterstained Hoechst 
33342 to visualise their cytoskeleton. Cells were plated at 0.6x106cells/well in E2 medium in 
an 8-well culture slide. Next day, the cells were induced to decidualisation as usual. The merged 
images of Phalloidin nuclear Hoescht 333432 staining confirmed the same reorganisation of 
actin cytoskeleton to the polygonal shape in decidualised cells with the formation of stress fibres 
(Figure 3.1A & B). 
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Figure 3.1: Morphological decidualistion of hESC. Confluent monolayers of St-T1b 
and primary hESC were incubated in E2 medium or MPC for 4 and 7 days. (A) 
Representative bright field images of proliferative and decidualised cells (10x 
objective). Scale bar = 100 µm. (B) Representative fluorescent images of proliferative 
and decidualised cells cytoskeleton and nuclei after staining with Phalloidin and 
Hoescht stain (20 x objective). Scale bar = 50 µm. 
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3.2.3. Biochemical characterisation of St-T1b cells decidualisation by qPCR and 
Western blotting 
Further characterisation of St-T1b cell decidualisation was performed by examining the 
expression of important decidual genes including FOXO1, KAI1, PLZF, SOD2, and IRF4 by 
real-time qPCR with β-actin as a house-keeping gene. Following decidualisation, a significant 
upregulation (p<0.05) of FOXO1 mRNA was observed (Figure 3.2A). Western blotting was 
used to confirm the upregulation of FOXO1 protein in decidualised St-T1b cells (Figure 3.2B). 
Other decidual products including SOD2, IRF4, KAI1, and PLZF were upregulated 
significantly in the decidualised cells at day 4 and day 7 compared to the proliferative cells at 
the same time points (Figure 3.2C, D, and E). qPCR and Western blots confirm the normal 
decidualisation response of St-T1b to progestational and cAMP stimuli and allowed for further 
progress in using these cells as a model for primary stromal cells. An interesting finding was 
the significant upregulation of LTBR mRNA with decidualisation at 4 and at 7 days of 
stimulation (Figure 3.2G). 
3.2.4. Characterisation of St-T1b cell marker gene expression 
 St-T1b cells were compared with primary hESC to examine their ability to show typical 
decidualisation biomarker genes coding for dPRL and IGFBP-1 by RT-PCR. The PCR products 
were separated on agarose gels. The results showed the dramatic induction of dPRL and IGFBP-
1 in St-T1b cells following 4 days of decidualisation, which was maintained at 7 days of 
stimulation. The dPRL and IGFBP-1 bands were not detected in the proliferative St-T1b cells 
(Figure 3.3). GAPDH was used as a house keeping control gene for these studies. 
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Figure 3.2: Biochemical characterisation of St-T1b cells by qPCR and Western blot. 
Confluent monolayers of St-T1b were incubated in MPC or in E2 for 4 and 7 days. Relative 
mRNA fold changes of (A) FOXO1, (C) SOD2, (D) IRF4, (E) KAI1, (F), PLZF, and (G) LTBR 
expressions normalised to β-actin. (B) Representative Western blots showing FOXO1 protein 
expression with Tubulin used as a loading control. Results are the mean (± SEM) of five 
independent experiments. Statistically significant differences (*P<0.05, **P<0.001). 
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Figure 3.3: Characterisation of St-T1b cell IGFBP-1 and dPRL induction. St-T1b cells 
were induced to decidualise or maintained as proliferative cells for 4 and 7 days. RT-PCR 
used to detect the expression of IGFBP-1 (product size 380 bp) and dPRL (product size 416 
bp) with GAPDH (product size 159 bp) as a housekeeping control. The products were 
separated on agarose gels RT-PCR in the decidualised day 4 and day 7 cells. 
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3.2.5. Biochemical characterisation of primary human endometrial stromal 
decidualisation 
Primary hESC were derived from endometrial tissues obtained from three individuals. To 
examine their decidualisation response and compare with those of St-T1b cells, the same 
protocol of St-T1b decidualisation was applied. qPCR for FOXO1 and PLZF was performed 
alongside Western blotting for FOXO1 protein. The result revealed a significant upregulation 
(p<0.001) of FOXO1 mRNA genes in the decidualised cells at day 4 and day 7 of the 
experiments (Figure 3.4A). This upregulation of FOXO1 in decidualised cells was further 
confirmed by Western blot (Figure 3.4B). FOXO1 was strongly upregulated at both 4 and 7 
days of decidualisation stimulation. PLZF mRNA was significantly upregulated (p<0.05) in 
day 4 and day 7 decidualised cells compared to proliferative cells (Figure 3.4C).  
3.2.6. Development of St-T1b and HTR-8 cells in vitro scratch assay 
Trophoblast and stromal cell migration is imprtant for embryo implantion (Grewal et al., 2008, 
Gellersen et al., 2013, Gellersen et al., 2010). In order to examine the role of hESC 
decidualisation and growth factors on hESC and trophoblast migratory and invasive activities, 
we developed a number of assays. Initially we used the scratch wound assay according to 
method develpoed by Liang et al (2007) to determine the migratory ability of stromal and 
trophoblast cells. A confluent T-75 flask of cells was stimulated for decidualisation with MMI 
medium for 72 h and then re-plated into a 6-well plate at a seeding density of 3x105 /well. 
The in vitro scratch assay allows the monitoring of cell migration in a two dimensional view 
into a space created in a cell monolayer (Cory, 2011).  This assay was selected because it is a 
relatively simple, straightforward and reproducible assay that does not require gradient 
(Boyden) chambers, and the cells can be monitored continuously under the light microscope.  
Chapter 3 – An in vitro model to investigate the role of decidualisation on stromal trophoblast 
interaction 
88 
 
 
 
 
 
 
 F
O
X
O
1
 m
R
N
A
Day 4 Day 7
0
50
100
150
200
✱✱
✱✱
Proliferative
Decidualiized
 P
L
Z
F
 m
R
N
A
Day 4 Day 7
0
500
1000
1500
2000
2500
✱
✱
A B
C
kDa
FOXO1
- + - + MPA + 8-Br-cAMP
75
48
Tubulin
4 days                  7 days
 
 
Figure 3.4: Biochemical decidualisation of primary hESC by qPCR and Western blot. 
Confluent monolayers of primary hESC were incubated in E2 medium or MPC for 4 and 7 days. 
Relative mRNA fold changes (A) FOXO1 and (C) PLZF expressions normalised to β-actin. (B) 
Representative Western blots showing FOXO1 protein with tubulin used as a loading control. 
Results are the mean (± SEM) of three independent experiments. Statistically significant 
differences (*P<0.05, **P<0.001). 
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During the development of the assay for the hESC and HTR-8 trophoblast cells, six different 
criteria were considered: The type of the pipette tip used to create the scratch, cell seeding 
density, the medium used, the time point at which migration is assessed and the use of 
fluorescent cell tracer dye to facilitate quantitation of migration, and the number of 
measurements/treatment condition to achieve reproducible results (Table 3.1).  
Table 3.1: Development criteria followed in migration assay. 
Criteria Optimisation measure 
Pipette tip used to generate scratch 100 µl tip 
Cells seeding density Equal seeding densities in all groups 
Type of medium used 1% FBS medium 
Follow up timing  18 h 
Type of imaging  Bright field   
Number of measurements 10 fields/ treatment condition 
 
We found that 100 µl pipette tips gave a nice sharp scratch with an appropriate size (~ 600 µm) 
to allow visualisation in a single field under a 4 x objective lens. Some authors used different 
seeding density between decidualised St-T1b cells and proliferative groups of experiments 
(Schwenke et al., 2013). However, the current project assumed that it could be more 
representative of migration potential differences if the same seeding density were used in both 
groups. To achieve this, St-T1b decidualisation stimulation were performed in T-75 cm flasks 
followed by trypsinisation and reseeding in 6-well plates in equal densities. Indicator-free 
DMEM/F12 containing a range of serum concentrations from 0.5% to 10% were assessed and 
1% FBS was selected for cell maintenance after scratch-wounding. This medium supported cell 
viability without stimulating much proliferation to reflect the situation in vivo. The optimal time 
Chapter 3 – An in vitro model to investigate the role of decidualisation on stromal trophoblast 
interaction 
90 
 
to assess St-T1b migration was determined to be 18 h following making the scratch-wound (0 
h). At this time point, approximately 40% closure of the wound was observed in groups. It also 
does not exceed 24 h, so the results are not confounded by the cell proliferation. 
 Initially, bright field imaging was used for the migration assay and a new software analysis 
protocol was developed using ImageJ software. The images initially undergo segmentation 
using the trainable weka plugin, followed by thresholding and automated measurement of the 
area of the wound remaining. Ten points/condition were followed at zero time and 18 h using 
4 x lens.  Although fluorescent cell tracer dyes combined with fluorescence microscopy were 
trialled to determine whether a greater contrast of areas containing cells versus plastic would 
results in an easier image analysis. However, the use of trainable weka allowed the analysis of 
bright field images without the need for complicating the assay with the use of a fluorescent 
dye. The migration was calculated as: 
% of migration = (
scratch area at 0 h − scratch area at 18 h
scratch area at 0 h
 ) ∗ 100 
3.2.7. Decidualisation reduces hESC migration  
To determine the effect of decidualisation on hESC cell migration, St-T1b and primary hESC 
were plated at 3x105cell/well to obtain confluent monolayers of proliferative and decidualised 
hESC on 6-well dishes. Cells were scratched /wounded, and their migration assessed at 18 h.  
As HB-EGF/ EGF has been shown previously to promote hESC migration (Schwenke et al., 
2013, Gentilini et al., 2007), it was used as a positive control for these studies. Most treatment 
groups showed a more than 50 % of wound closure at 18 h (Figure 3.5A &B; Figure 3.6A & 
B). Decidualisation of hESC reduced their migration, irrespective of the conditions, compared 
with the proliferative cells.  
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Figure 3.5: Decidualisation reduces St-T1b hESC migration. Confluent monolayers 
of St-T1b proliferative (control – black bars) or hESC decidualised (blue bars) for 4 and 
7 days were scratch-wounded and stimulated with TNF-α (50 ng/ml) or EGF (200 ng/ml) 
in 2 ml of 1% FBS medium. Cell migration was assessed after 18 h at 10 points /treatment 
condition in 2 wells and calculated as migration % = (Scratch area at 0 h - scratch area at 
18 h / scratch area at 0 h) *100. (A) Representative bright field images (4 x objective) 
showing the scratch areas at 0 and 18 h. (B) Results are means (± SEM) of the migration 
percentage at 18 h relative to the zero time point of three independent experiments.  
Statistically significant differences (*P<0.05). Scale bar = 400 µm.   
Chapter 3 – An in vitro model to investigate the role of decidualisation on stromal trophoblast 
interaction 
93 
 
 
 
 
 
 
 
       A 
Chapter 3 – An in vitro model to investigate the role of decidualisation on stromal trophoblast 
interaction 
94 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M
ig
ra
ti
o
n
 %
Control    Decidualised EGF
0
20
40
60
80
✱
✱
 
B 
Figure 3.6: Decidualisation reduces primary hESC migration. Confluent 
monolayers of primary proliferative (control – black bars) or hESC decidualised (blue 
bar) for 4 and 7 days were scratch-wounded and stimulated with EGF (200 ng/ml in 
2 ml of 1% FBS medium. Cell migration was assessed after 18 h at 10 points / 
treatment condition in 2 wells and calculated as migration % = (Scratch area at 0 h-
scratch area at 18 h/scratch area at 0 h)*100. (A) Representative bright field images 
(4 x objective) showing the scratch areas at 0 and 18 h. (B) Results are mean (± SEM) 
of the migration percentage at 18 h relative to the zero time point of three independent 
experiments. Statistically significant differences (*P<0.05).  
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TNF-α (50 ng/ml) was found to have no effect on the migration of either the proliferative or 
decidualised cells in comparison with the untreated controls. EGF (200 ng/ml) stimulated both 
proliferative and decidual cell migration. Additionally, the EGF treated decidualised cells 
showed a faster migration in comparison with decidualised cells of the control and TNF-α 
treated groups (Figure 3.5A & B; Figure 3.6A & B). 
TNF-α can cause apoptosis in some cell types (Prins et al., 1997). To ensure that any effects 
observed with TNF-α treatment are not due to cytotoxic effects or loss of cells, MTT assays 
(Ciapetti et al., 1993) were used to analyse cell viability. St-T1b and HTR-8 cells were seeded 
at 3x104 cells/well in 96-well plates in 100 µl of the complete growth medium and incubated 
for 24 h. TNF-α (50 ng/ml) was added to the cells in DMEM/Ham F12 containing 1 % FBS for 
72 h and the MTT assay performed. The viability of St-T1b cells (Figure 3.7A) and HTR-8 cells 
(Figure 3.7B) was not significantly different to the untreated controls. 
3.2.8. EGF stimulates trophoblast migration while decidualised hESC-
conditioned medium does not alter it. 
It was reported that treating trophoblasts with a proliferative or decidual conditioned medium 
could change their migratory potential (Yong et al., 2018). The HTR-8 cells were plated at 
3x105 cell/well in a six-well plate. The cells were scratched, and their migration were followed 
after 18 h while treated with EGF (200 ng/ml) or decidualised and proliferative St-T1b cells’ 
conditioned medium. The result showed that EGF stimulates HTR-8 migration (Figure 3.8A & 
B) represented by migration percentage which represent the wound closure. The proliferative 
or decidualised St-T1b cells conditioned medium did not affect HTR-8 cells migration in 
comparison with the control cells in which 1% FBS medium was used (Figure 3.9A & B). 
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Figure 3.7: TNF-α treatment does not affect hESC or trophoblast viability. St-T1b and HTR-
8 cells were seeded at 3x104 cells/well in a 96-well plate. 24 h later, 50 ng/ml of TNF-α in DMEM 
ham F12 (1% FBS) was added for 72 h period using the MTT assay. The results are mean % (± 
SEM) of cell viability with respect to the untreated controls of three experiments in (A) St-T1b 
cells and (B) HTR-8 cells. 
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Figure 3.8: EGF stimulates HTR-8 cells in vitro migration. Confluent monolayers of HTR-
8 cells were scratch/wounded. The migration was assessed in the presence of 2 ml of 1% FBS 
medium (control) and treatment with EGF (200 ng/ml). Cell migration was assessed after 18 
h at 10 points /treatment condition in 2 wells and calculated as migration % = [(Scratch area 
at 0 h - scratch area at 18 h)/scratch area at 0 h)]*100. (A) Representative bright field images 
(10 x objective) showing the scratch areas at 0 and 18 h. Results are mean (± SEM) of three 
independent experiments. Statistically significant differences (*P<0.05).  
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Figure 3.9: Differences in conditioned media have on effect in HTR-8 in vitro 
migration. Confluent monolayers of HTR-8 cells were scratch/wounded. Their migration 
was assessed after 18 h in the presence of 2 ml of 1% FBS medium (control – black bars), 
proliferative ST-T1b conditioned medium (red bar), and decidualised St-T1b conditioned 
medium (grey bar). Cell migration was assessed after 18 h at 10 points /treatment condition 
in 2 wells and calculated as migration % = [(Scratch area at 0 h - scratch area at 18 h)/scratch 
area at 0 h)]*100. (A) Representative bright field images (10 x objective) showing the scratch 
areas at 0 and 18 h. (B) Results are means (± SEM) of three independent experiments. 
Statistically significant differences (*P<0.05). Scale bar = 200 µm. 
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3.2.9. Development of HTR-8 spheroid expansion assay 
Gonzalez et al (2011) described a trophoblast spheroid expansion model, which aims to 
simulate blastocyst spreading/invading over the decidua in the early stages of implantation. This 
model was further developed using HTR-8 cells cultured as spheroids to represent the 
implanting blastocyst, and St-T1b cells to mimic the endometrial side of interface.  
During the development of spheroid expansion assay, different  criteria were considered 
including; methods of spheroid cell preparations, the size of each spheroid, the number of 
spheroids placed in each well, how to follow the cells in using continuous real time analysis, 
and the type of florescent dye to optimise visualisation (Table 3.2).  
Table 3.2: Spheroid criteria followed in HTR-8 spheroid expansion assay 
development.  
Criteria Optimisation measure 
Spheroid preparation method Methyl cellulose method 
Spheroid size 3000 HTR-8 cells /spheroid 
Spheroid number 3 spheroids/well in 24 well plates 
Fluorescent dye  Vibrant green cell tracer dye 
 
The project adopted the method of Korff and Augustin (1998), which used to generate 
trophoblast spheroids in 0.24 % (w/v) methyl cellulose. To optimise the size of the HTR-8 
spheroids, different sizes ranging from 750, 1500, 3000, and 7500 HTR-8 cells/spheroid were 
tried. 3000 HTR-8 cells/spheroid was used following the method of Gonzalez et al (2011). This 
generated a spheroid of approximately 200 µm, which mimics blastocyst size (~70-200 µm), as 
well as yielding a good analysable expansion size without the risk of cells taking apart  and not 
keep compact body or the dying risk of spheroid core cells death  in case of a larger size (Figure 
3.10).  
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Figure 3.10: HTR-8 spheroid production. A flow-chart showing the generation of HTR-8 
spheroids using methylcellulose in a non-tissue treated 96 wells-plate over 24h. The harvested cells 
were used either in the spheroid sprouting or spheroid expansion assay. Scale bar = 250 µm. 
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Three spheroids were placed in each well to avoid the clumping of spheroids to each other and 
to give a space for spheroid expansion that can be visualised with 4 x lenses in a manner that 
could allow calculation of individual expansion. 
Gonzalez et al (2011) used an immunohistochemistry stain to visualise the spheroid after fixing 
the slides. In the current study, Vybrant green cell tracer dye was used, which allowed 
continuous monitoring of the assay and facilitated the observation of the same group of cells 
under the same experimental conditions. During assay optimisation, different dyes were tried 
calcein green-AM and Vybrant green cell tracer. The first dye was continuously leaking from 
spheroid cells and lead to fluorescence fading over 72 h. Vybrant green dye provided a better 
visualisation and analysis of spheroid expansion using a novel adopted protocol. The protocol 
allowed automatic measurement of the expansion area by segmentation with a trainable weka 
plugin followed by thresholding and area measurement in ImageJ. The spheroid expansion was 
relatively calculated according to the following equation: 
Spheroid expansion =
spheroid size at 48 h or 72 h
spheoid size at 0 h
                      
3.2.10. HTR-8 spheroid expansion is stimulated with the decidualisation of a 
feeder underneath hESC monolayer and treatment with EGF and TNF-α 
Three HTR-8 spheroid cells were placed in each well of 24 well/plate and labelled with Vybrant 
green cell tracer dye. The spheroids were placed on St-T1b cells, which were grown as 
monolayers on the well dishes and labelled with Syto64 dye. Using St-T1b cells labelled with 
Syto64 dye, the cell monolayer appeared intact and unaffected by the spreading HTR-8 
spheroid/cells, which appeared to spread over them rather than integrating in the monolayer on 
the surface of the flask (Figure 3.11). 
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Figure 3.11: Fluorescent labelling of a trophoblast spheroid cultured on hESC monolayer. 
Representative images showing (A) HTR-8 spheroid bright-field image, (B) an HTR-8 spheroid 
labelled with Vybrant green CFDA-SE, (C) a St-T1b cell monolayer labelled with Syto64 dye 
at 48 h time point, and (D) merged image (40x magnification). Scale bar = 300 µm. 
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HTR-8 spheroids were added in 1% FBS DMEM HAM F12 medium and monitored over three 
days using 4 x lenses.  The spheroids expanded and migrated out over the hESC with an increase 
in the area of > 4-fold at 48 h and ~ 8-fold at 72 h (Figure 3.12A & B) compared with the initial 
adherent spheroid size. The rate of spheroid expansion was greater on TC plastic than hESC.  
Spheroid expansion was evaluated in response to endometrial decidualisation and to a range of 
growth factors and cytokines that have been implicated in embryo implantation including EGF 
and TNF-α.  The HTR-8 spheroid expansion was enhanced in the TNF-α treated proliferative 
cells and in both proliferative and decidualised EGF-treated hESC when compared with the 
control cells at 48 h (Figure 3.12A & B). At 72 h, the EGF treated co-culture spheroids 
displayed marked (P<0.05) trophoblastic outgrowth and spreading over proliferative and 
decidualised hESC in comparison with the corresponding control cells. TNF-α treatment also 
increased (P<0.05) spheroid expansion in both proliferative and decidualised groups in 
comparison with the control cells. Decidualised TNF-α treated cells showed a greater increase 
(P<0.05) in spheroid expansion than the corresponding proliferative cells and the control 
decidualised cells (Figure 3.12A & B). 
3.2.11. Development of HTR-8 spheroid sprouting assay. 
Abnormal trophoblast invasion can result in the failure of embryo implantation, recurrent 
miscarriage, intrauterine growth restrictions, and  pre-eclampsia  (Maynard et al., 2003). To 
evaluate the role of endometrial decidualisation on trophoblast activity, a spheroid 
sprouting/invasion assay was developed by adopting the versatile three dimensional 
cytotrophoblast spheroidal model of Korff et al (2004) into a  co-culture model. The wells were 
already plated with a confluent monolayer of St-T1b cells either in a decidualised or in a 
proliferative state. 
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Figure 3.12: EGF and TNF-α enhanced HTR-8 spheroid expansion. HTR-8 spheroids 
were labelled with Vybrant green dye and seeded onto proliferating (black bar) or 
decidualised (blue bar) monolayers of St-T1b cells. The co-cultures were then treated with 
TNF-α (50 ng/ml) or EGF (200 ng/ml) in 1% FBS medium. The HTR-8 spheroid expansion 
was calculated as spheroid size at 48 h or 72 h /spheroid size at 0 h using ImageJ. Ten 
spheroids/treatment condition were measured in 4 wells. (A) Representative fluorescent 
images using Vybrant green dye (4x objective) showing spheroid expansion areas at 48 and 
72 h. (B) Results are the means (± SEM) of three independent experiments. Statistically 
significant differences (*P<0.05).  Scale bar = 200 µm.   
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Three to four labelled spheroids (750 HTR-8 cells/spheroid) were added to each well. 0.5 ml 
DMEM/Ham F12 medium containing 1% FBS and EGF (200 ng/ml) or TNF (50 ng/ml) was 
added. Fluorescence imaging was performed at 48 h and 72 h. During the early trials of model, 
several criteria were included as the size of spheroids, type of gel used, fluorescent dye, and the 
methods of embedding the spheroids into the gel (Table 3.3).  
Table 3.3: Spheroid criteria used in HTR-8 spheroid sprouting assay development 
Criteria Optimisation measure 
Size of spheroid cell 750 HTR-8 cells/spheroid 
Gel Fibrin 
Imaging  Florescent using vibrant green-labelled cells 
Method of embedding spheroids in the gel Spheroids suspended in fibrinogen applied/set 
over a thin preformed gel 
 
To select a suitable size of spheroids, 750, 1500, and 3000 HTR-8 cell/spheroid were tried. 750 
cell/spheroid was the most appropriate size as it enabled the incubation of  three spheroids (~ 
500 µm) per well in the 24-wells plate without clumping, as well as a capability to visualise 
spheroid cell sprouting by 4 x lens. Collagen (Korff et al., 2004) or fibrin gels (Cartwright et 
al., 1999) have been used to study the spheroid sprouting or invasion before. In the current 
project, fibrin gels were used as they resemble the physiologic matrix at the embryo 
implantation site (Bischof and Campana, 1996). Initially, the spheroids were introduced directly 
into the wells in fibrinogen (3 mg/ml) which was then cross-linked (Figure 3.13). Unfortunately, 
this often resulted in the spheroids resting on the tissue culture plate at the bottom of the well. 
This interfered with the sprouting/invasion of cells as well as the analysis. 
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Figure 3.13: Spheroid invasion assay. A diagram showing the generation of spheroid from 
750 HTR-8 cells using methylcellulose in a non-tissue treated 96-wells plate. The cells were 
followed using a fluorescent microscope (4x magnification). Scale bar = 100 µm. 
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The problem was resolved by applying a thin layer of fibrin gel first, over which the spheroid 
containing gel was set. Observations showed that HTR-8 spheroids embedded in fibrin gels 
started to form sprouts after ~ 24 h of embedding, indicating that HTR-8 cells were a good 
choice as a representative model of invasive trophoblasts. However, the degree of sprouting at 
24 h was minimal, therefore imaging the HTR-8 spheroids was performed at 48 h and 72 h. The 
HTR-8 spheroids were labelled with Vybrant green cell tracer dye to enable the monitoring of 
the sprouts over 72 h and facilitate the capture and analysis of images. A new analysis protocol 
was developed using a trainable weka plugin.  This allowed segmentation of the spheroid and 
to perform automated subtraction of the core area followed by thresholding and measurement 
of sprouting density and length using ImageJ. 
3.2.12. Reduction of HTR-8 spheroids sprouting with decidualisation of 
underlying stromal monolayer and stimulated with EGF treatment. 
The spheroid sprouting/invasion assay was assessed by the three dimensional cytotrophoblast 
spheroidal model of Korff et al (2004). Three HTR-8 spheroids/well of 750 HTR-8 cell 
/spheroid were placed in a fibrin gel in a 24-well plate over a monolayer of decidualised or 
proliferative St-T1b cells. The cells were followed over 48 h and 72 h using a 4 x lens. The   
density of spheroid sprouting was found to be lower in spheroids set over an EGF treated 
decidualised hESC monolayer than those set over a proliferative one at 48 h.  
The EGF treated group at this time period showed the maximum sprouting density and length 
of invasion extending into the fibrin gel (Figure 3.14A & B). At 72 h, the decidualised cells 
invasion was lower than the proliferative group in all type of treatments. EGF treated HTR-8 
spheroid cells, whether seeded over a decidualised or proliferative monolayer showed the 
maximum sprouting density and length (Figure 3.14A & B). 
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Figure 3.14: Reduced HTR-8 spheroid invasion over a decidualised St-T1b layer in 
comparison with proliferative cells. Labelled HTR-8 spheroids were set in a fibrin gel over a 
proliferating or decidualised labelled monolayer of St-T1b hESC. The co-cultures were then 
treated with TNF-α (50 ng/ml) or EGF (200 ng/ml) in 1% FBS medium. The sprout density and 
sprout length were calculated for 10 spheroids / condition in 4 wells using ImageJ. (A) 
Representative fluorescent images of HTR-8 spheroid invasion into fibrin gel at 48 h and 72 h 
(4x objective). (B) Results are means (± SEM) of 3 independent experiments. Statistically 
significant differences (*P<0.05, **P<0.001). Scale bar = 200 µm.     
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3.3 Discussion 
3.3.1. In vitro characterisation of St-T1b decidualisation 
In order to study the effects of decidualisation on gene expression and function, we selected a  
Telomerase-immortalised endometrial stromal cell (St-T1b) cell line (Rinehart et al., 1993, 
Samalecos et al., 2009c). This cell line has been used to study endometrial stromal cell 
decidualisation (Samalecos et al., 2009c), invasiveness (Gellersen et al., 2010), motility 
(Schwenke et al., 2013) , and an in vitro modelling of embryo implantation (Gonzalez et al., 
2011). 
 In order to be used successfully in in vitro embryo implantation models, endometrial stromal 
cell lines need to possess two essential characteristics. First, the ability to retain the key 
phenotypic properties of the original primary cells. Second, the ability to respond and undergo 
a progestational response to the appropriate stimuli and express the morphological and 
biochemical changes characteristic of decidualisation. The process of differentiation of 
endometrial fibroblasts into enlarged polygonal cells, rich with lipid and glycogen, is a part of 
MET typical of decidualisation (Zhang et al., 2013b) to create a receptive  implantation 
environment. For these studies we examined the cells at two-time intervals, 4 and 7 days. These 
were selected to the time leading up to implantation cover the implantation window, which 
normally spans the 20-24th day of the menstrual cycle (Kao et al., 2002) 
 Collectively, the findings indicate that upon induction with MMI medium containing MPA and 
8-Br-cAMP, the St-T1b cells showed morphological transformation from small elongated 
fibroblast cells into large rounded epithelioid cells over 7 days. This transformation of the 
decidualised St-T1b cells was similar to those seen in primary cells used in the project and 
obtained from three different individuals. The merged images of stained decidualised cells 
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showed a reorganisation in the cytoskeleton and the appearance of stress fibres similar to that 
reported by Samalecos et al (2009c). The cytoskeleton plays a fundamental role in mitosis, 
motility, apoptosis, and contractility (Ayscough and Winder, 2004). Cytoskeleton 
reorganisation is controlled by the phosphorylation of myosin light chain and actin dynamics. 
The down-regulation of α-smooth muscle actin is seen  in vitro decidualisation in baboon 
(Strakova et al., 2005), while upregulation of myosin phosphorylation inhibits decidualisation 
(Ihnatovych et al., 2007). 
3.3.2. Summary of hESC decidualisation. 
 The strong up-regulation of key decidual markers in St-T1b cells such as dPRL IGFBP-1 
FOXO1, KAI1, PLZF, SOD2, and IRF4 indicates that they have undergone successful 
decidualisation. The results obtained for the St-T1b cells over many passages (20- 40) were 
similar to the primary hESC confirming the original study by Samalecos et al (2009c) and 
validated their use as a suitable surrogate for primary hESC in the development of in vitro 
models throughout this study. Samalecos et al (2009c) found that cAMP can induce transient 
decidualisation and IGFPB-1 expression, but the use of MPA on cAMP-primed hESC led to a 
robust sustained decidual response. hTERT generated St-T1b cells have advantages over T- 
hESC fibroblast immortalized with hTERT or hESC immortalised with SV40 large T antigen, 
such as the St-2 cell line (Brosens et al., 1996), in their ability to retain their decidualisation 
response over prolonged periods in culture. Beside P, the decidualisation of hESC is built on 
cAMP and the continuous effect of the PKA pathway. cAMP exerts its P sensitisation effect via 
the Protein kinase A (PKA) pathway (Gellersen and Brosens, 2003b). 
 
 The MPA response depends on P as well as on androgen receptors (Samalecos et al., 2009c). 
FOXO1 has been identified as the initial induced target of the PKA pathway. cAMP and 
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progestin increase nuclear FOXO1 levels and attenuate phosphorylated AKT levels in hESC 
(Feroze-Zaidi et al., 2007, Labied et al., 2006). Different studies elucidate the transcription of 
decidual products and markers. Knockout of FOXO1 in primary hESC resulted in the inhibition  
of 75% of IGFBP-1 and dPRL RNA (Grinius et al., 2006). SOD2, which is ROS scavenger 
during decidualisation is a direct target of FOXO1 and confers the decidua an OS resistance by 
direct regulation of mitochondrial protection antioxidant enzymes (Kajihara et al., 2011). 
Gellersen et al (2007a) found that KAI1 protein in primary hESC is stimulated by cAMP and 
not by P and on silencing of KAI1, IGFBP-1 protein inhibition occurs. PLZF is another decidual 
product that has been recognised with Chromatin immunoprecipitation RNA sequence (ChIP-
DNA Seq) as having approximately ten PGR response binding elements, which suggest that 
PLZF is a direct target of P (Kommagani et al., 2016). Chip-qPCR study has identified that 
there is a co-binding of FOXO1 at most of PGR binding sites in 10 Kb genomic boundaries 
including the highly enriched motif of an important decidual product which is IRF4. IRF4 is a 
direct target of FOXO1 and PR. The knockdown of either progesterone receptor or FOXO1 can 
ablate IRF4. IRF4 ablation can alter the decidualisation morphological transformation and 
secretion of dPRL and IGFBP-1 (Vasquez et al., 2015). 
Interestingly, this study found for the first time the upregulation of Lymphotoxin Beta Receptor 
(LTBR) mRNA in hESC decidualisation, a member of the  TNF-α receptor family  
(McDERMOTT, 2001), LTBR is critical for secondary lymphoid tissue generation and 
peripheral natural killer maturation (Fu and Chaplin, 1999). The decidual LTBR upregulation 
can lead us to suggest further studies to investigate the role of the decidualisation process in 
innate immunity and in the increased immunological protection of the fetus or the mother such 
as against viral infection.   
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Following decidualisation, St-T1b cells were found to have a significantly lower migration rate 
than the proliferative controls. The long standing concept of the passive decidua and invasive 
embryo has more recently been widely challenged by the observation that the endometrial 
decidua has a propensity to migrate during trophoblast invasion (Grewal et al., 2008) and 
encapsulate or engulf the invading blastocyst (Brosens and Gellersen, 2010). This decidual 
motility may even act as a selective tool of good embryos. Weimar et al (2012) demonstrated 
that the decidual stromal cells of women with recurrent miscarriage have an active migratory 
potential even in the presence of compromised embryos whereas the decidual cells of fertile 
women can discriminate by  reduced migration towards bad embryos. Salker et al (2010) might 
explain this poor discrimination due to the extended receptive period, which allows the 
implantation of even a compromised embryo. These  results are in a broad agreement with Fabi 
et al (2017) who did an in vitro scratch assay in primary hESC and found a reduced motility in 
decidualisation and MET due to the inhibition of the AKT/PI3K survival pathway. In contrast, 
the activation of the AKT/PI3K pathway, in epithelial to mesenchymal transition (EMT), 
generally increases cell proliferation, motility and invasiveness (Grille et al., 2003). 
Furthermore, the increased expression of KAI1 with decidualisation as proved earlier in this 
chapter can contribute to the reduced decidual motility. KAI1 inhibits cell invasion and tumour  
metastasis (He et al., 2005). 
 It had been reported that EGF stimulates hESC migration in a transwell migration assay  
(Gentilini et al., 2007). However, Schwenke et al (2013) reported that decidualised St-T1b cells 
were more mobile than proliferative cells in a chemoattractant manner due to  the concentration 
gradient difference in HB-EGF treatment between the upper and lower chambers in the trans 
well migration assay. This difference may be attributed to the different assay techniques used 
by Schwenke et al, who used a higher seeding density for decidualised cells than proliferative 
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cells. In this study I used the same seeding density with the decidualised and proliferative cells 
and looked for trans-kinetic migration. The current finding of reduced migration of decidualised 
cells in comparison with proliferative cells might be explained based on the knowledge that 
decidualised cells have a larger size, with rich lipid and glycogen contents to provide nutritional 
privilege to the growing embryo. EGF was used in  the scratch wound assays to study the effect 
of local growth factor as HB-EGF on hESC motility. HB-EGF plays a critical role in embryo 
implantion as it induces the differentation of trophoblasts (Leach et al., 2004). The deletion of 
HB-EGF in mouse results in a compromised implantion (Xie et al., 2007). Its mRNA expressed 
in hESC (Leach et al., 2004) and by stimulating an incresed level of dPRL and IGFBP-1, EGF 
enhances decidualisation (Chobotova et al., 2002, Chobotova et al., 2005). 
3.3.2. TNF-α did not affect hESC migration in comparison with the control. 
TNF-α is produced by both stromal and trophoblastic cells (Todt et al., 1996). Increased TNF-
α levels have been reported in endometriosis (Kyama et al., 2006). Peng et al (2019) found that 
TNF-α increases the motility of ectopic endometrium via the upregulation of CXC chemokine 
16 (CXCL16), which stimulates phosphorylation of Extracellular signal-regulated protein 
kinases 1 and 2 (ERK1/2). One of the common symptoms of endometriosis is infertility, which 
makes this disease  possesses a critical burden to the society and patient quality of life (Bulun, 
2009). TNF-α can be considered as one of the causes of reproductive failure. The use of anti-
TNF-α medication can help in the treatment of infertility and improve fetal survival (Chaouat 
et al., 1990), also, inhibit stress- induced abortion in mice (Arck et al., 1997). The results 
showed that TNF-α treatment did not alter stromal cell migration during in vitro wound scratch 
assay. To my knowledge, no previous evaluation of the effect of TNF-α on normal stromal cell 
migration has been performed. However, TNF-α has been reported to have a negative effect on 
HTR-8 and JEG3 migration (Todt et al., 1996). Furthermore, TNF-α enhances endometrial 
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stromal contractility using an in vitro collagen gel contraction assay. This supports the 
hypothesis that TNF-α takes part in peri-menstrual endometrial remodelling and repair 
3.3.3. Treatment with decidualised conditioned medium does not affect HTR-8 
migration. 
Protein array studies performed in our lab have shown that decidualisation of St-T1b leads to 
changes in the profile of secreted growth factors and cytokines. In order to determine the 
implication of these changes for blastocyst invasion and implantation, proliferative or 
decidualised St-T1b cell conditioned medium was used in scratch-wounded assays to 
investigate their activity on HTR-8 cells migration. The result revealed no difference in HTR-
8 cell migration following treatment with conditioned medium from decidualised or 
proliferative St-T1b cells in comparison with the control cells in which 1% FBS medium was 
used. 
Whilst these investigations were ongoing a study was published by Yong et al (2018), which 
reported the effects of St-T1b cells decidualised condition medium on HTR-8 cell migration. 
They found a reduced migration of HTR-8 treated with decidualised St-T1b cell conditioned 
medium. This discrepancy with our results might be attributed to the different evaluation 
techniques of cell migration. They used the xCELLigence assay, which is a real time analysis 
that counts cell numbers rather than the scratch area depending on a change in the electrical 
signal. This signal is used an indicator of cellular status, such as cell number without repeating 
time points and multiple imaging. Therefore, it followed the same cell group throughout the 
experiment (Scrace et al., 2013). Their studies used 25% conditioned medium ours used 100% 
conditioned medium. In addition, decidualisation of St-T1b cells was induced using only cAMP 
for 72 h, in contrast, this project used 5 days of stimulation with cAMP and MPA (MPC 
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medium) followed by replating in in MPC medium 24 h prior to the conditioned medium 
harvesting. 
3.3.4. Development of the trophoblast expansion assay 
 The HTR-8 spheroid expansion assay was developed to examine the spreading of HTR-8 
spheroids on the hESC monolayer following decidualisation. The results revealed an enhanced 
HTR-8 spheroid expansion with the decidualisation of the underlying stromal monolayer as 
well as treatment with EGF and TNF-α. 
The original spheroid expansion assay developed by Gonzalez et al (2011) used the AC-1M88 
cells grown as spheroids and cultured over a T-hESC layer. At 48 and 72 h, the cells were fixed, 
and immunohistochemical staining used to allow the discrimination of AC-1M88 trophoblasts 
from the hESC monolayer. In this chapter, the assay has been further developed using HTR-8 
spheroids and optimised to allow continuous monitoring of the same spheroids over the test 
period instead of fixing the cells at multiple time points. Following the decision to use HTR-8 
cells as trophoblast cells in the assay, the type of spheroid preparation was determined. 
Previously, different techniques have been used to create trophoblast spheroids. For instance, 
the widely used hanging drop method (Timmins and Nielsen, 2007). Although this method is 
relatively easy and time saving, its major disadvantage is the difficulty of obtaining uniform 
spheroids of similar sizes. The method of Korff and Augustin (1998) was used to generate HTR-
8 cell spheroids by culturing the cells in 0.25% (w/v) methyl cellulose stock in HTR-8 medium 
(1:5) in non-TC treated round bottom plates, which yielded spheroids of an approximately equal 
size and a uniform shape. 
Our finding of similar HTR-8-spheroid expansion, whether they were seeded over  decidualised 
or proliferative stromal cells, contradicts the stimulated expansion by decidualisation in the 
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Gonzalez et al (2011) study. This may be explained by the different cell line they used, AC-
188 cells, which might have more invasion potential. 
 The enhanced expansion with TNF-α as well as EGF treatment in the assay is  similar to the 
stimulated expansion in the Gonzalez et al (2011) study, although they found more expansion 
with HB-EGF in the HTR-8 spheroids seeded over a proliferative monolayer. This contradiction 
may be that the decidual cells already secrete HB-EGF, which makes the proliferative cells 
more sensitive to the exogenous growth factor. Alternatively, the discrepancy can be  explained 
based on the Grewal et al (2008) co-culture model of donated human embryo and primary hESC 
which  reported that decidualised endometrial cells move in an opposite direction from the 
implantation site leading to more trophoblast expansion. Impaired trophoblast spheroid 
expansion during the implantation window was seen in co-cultures of endometrial tissues from 
recurrent miscarriage patients due to the overexpression of cellular retinoic acid-binding protein 
2 (CRABP2), which may inhibit endometrial cell growth (Lee et al., 2011b). 
3.3.5. Optimization of image processing 
  Image analytic procedures are largely dependent on the quality of processed images. 
Variations in pixel sizes and contrast produce images with variable qualities, which affect 
experiment findings that are based on comparative evaluations. As image pixel size is the 
function of the imaging microscope type and magnification, the standardisation of contrast has 
been guaranteed here by developing macros on ImageJ to ensure uniform adjustment 
procedures for all images in the same experiment.  
Image segmentation is a key process in image analysis to isolate a specific object within a high 
quality image. The trainable weka segmentation plugin has been demonstrated as a precise tool 
to differentiate between image objects (Vyas, 2017). In this project, the application of that 
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plugin has enabled a clear differentiation between the scratched area and cells. This allowed for 
estimating the total remaining scratch area rather than measuring the distance between scratch 
margins at different points (Abdulkareem, 2017). Also, the plugin eliminated the need for the 
manual determination of spheroid boundaries during the calculation of spheroid expansion.  
The extent and magnitude of sprouting are essential criteria to determine the invasiveness of a 
spheroid to the surrounding tissue (Laschke and Menger, 2017). Therefore, both sprout length 
and sprout density were estimated in this study. Previous sprout models relied on automatic 
skeleton analysis of the spheroid after extracting the core area (Hermant et al., 2007). During 
preliminary studies, the visual comparative assessment of the skeleton analysis method 
indicated that the thick sprout can be represented in more than one skeletonized line. Obviously, 
this will add further length to the actual sprout length, the number of sprouts will be more than 
the actual number. Therefore, direct measurement of individual sprout length seems to be more 
reliable than the skeleton method. However, sprout overlapping makes measuring the length of 
every single sprout unachievable. Accordingly, we followed the method of Korff and Augustin 
(1999) who measured the longest sprout at each spheroid quadrant. To evaluate the sprout 
density, we measured the sprout area, which involves all invading sprouts, as a means to avoid 
errors that can be encountered during the non-automatic counting of sprout numbers.            
3.3.6. Reduction of HTR-8 spheroids sprouting with decidualisation of the 
underlying stromal monolayer and stimulated with EGF treatment 
The results revealed that HTR-8 spheroids invasion density is reduced in the control spheroids 
embedded in the gel over a decidualised monolayer of St-T1b cells. In contrast, adding EGF 
during HTR-8 and St-T1b co-culture assays resulted in maximum HTR-8 spheroids sprouting 
density and length when these spheroids were seeded over a proliferative monolayer of stromal 
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cells than those in the decidualised state. Enhancement of HTR-8 spheroid invasion with 
treatment with EGF is in agreement with Bass et al (1994) and Staun-Ram et al (2004) who 
found that EGF increased the invasion of primary human trophoblast cells through the increased 
expression of MMP2 and 9. 
The finding of reduced trophoblast invasion in the presence of the decidualised hESC 
monolayer might be attributed to the fine tuning of different factor influences, such as  IGFPB-
1, which is a decidualisation marker that increases the invasion (Chakraborty et al., 2002),  and 
to the interaction between metalloproteinase inhibitors and metalloproteinase to regulate 
trophoblastic invasion (Staun-Ram et al., 2004). Accordingly, this project supports the notion 
that the decidua works as a physiological barrier, which controls trophoblastic invasion to the 
physiological limit without invading into the inner layer of myometrium. In contrast, pregnancy 
without proper decidualisation, as in ectopic pregnancy, can reflect uncontrolled invasiveness 
leading to the expulsion of the gestational sac (Refaat et al., 2008, Lala and Graham, 1990, 
Billington, 1971) 
 In conclusion; St-T1b cell line showed a decidual response similar to that of primary hESC, 
therefore, can be considered as an appropriate robust model for primary hESC. Also, the HTR-
8 cell line cultured as spheroids showed expansion and invasive properties, which indicate they 
are a good choice to represent the trophoblasts of the invading blastocyst. Functionally, stromal 
cell motility increased with EGF treatment and reduced following decidualisation. HTR-8 cell 
migration did not change with decidualised hESC conditioned medium. HTR-8 spheroid 
expansion increases with decidualisation while the invasion was controlled. The established 
assays can serve as platforms to further investigate the factors affecting the maternal-fetal 
interface at the time of implantation. These assays are simple, reproducible, and can be analysed 
with freely available software using the developed protocol. 
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4.1. Introduction  
PDGF can affect different cell functions such as proliferation, matrix synthesis, chemotaxis, 
vascularization, antiapoptosis, and wound healing (Islam et al., 2016). PDGFR-α was originally 
identified as a mitogen for cells of mesenchymal origin such as fibroblasts (Pierce et al., 1991). 
Different roles have been reported for PDGF in female reproductive function such as ovarian 
function, embryo implantation, decidualisation, trophoblast invasion, angiogenesis, and 
infertility problems such as endometriosis. Piscale et al (2015) found that injection of PDGF 
receptor inhibitors to the female rat can inhibit folliculogenesis as PDGF is required for the 
transition from primordial to primary follicle in the rat (Nilsson et al., 2006). Higher levels of 
PDGF were detected in the peritoneal fluid of the fertile women in comparison with nulliparous 
individuals (Overton et al., 1996). Lee et al (2007b) reported a low level of PDGF-AA mRNA 
expression in the euotopic endometrium during the secretory phase in women with excessive 
endometriosis and infertility. In the uterus, PDGF stimulates the proliferation of hESC (Surrey 
and Halme, 1991) and decidual cells (Saji et al., 1997). It can modulate the expression of LIF 
during decidualisation (Arici et al., 1995). PDGF was shown to stimulate the migration of hESC 
(Jeong et al., 2015) in both in vitro scratch and trans-well migration assays (Matsumoto et al., 
2005). PDGF-BB was reported to enhance the chemokinesis and chemotactic migration of St-
T1b and primary hESC, whilst PDGF-AA increases their chemotactic migration only 
(Schwenke et al., 2013). PDGF has been reported not to affect the invasive ability of cyto-
trophoblasts (Bass et al (1994), whilst other studies as Ferretti et al (2007) indicated that PDGF 
enhances trophoblastic invasion. 
Different studies have investigated the localisation of PDGF isoforms and their receptors in the 
blastocyst and endometrium in order to explore whether it works in a paracrine or autocrine 
manner on the affected cells. In the endometrium, Boehm et al (1990) reported the presence of 
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PDGF-B transcripts in late proliferative human endometrium tissue (which is the only type 
used) whilst PDGF-AA was rarely detected  by northern blotting. In contrast, Chegini et al 
(1992) recognised that primary hESC expressed immunoreactive PDGF-AB and PDGFR-β 
only. Immunohistochemical staining of human fetal-maternal interface shows an intense 
immunostaining of PDGFR-β and to a lesser extent PDGFR-α in decidual cells, whilst 
trophoblasts and endothelial cells fail to show staining (Jokhi et al., 1997). An additional study 
performed by Mazur et al (2015) using RNA analysis in primary hESC reported that PDGF-
CC, PDGF-AA, and PDGFR-α  are differentially expressed before or after decidualisation 
stimulation. In mice, an immunohistochemistry study showed intense immunostaining for 
PDGF in the peri-implanting decidual endometrial zone  during pregnancy (Jaber and Kan, 
1998).  
4.1.1. Aims and objectives 
 Although PDGF isoform and receptor expression, the expression and potential activity of these 
growth factors, ligands, or their effect on hESC–trophoblast interactions has not been 
demonstrated comprehensively. We hypothesised that decidualisation would alter the 
expression of PDGFs and their receptors in hESC, and that PDGF would affect the interaction, 
migration and invasion of hESC and trophoblasts. 
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4.2 Results  
To investigate the potential role of PDGFs in hESC and trophoblast function, the expression of 
PDF isoforms and their receptors were first investigated in hESC and the HTR-8 cell line. 
4.2.1. Expression of PDGF isoforms by HTR-8 and St-T1b cells 
PDGFs are reported to be expressed by endothelial cells (Heldin and Westermark, 1999). 
HUVEC and the HMEC-1 cells were used as a control for these studies. The cells were grown 
to confluence on 6-well dishes and the mRNA and protein harvested, and qPCR and Western 
blotting performed.  
As expected, endothelial cells showed a clear PDGF-AA mRNA and protein expression (Figure 
4.1A). The HTR-8 trophoblast cell line expressed a high level (p<0.001) of PDGF-AA mRNA 
in comparison with HUVEC, HMEC-1 and proliferative St-T1b cells. Likewise, protein 
expression in HUVEC was higher (p<0.05) than those in St-T1b cells. Recombinant PDGF-
AA (R-AA) produced in E. coli was used as a positive control. Western blotting produced a 
band of 17 kDa, whereas the endogenous PDGF-A chain produced a band of ~ 20 kDa (Figure 
4.1B).   
PDGF-BB mRNA was not detected in hESC (Figure 4.1C). PDGF-BB was detected in HTR-8 
cells, although levels were significantly lower than HUVEC (Figure 4.1A). The lack of PDGF-
BB expression in hESC was confirmed by Western blot analysis (Figure 4.1D). In HTR-8 and 
endothelial cells, a positive band (<20 kDa) was detected and Recombinant human PDGF-BB 
(R-BB) (2 ng) produced in E. coli was used as a positive control which ran as a single band at 
~17 kDa. 
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Figure 4.1: HTR-8 express PDGF-AA and PDGF-BB and PDGF-CC while hESC didn’t 
express PDGF-BB. Confluent monolayers of HUVECs, HMEC-1, HTR-8, and St-T1b cells were 
incubated in their complete growth medium for 24 h. Relative mRNA fold changes of (A) PDGF-
AA (C) PDGF-BB and (E) PDGF-CC expression normalised to β-actin. Representative Western blot 
showing (B) PDGF-AA and (D) PDGF-BB protein expression with Tubulin used as a loading 
control. Results are the mean (± SEM) of three independent experiments. Statistically significant 
differences (*P<0.05, **P<0.001). Recombinant PDGF-AA (R-AA) and PDGF-BB (R-BB). 
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By comparing the expression of PDGF-CC mRNA expression in endothelial, HTR-8, and St-
T1b cells, qPCR analyses revealed that HUVEC significantly expressed a higher level of 
PDGF-CC mRNA (Figure 4.1.E) 
4.2.2. Expression of PDGF receptors and endosialine by HTR-8 and stromal cells 
The results revealed significantly greater PDGFR-α mRNA expression in St-T1b cells in 
comparison with HTR-8 cells and endothelial cells (Figure 4.2A). This finding was confirmed 
with a strong band protein expression corresponding to PDGFR-α in St-T1b cells in comparison 
with HTR-8 and endothelial cells (Figure 4.2B). 
As expected, PDGFR-β was detected in hESC with similar levels, also it was present in HTR-
8 cells (Figure 4.2C). Although PDGFR-β mRNA was significantly lower than St-T1b cells, no 
PDGFR-β protein was detected by Western blotting in HUVEC and HMEC-1 cells (Figure 
4.2C & D). 
As endosialin can affect fibroblast cells through its binding to PDGFR-β (Tomkowicz et al., 
2010, Wilhelm et al., 2016), its expression in HTR-8 and hESC was investigated. This result 
revealed that HTR-8 and endothelial cell lack this protein which is strongly expressed by St-
T1b cells (Figure 4.2E). 
4.2.3. Reduction of PDGF-AA expression during hESC decidualisation 
In St-T1b cells, PDGF-AA mRNA was significantly higher in the proliferative group than the 
decidualised group at day 4 (Figure 4.3A). In parallel, Western blotting revealed a stronger band 
(20 kDa) in proliferative cells on day 4 and 7 than the decidual hESC (Figure 4.3B).  
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Figure 4.2: HTR-8 express PDGFR-α and PDGFR-ß and lack endosialin expression. 
Confluent monolayers of HUVEC, HMEC-1, HTR-8, and St-T1b cells were incubated in their 
complete growth medium for 24 h. Relative mRNA fold changes of (A) PDGFR-α and (C) 
PDGFR-ß expression normalised to β-actin. Representative Western blot showing (B) PDGFR-
α, (D) PDGFR-ß, and (E) endosialin protein expression with Tubulin used as a loading control. 
Results are the mean (± SEM) of three independent experiments. Statistically significant 
differences (*P<0.05).  
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Figure 4.3: PDGF-BB is not expressed in hESC. Confluent monolayers of St-T1b and primary 
hESC cells were incubated in E2 or in MPC medium for 4 and 7 days. Relative mRNA of PDGF-
AA in (A) St-T1b cells and (C) in primary hESC normalised to β-actin. Representative Western 
blots showing PDGF-AA protein expression in (B) St-T1b cells and (D) Primary hESC; and 
PDGF-BB protein expression in (E) St-T1b cells and (F) primary hESC with Tubulin used as a 
loading control. Results are mean (± SEM) of three independent experiments. Statistically 
significant differences (*P<0.05).  C4 (control day 4), C7 (control day 4), D4 (decidualised day 
4), D7 (decidualised day 7), R-AA (Recombinant PDGF-AA), and recombinant PDGF-BB (R-
BB). 
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In primary hESC, PDGF-AA mRNA was also significantly higher in proliferative in 
comparison with decidualised cells on day 7 (Figure 4.3C). Likewise, Western blotting revealed 
a strong PDGF-AA protein expression on proliferative day 4, day 7, and HTR-8 cells (Figure 
4.3D).  
4.2.4. hESC does not express PDGF-BB  
As the PDGF-BB gene was reported to be regulated during hESC decidualisation (Mazur et al., 
2015), its expression by hESC was evaluated. qPCR and Western blotting were performed 
following decidualisation induction in hESC at 4- and 7-days intervals. PDGF-BB mRNA was 
undetected by qPCR (Figure 4.1C), and Western blotting showed the absence of PDGF-BB 
protein in St-T1b and primary hESC (Figure 4.3E & F). 
4.2.5. Increased PDGF-CC expression during hESC decidualisation 
PDGF-CC was reported to be regulated during hESC decidualisation (Mazur et al., 2015). This 
experiment evaluated the PDGF-CC mRNA expression during hESC decidualisation. The result 
revealed for the first time that PDGF-CC mRNA is significantly upregulated during the early 
decidualisation of primary hESC (Figure 4.4A & B). 
4.2.6. Upregulation of PDGFR-α expression during hESC decidualisation 
 In order to confirm the expression of PDGFR-α in hESC and assess the effect of decidualisation 
on its mRNA and protein expression, we performed qPCR and Western blotting. Upon 
decidualisation of hESC, the mRNA expression of PDGFR-α was found to be significantly 
upregulated at day 4 and day 7 in both St-T1b and primary hESC (Figure 4.5A & C). This result 
was confirmed in both types of hESC by Western blots, which showed a strong induction of 
PDGF receptor particularly in primary hESC with decidualisation (Figure 4.5B & D).  
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Figure 4.4: Upregulation of PDGF-CC expression during primary hESC decidualisation. 
Confluent monolayers of St-T1b and primary hESC were incubated in E2 or in MPC medium 
for 4 and 7 days. Relative mRNA fold changes of PDGF-CC in (A) St-T1b cells and (B) primary 
hESC. Results are mean (± SEM) of three independent experiments. Statistically significant 
differences (*P<0.05**P<0.001). 
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Figure 4.5: Upregulation of PDGFR- α expression during hESC decidualisation. Confluent 
monolayers of St-T1b and primary hESC were incubated in E2 or in MPC medium for 4 and 7 days. 
Relative mRNA of PDGFR-α in (A) St-T1b cells and (C) primary hESC. Representative Western 
blot showing PDGFR-α protein expression in (B) St-T1b cells and (D) primary hESC with Tubulin 
used as a loading control. Results are mean (± SEM) of three independent experiments. Statistically 
significant differences (*P<0.05). C4 (control day 4), C7 (control day 4), D4 (decidualised day 4), 
D7 (decidualised day 7) 
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4.2.7. Upregulation of PDGFR-ß during hESC decidualisation 
 To further evaluate the expression of PDGFR-ß by hESC, the effect of decidualisation on 
mRNA and protein expression was determined in these cells. Upon the decidualisation of St-
T1b and primary hESC, PDGFR-ß mRNA expression was significantly upregulated on day 4 
decidualised St-T1b cells (Figure 4.6A & C). However, although PDGFR-ß was readily 
detected by Western blotting in hESC, there were no observable differences between the 
decidual and proliferative cells (Figure 4.6B & D). 
4.2.8. Upregulation of endosialin expression during primary hESC 
decidualisation 
As the expression of endosialin had not been explored previously in hESC, we determined the 
relative level of endosialin in St-T1b cells and primary hESC and its regulation by 
decidualisation. The results revealed that endosialin mRNA and protein are expressed in St-t1b 
cells as well as primary hESC (Figure 4.7A & C). Whilst in St- T1b cells, decidualisation did 
not significantly affect endosialin expression, in primary cells, endosialin mRNA was 
significantly upregulated in day 4 decidualised primary hESC. Western blotting showed a 
strong band of endosialine in St-T1b cells (Figure 4.7B). In primary cells, protein bands were 
more intense in day 4 and day 7 decidualised cells (Figure 4.7D). 
4.2.9. The effect of FOXO1 on PDGF expression:  Positive correlation between 
FOXO1 and PDGFR-α mRNA expression during hESC decidualisation 
Mazur et al  (2015) found that PDGFR-α and FOXO1 were differentially expressed during 
decidualisation of hESC by RNA analysis. To determine whether there was an association 
between FOXO1 and PDGF expression, changes in the levels of gene expression in St-T1b and 
hESC were correlated (Figure 4.8). 
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Figure 4.6: Upregulation of PDGFR-β expression during hESC decidualisation.  Confluent 
monolayers of St-T1b and primary hESC were incubated in E2 or in MPC medium for 4 and 7 
days. Relative mRNA fold changes of PDGFR-ß in (A) St-T1b cells and (C) primary hESC. 
Representative Western blots showing PDGFR-ß protein expression in (B) St-T1b cells and (D) 
Primary hESC with Tubulin used as a loading control. Results are mean (± SEM) of three 
independent experiments. Statistically significant differences (*P<0.05). C4 (control day 4), C7 
(control day 4), D4 (decidualised day 4), D7 (decidualised day 7) 
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Figure 4.7: Upregulation of endosialin expression during primary hESC decidualisation.  
Confluent monolayers of St-T1b and primary hESC were incubated in E2 or in MPC medium for 
4 and 7 days. Relative mRNA of endosialine in (A) St-T1b cells and (C) primary hESC. 
Representative Western blot showing endosialin protein expression in (B) St-T1b cells and (D) 
primary hESC. Tubulin used as a loading control. Results are mean (± SEM) of three independent 
experiments. Statistically significant differences (*P<0.05). C4 (control day 4), C7 (control day 
4), D4 (decidualised day 4), D7 (decidualised day 7).  
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A positive correlation of mRNA expression levels between PDGFR-α and FOXO1 for both St-
T1b and primary hESC upon decidualisation was found using Pearson’s correlation coefficients 
(r2) for statistical analysis (Figure 4.8).  
To determine whether upregulation of PDGFR-α during decidualisation was regulated by 
FOXO1, FOXO1 knockdown was performed in St-T1b cells using Viromer blue transfection 
reagent. The levels of PDGFR-α mRNA were reduced following FOXO1 knockdown; 
however, the differences did not reach significance (Figure 4.9A). Additionally, we were unable 
to detect a difference in PDGFR-α protein expression between the decidualised FOXO1 
transfected cells (siFOXO1) and non-targeted decidualised group (siControl) (Figure 4.9D). 
4.2.10. Expression of PDGF-AA with TNF-α treatment in St-T1b cells  
HTR-8 spheroid expansion was enhanced in the TNF-α treated ST-T1b cells. To investigate the 
effects of TNF on endometrial stromal cell PDGF and receptor expression, St-T1b cells were 
treated with TNF-α (50 ng/ml) for 16 h or 24 h. qPCR and Western blot analyses of PDGF-AA, 
PDGFR-α, and PDGFR-β were performed. PDGF-AA mRNA expression was significantly 
induced with TNF-α at both treatment intervals (Figure 4.10A). However, no obvious 
differences in protein expression were detected by Western blot (Figure 4.10B). PDGFR-α and 
PDGFR-β RNA and protein expressions were not significantly changed with TNF-α treatment. 
(Figure 4.10C- F). 
4.2.11. PDGF-BB stimulates hESC migration 
PDGF-BB and PDGF-AA were reported to enhance the migration of hESC (Schwenke et al., 
2013). To elucidate the effect of PDGF on stromal cell migration during decidualisation, St-
T1b were grown to confluence on 6-well dishes, induced to decidualise in MMI medium, 
followed by scratch-wound and treatment with PDGF-BB (10 ng/ml). 
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Figure 4.8: Positive correlation between FOXO1 and PDGFR-α expression during hESC 
decidualisation. Confluent monolayers of St-T1b cells and primary hESC were incubated in an 
E2 or MPC medium for 4 and 7 days. Relative mRNA expressions of decidualised PDGFR-α 
and FOXO1 of five independent experiments in St-T1b cells, and three independent experiments 
in primary hESC were determined by qPCR. Pearson correlation (r2) analyses were applied 
between FOXO1 and PDGFR- α during day 4 and day 7 hESC decidualisation.  
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Figure 4.9: Effect of FOXO1 knockdown on PDGFR-α expression in hESC. Confluent 
monolayers of St-T1b were treated with transfection siRNA (37.5 nM) for 24 h followed by 
incubation in a E2 or in MPC medium for 24 h. qPCR and Western blot analyses were 
performed. Relative mRNA of (A) FOXO1 and (C) normalised to β-actin. Representative 
Western blot of (B) FOXO1 and (D) PDGFR-α protein expression. Tubulin used as a loading 
control. Results are the mean (± SEM) of three independent experiments. Statistically 
significant differences (*P<0.05).  
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Figure 4.10: Effect of TNF-α treatment on PDGF-AA and cognate receptors in hESC. A 
confluent monolayer of St-T1b cells were treated for 16 h or 24 h with TNF-α (50 ng/ml) in 1% 
FBS DMEM/HAM F12 medium. Relative mRNA of (A) PDGF-AA, (C) PDGFR-α, and (E) 
PDGFR-β normalized to β-actin. Representative Western blot of (B) PDGF-AA, (D) PDGFR-α, 
(F) and PDGFR-β. Tubulin used as a loading control. Results are the mean (± SEM) of three 
independent experiments.  Statistically significant differences (*P<0.05). 
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hESC migration was significantly increased with PDGF-BB treatment in both proliferative as 
well as decidualised cells (Figure 4.11B). The migration of decidualised cells was significantly 
lower than that of the corresponding proliferative cells. The images showed that the remaining 
scratched areas were smaller in the proliferative than in the decidualised cells (Figure 4.11A). 
Additionally, in the PDGF-BB-treatment group, the scratched regions were smaller than in the 
untreated controls. 
Additional evaluation of stromal cell migration was performed using PDGF-AA (100 ng/ml) or 
HTR-8 cell-conditioned medium. For this purpose, confluent monolayers of St-T1b cells 
growing on 6-well dishes were scratch-wounded and treated with either PDGF-AA or HTR-8 
cell conditioned medium. PDGF-BB-treated cells were used as a positive control. PDGF-AA 
treatment or adding HTR-8 conditioned medium had no effect on St-T1b migration in 
comparison with untreated cells (Figure 4.12B). The photomicrographs showed that PDGF-AA 
or HTR-8 conditioned medium does not promote hESC migration (Figure 4.12A).  
4.2.12. PDGF-BB promotes HTR-8 spheroid expansion 
Decidualisation and growth factors have been reported to affect the expansion of spheroid cells 
over the endometrium during embryo implantation (Gonzalez et al., 2011); however, the role 
of PDGF-BB on hESC has not been evaluated yet. Therefore, a spheroid expansion assay was 
performed under PDGF-BB treatment. In this assay, Vybrant green labelled HTR-8 spheroids 
were seeded over proliferative or decidualised St-T1b monolayers that were treated with PDGF-
BB. The spheroid expansion was followed for 48 h and 72 h and analysed in relation to 0 h 
spheroid using ImageJ (𝑆𝑝ℎ𝑒𝑟𝑜𝑖𝑑 𝑒𝑥𝑝𝑎𝑛𝑠𝑖𝑜𝑛 =
𝑆𝑝ℎ𝑒𝑟𝑜𝑖𝑑 𝑎𝑟𝑒𝑎 (48 ℎ 𝑜𝑟 72 ℎ)
𝑆𝑝ℎ𝑒𝑟𝑜𝑖𝑑 𝑎𝑟𝑒𝑎 (0 ℎ)
 ). 
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Figure 4.11.: PDGF-BB stimuli effect on St-T1b in vitro migration. Confluent monolayers of 
St-T1b hESC were induced for decidualisation or left as proliferative cells and scratch-wounded. 
Their migration assessed after 18 h in the presence of PDGF-BB (10 ng/ml) in 1% FBS Ham F12 
DMEM medium. Cell migration was assessed after 18 h at 10 points/treatment conditions in 2 wells 
and calculated as migration % = (Scratch area at 0 h - scratch area at 18 h/scratch area at 0 h)*100. 
(A) Representative bright field images (4 x objective) showing the scratch areas at 0 and 18 h. (B) 
Results are means (± SEM) of the migration percentage at 18 h relative to zero time point of three 
independent experiments.  Statistically significant differences (*P<0.05).  Scale bar = 400 µm. 
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Figure 4.12. Effect of PDGF-AA or HTR-8 on ST-T1b migration. Confluent monolayers 
of proliferative St-T1b hESC were scratch-wounded. Their migration assessed after 18 h in 
the presence of HTR-8 conditioned medium, PDGF-BB (10 ng/ml), and PDGF-AA (10 ng/ml) 
in 1% FBS medium. Cell migration was assessed after 18 h at 10 points /treatment condition 
in 2 wells and calculated as migration % = (Scratch area at 0 h - scratch area at 18 h/scratch 
area at 0 h)*100. (A) Representative bright field images (4 x objective) showing the scratch 
areas at 0 and 18 h. Scale bar = 400 µm. (B) Results are means (± SEM) of the migration 
percentage at 18 h relative to zero time point of three independent experiments.  Statistically 
significant differences (*P<0.05).  
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PDGF-BB treatment was found to enhance the expansion of HTR-8 spheroids over a 
proliferative St-T1b monolayers at 48 h (Figure 4.13B). By 72 h the spheroids continue to 
expand as seen in the images (Figure 4.13A). The PDGF-BB treated decidualised St-T1b cell 
monolayers promoted HTR-8 spheroid expansion to a significantly greater extent in comparison 
with PDGF-BB treated proliferative hESC and untreated decidualised hESC (Figure 4.13B & 
A).  
4.2.13. PDGF-BB enhanced the invasion of HTR-8 spheroids 
Trophoblastic invasion was reported to be stimulated by PDGF-BB (Ferretti et al., 2007); 
however, a clear role of PDGF-BB on trophoblastic invasion in the context of decidualisation 
is not yet explored. Thus, HTR-8 spheroid invasion assay was utilised. The assay performed by 
embedding the Vybrant green-labelled HTR-8 spheroids in fibrin gels set over a layer of 
proliferative or decidualised St-T1b cells. The findings show that spheroid sprouting density 
and length at 48 h of the experiment were enhanced in PDGF-BB treatment whether seeded on 
proliferative or decidualised monolayers. However, the sprouting density was lower in the 
spheroids in the presence of decidualised St-T1b monolayers (Figure 4.14B). The images show 
enhanced trophoblast spheroid sprouting in the presence PDGF-BB treated decidualised hESC 
groups (Figure 4.14A). 
At 72 h of the experiment, the sprouting density of PDGF-BB treated group was higher 
(p<0.001) in the spheroids seeded over the proliferative monolayers than those seeded over the 
decidualised monolayers. The sprouting length was also increased (p<0.05). In comparison 
with the untreated cells, the sprouting density and length were lower than those of PDGF-BB 
treated cells (Figure 4.14B). The images of labelled HTR-8 spheroids showed reduced invasion 
in the cells seeded over decidualised St-T1b monolayers (Figure 4.14A).  
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Figure 4.13: PDGF-BB increased HTR-8 spheroid expansion.  HTR-8 spheroids were labelled 
with Vybrant green dye and seeded onto proliferating (black bar) or decidualised (blue bar) 
monolayers of St-T1b cells. The co-cultures were then treated with PDGF-BB (10 ng/ml) in 1% 
FBS medium.  HTR-8 spheroid expansion was calculated as spheroid size at 48 h or 72 h /spheroid 
size at 0 h using ImageJ. Ten spheroid/treatment condition were measured in 4 wells. (A) 
Representative fluorescent images using Vybrant green dye (4x objective) showing spheroid 
expansion areas at 48 and 72 h (B) Results are the means (± SEM) of three independent experiments.  
Statistically significant differences (*P<0.05). Scale bar = 400 µm. 
Chapter 4 – The role of decidualisation on PDGF family expression 
149 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
 
Chapter 4 – The role of decidualisation on PDGF family expression 
150 
 
Control PDGF-BB 
0
5000
10000
15000
S
p
r
o
u
t 
d
en
si
ty
  
(
m
2
)
Prolifertive
Decidualised
✱✱
✱
Control PDGF-BB 
0
50
100
150
S
p
ro
u
t 
le
n
g
th
  
(
m
)
✱
✱
Control PDGF-BB 
0
50
100
150
sp
ro
u
t 
le
n
g
th
 (

m
)
✱
✱
✱✱
Control PDGF-BB 
0
5000
10000
15000
S
p
r
o
u
t 
d
en
si
ty
  
(
m
2
)
✱
✱
Sprout density
Sprout length
48 h 72 h
48 h 72 h
 
B 
Figure 4.14: PDGF-BB stimulated hESC promotes the invasion of HTR-8 spheroids. 
Labelled HTR-8 spheroids were set in a fibrin gel over proliferating or decidualised labelled 
monolayer of St-T1b hESC. The co-cultures were then treated with PDGF-BB (10 ng/ml) in 
1% FBS medium. The sprout density and sprout length were calculated for 10 spheroids / 
condition in 4 wells from 3 independent experiments using ImageJ. (A) Representative 
fluorescent images of HTR-8 spheroid invasion into the fibrin gel at 48 h and 72 h (4x 
objective). (B) Results are means (± SEM) of 3 independent experiments. Statistically 
significant differences (*P<0.05, **P<0.001). Scale bar = 200 µm. 
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4.3. Discussion 
4.3.1. Expression of PDGFs in hESC. 
It is well known that endothelial cells such as HUVEC and HMEC-1 are expressers of PDGF 
angiogenic factors. Therefore, they have been used in this project as a positive control to 
investigate PDGF expression by trophoblastic cell lines and hESC. The result revealed that 
PDGF-AA is expressed by hESC and HTR-8 at mRNA and protein levels. The PDGF-AA 
expression in HTR-8 cells were even higher than in endothelial cells. While PDGF-BB was 
expressed in HTR-8 both at an mRNA and protein level, however it was undetected in St-T1b 
cells. 
 The results of this chapter revealed that PDGF-AA mRNA expression in St-T1b cells was 
lower in decidualised day 4 cells than in proliferative cells. Similar expression was seen in day 
7 primary hESC. PDGF-AA can bind to PDGFR-α on stromal cells and exerts its effect on the 
maternal fetal interface. PDGF-BB exerts its effect through PDGFR- α or with a higher binding 
affinity to PDGFR-β. Both receptors have been proved to be expressed in hESC and HTR-8 
cells. In Western blots of PDGF-AA and PDGF-BB, the recombinant PDGF-AA and PDGF-
BB bands appeared at a lower level than the endogenous PDGF bands detected in the hESC 
endothelial or HTR-8 cells. Dai et al (2015) has recognised the same discrepancy in band levels 
when using PDGF recombinant protein produced in yeast due to post translation modifications. 
The recombinant PDGF-AA and PDGF-BB proteins used in this thesis were produced in E. 
coli, which is not capable of post translation modifications. Both PDGF-B and PDGF-A possess 
pro-peptide sequences (~60 amino acids in length), which  are cleaved from the mature PDGF 
by proprotein convertases such as furin (Fredriksson et al., 2004). The recombinant protein is 
formed from disulphide-linked homodimers of two mature forms of PDGF-B chains of ~16 
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kDa size. When performing the Western blotting under denaturing and reducing conditions the 
homodimers of PDGF-BB will be destabilised and only the PDGF-B monomers are detected. 
On the other hand, the protein band detected in the cell lysates most likely is the mature form, 
which in eukaryotic cells will be in proprotein sequence and runs above 20 kDa. 
 The low expression of PDGF-AA with decidualisation goes in agreement with Lee et al 
(2007b) who found a low expression of PDGF-AA mRNA in the eutopic endometrial tissue 
obtained either by curettage or following hysterectomy during the secretory phase of the 
menstrual cycle. Lash et al  (2011) reported the  absence of PDGF-BB immunoreactivity in 
primary hESC at any stage of the menstrual cycle which is in agreement  with our findings of 
qPCR and Western blotting. Additionally, Gray et al (1995) by an immunohistochemistry study  
found a steroid related regulation of PDGF ligands and receptors in a pregnant mice, also found 
that Diethylstilbestrol (DES) treatment can reduce PDGF ligands and receptors. The steroid 
regulation of PDGF ligands might explain the current finding of changed PDGF-AA expression 
during decidualisation on treatment with the progestational compound. Likewise, other authors 
showed the absence or the rarely detection of PDGF-AA and PDGF-BB in hESC. Schwenke et 
al (2013) showed the absence of PDGF-AA and PDGF-BB during St-T1b decidualisation in a 
microarray study. In contrast, Boehm et al (1990) reported the presence of PDGF-BB and rare 
detection of PDGF-AA transcripts by Northern blotting of primary hESC mRNA. Chegini et al 
(1992) recognised the absence of immunoreactivity of both PDGF-AA and PDGF-BB and the 
presence of PDGFR-β immunoreactivity in  primary hESC.  
4.3.2. PDGF-CC upregulation during decidualisation in primary cells 
PDGF-CC is a polypeptide which has C-terminal and N-terminal with a Complement 
subcomponents C1r/C1s, Urchin EGF-like protein, and Bone marrow protein 1 (CUB) domain, 
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which found almost exclusively in plasma membrane-associated and extracellular proteins. The 
possession of this domain gives the PDGF-CC a similarity to VEGF family. Furthermore, PDG-
CC expressed the cysteine motif of growth family similar to  PDGF family (Tsai et al., 2000a) 
(Li et al., 2000). PDGF-CC binds to PDGFR-α and PDGFR- β (Cao et al., 2002). PDGF-CC is 
highly expressed in the platelets, prostate, testis and uterus. It plays an important role in the 
embryo development as well as in wound healing through improving proliferation, remodelling, 
survival and chemotaxis (Grazul-Bilska et al., 2003).  
PDGF-CC mRNA was detected in HTR-8 cells, but the expression was less than that seen in 
endothelial and stromal cells. A significant up-regulation of PDGF-CC mRNA was detected in 
decidualised primary hESC. These results disagree with Mazur et al.  (2015) who found in a 
microarray study that PDGF-CC is one of the genes upregulated during the decidualisation of 
hESC through a PGR binding mechanism. PDGF-CC was first recognized in human 
endometrium and fallopian tubes and initially termed Fallotein (Tsai et al., 2000a). Li et al 
(2000) found through a northern blot analysis that PDGF-CC is also highly expressed in 
placenta. Vasquez et al (2015) found that PDGF-CC has a binding site for FOXO1 and PGRs 
in a 10 Kb region upstream of the transcriptional start site. The finding of PDGF-CC 
upregulation during decidualisation needs further research particularly in the context of the 
effect on the cell functions at the maternal-fetal interface by knockdown and see whether this 
affects cell migration.  
4.3.3. Increased expression of PDGF receptor during decidualisation of hESC 
The result revealed a greater expression of PDGHFR-α in St-T1b cells when compared with the 
trophoblast cell line and HTR-8 cells. PDFR-ß was also expressed in St-T1b and HTR-8 cells 
but its protein was not detected in endothelial cells. Also, the results revealed a consistent 
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upregulation of PDGFR-α mRNA and protein during decidualisation in both types of hESC. 
These findings imply a steroid regulation role in PDGF receptor expression, which can further 
lead to functional differences in these cells. Lash et al (2011) indicated a reduction in those 
receptors’ immunostaining in the secretory phase of women with recurrent miscarriage as well 
as following diethylstilbestrol (DES) administration in mice (Gray et al., 1995). Mazure et al 
(2015) supported our finding as it recognised PDGFR-α as a decidualisation differentiated gene 
regulated by the PGR, whilst FOXO1 was not identified as a regulator of PDGFR-α  (Vasquez 
et al., 2015). Additionally, Mazure et al (2015) reported that PDGFR-β is not regulated during 
primary hESC decidualisation and this supports our finding in primary cells. 
PDGF Ligands binding to PDGF tyrosine kinase receptors stimulates receptor dimerisation and 
initiates different signalling. Ligands-receptors binding is a complex process which functionally 
limited in vivo mainly to the interaction with PDGFR-α and PDGFR-β (Andrae et al., 2008), 
while  heterodimers such as PDGFR-αß receptor also exists as  have been described in mice in 
vitro (Klinghoffer et al., 2001). For this reason, this project focused on the expression of 
PDGFR-α and PDGFR-β only.  
According to our finding it can be suggested that PDGF-AA can work in an autocrine manner 
on hESC, also in a paracrine manner through its release from endothelial and trophoblastic cells. 
The absence of PDGF-BB in the stromal cells can indicate that it works through a paracrine 
manner through its release from endothelial and trophoblastic cells.  
4.3.4. Upregulation of endosialin in primary hESC 
Endosialin is a stromal cell surface receptor that has been shown to be highly expressed in the 
embryo. It has lower expression levels in the adult life except where its expressed in normal 
blood vessels, the corpus luteum, and during wound healing (Croix et al., 2000), or in a 
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pathological conditions as tumours, arthritis (Maia et al., 2010), and atherosclerosis (Hasanov 
et al., 2017). Endosialin can stimulate mesenchymal cell proliferation through the PDGFR-β 
activity (Tomkowicz et al., 2010, Wilhelm et al., 2016). Interestingly, the results show for the 
first time the intense endosialin protein expression by St-T1b and upregulation in its mRNA 
and protein expression in the decidualised primary hESC. The intense endosialine expression 
by the St-T1b cell line may be explained based on the knowledge that endosialin is associated 
with tumour and is not expressed in normal cells. Further evaluation of the endosialine role in 
the embryo-trophoblast interactions is required. For instance, by using endosialin 
overexpressed or knockdown experiments to investigate its effect on the migration, 
proliferation, and invasion of cells in embryo implantation. If any effect can be proved then 
further evaluation to map the effect pathway whether it is through the modulation of PDGF-
BB, ERK, or PDGFR-ß as seen in human pericytes (Tomkowicz et al., 2010)  
4.3.5. Regulation of PDGFRs in hESC 
A positive correlation between PDGFR-α and FOXO1 has been found in this project.  However, 
on FOXO1 knocked-down there was no significant change in PDGFR-α expression. This 
positive correlation supports the study of Mazur et al (2015), who recognised the PDGFR-α 
and FOXO1 as both differentially expressed in decidualisation of primary hESC with the P has 
a regulatory effect on PDGFR- α. Mei et al (2012) found that triple knockdown of 
FOXO1/3/and 4 in human neuroblastoma cell line resulted in the ablation of PDGFR-α. 
However, the isolated knockdown of any of these did not abolish PDGFR- α transcription. More 
evaluation of PDGFR- α regulation through the use of dual knock down of FOXO1 and FOXO3 
is suggested. 
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4.3.6. The effect of TNF-α treatment on PDGF expression 
In this project, PDGF-AA and PDGF-BB and their receptors were investigated in the context 
of their possibility to be expressed under the influence of TNF- α. This cytokine was applied at 
two intervals to explore any difference, which might be missed by the length of treatment. The 
results revealed that PDGF-AA mRNA increased with this treatment. Despite this increase, the 
protein expression of PDGF-AA or the receptors mRNA and proteins were not changed. This 
might link with the finding in nulliparous women with endometriosis who expressed a high 
level of TNF-α and a low level of PDGF in comparison with fertile women who expressed a 
higher level of PDGF in the peritoneal fluid (Overton et al., 1996) 
4.3.7. PDGF-BB has a stimulatory functional role over the cells in the maternal 
fetal interface. 
It is generally agreed that trophoblast invasion is driven by gradients of chemo-attractants to 
invade the endometrial decidual stroma and blood vessels (Salamonsen et al., 2007). This 
project gives a new evidence to support the concept that the decidua is an active tissue during 
embryo implantation and not only a passive one. This notion is further supported  by our finding 
that endometrial stromal cells have a motile response towards the angiogenic factor PDGF-BB 
as previously reported by Schwenke et al (2013). However, the migration is slower in the 
decidualised cells in comparison with the proliferative cells. Although it is proved that PDGFR-
α receptors are upregulated during decidualisation, but the PDGF-BB has a strong affinity 
towards PDGFR-ß. Additionally, slower migration might be explained again due to the larger 
sizes of the decidualised cells, which make their movement slower and mask receptors 
upregulation. The presence of PDGF-BB response in the St-T1b cells, with the absence of its 
secretion, indicates that PDGF-BB acts in a paracrine manner in hESC  
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Further examination of the effect of PDGF on the endometrial stromal cell movement were 
performed by using PDGF-AA treatment or the HTR-8 cells conditioned medium, which were 
shown to express PDGF-AA. The use of condition medium was to investigate the presence of 
any other secretion from the HTR-8 cells that might affect stromal cell motility during 
implantation window. However, the result revealed no difference in the chemokinesis migration 
with the use of any of these treatments. This agrees with the finding of Schwenke et al (2013) 
who demonstrated an effect of PDGF-AA on chemoattractant stromal migration and not on 
chemokinetic migration. 
The fetal-maternal interface functions were evaluated by measuring HTR-8 trophoblast 
expansion and invasion following the treatment of the co-culture of trophoblast and stromal 
monolayer with PDGF-BB. The results revealed that PDGF-BB increase the expansion rate. 
Additionally, PDGF-BB stimulates the invasion of HTR-8 spheroid. This may be explained by 
the PDGFR upregulation as proved in this project. As well as, by the high expression of integrin 
B1 in hESC and trophoblastic cells. The integrin B1 binds to collagen, fibronectin, and laminin, 
those are highly expressed during decidualisation (Aplin et al., 2008). On the use of integrin 
B1 antibody, the expansion was suppressed  (Shiokawa et al., 2000) 
The result of enhanced invasion of HTR-8 spheroid with PDGF-BB treatment may be attributed 
to the presence of PDGF-BB receptors in both trophoblast and stromal cells. This finding agrees 
with the Ferretti et al (2007), who demonstrated that PDGF-BB was a potent stimulator of 
trophoblast invasion. They also show a similarity between trophoblast cells and an invasive 
tumour through the expression of integrin, low expression of E-cadherin, high expression of 
matrix metalloprotease 9, and activation of PI3K/AKT axis which enhance the migratory and 
invasive abilities. These factors enhance the invasive attitude of tumour and trophoblastic cells. 
Primac et al (2019) recognised an interaction between integrin α11 and PDGFR-β that led to 
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support the invasion in breast cancer fibroblasts with PDGF-BB through the use of human and 
mouse models. However, Bass et al  (1994), using human placental cell in Matrigel coated trans 
well inserts invasion assay, reported that EGF can stimulate trophoblastic invasion duo to the 
presence of its receptor in the trophoblastic cells, while PDGF-BB showed no effect.  
In conclusion, the expression of PDGF-AA, PDGF-CC, PDGFR-α, PDGR-β, and endosialin 
have been expressed differentially with decidualisation in hESC, while PDGF-BB was not 
detected. TNF-α treatment upregulates the PDGF-AA mRNA expression. PDGF-BB enhances 
the migration of stromal cells as well as the expansion and invasion of trophoblastic cells and 
this supports the proposed hypothesis that assumes that PDGF-BB can have an effect on 
migration. 
Table 1.1Table Summary of PDGF isoform and receptors expression in hESC. 
PDGF Isoform 
or receptor 
St-T1b cell Primary hESC 
Proliferative 
type 
Decidualised 
type 
Proliferative 
type 
Decidualised 
type 
PDGF-AA ++ + ++ + 
PDGF-BB _ _ _ _ 
PDGF-CC + ++ + ++ 
PDGFR-α + ++ + ++ 
PDGFR-β + ++ + ++ 
-undetected, + detected, ++ increased 
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5.1. Introduction 
HO-1 plays an important role in protection against hypoxia, cytotoxicity, inflammation, and 
different types of oxidative stress (Maines and Panahian, 2001, Peng et al., 2019). HOs and 
their by-products are physiologically active during pregnancy. They are considered master 
players in the establishment and maintenance of a healthy pregnancy (Wong et al., 2012). They 
have been found to reduce uterine contraction (Acevedo and Ahmed, 1998), control the 
hemodynamic function, maintain the oxidative and antioxidative balance, regulate apoptotic 
and anti-inflammatory mechanisms, and control immunological tolerance to the allogenic fetus 
(Bainbridge and Smith, 2005). HO-1 expression is upregulated during pregnancy in both the 
human and mouse (Barber et al., 2001, Zenclussen et al., 2003) and low HO-1 levels can result 
in a failure of implantation and have been linked with the development of pre-eclampsia 
(Zenclussen et al., 2015) and IUGR later in pregnancy (Barber et al., 2001, Donnez et al., 2016)  
Yoshiki et al (2001), reported that HO-1 is predominantly localised in the endometrial epithelia 
and macrophages by immunohistochemistry, and there was a constitutive expression of HO-1 
throughout the menstrual cycle in these cells as observed by  by RT-PCR and Western blotting. 
Dassen et al (2008) found through immunohistochemistry and qPCR of the human endometrial 
tissue that tissue obtained from mestrual phase expressed significantly higher HO-1 mRNA 
than those obtained during the proliferative phase. Zenclussen et al (2014) found in mice uteri 
that HO-1 mRNA was upregulated in the receptive period of the estrus phase. Low HO-1 levels 
were reported in aborted mouse decidual tissue (Zenclussen et al., 2002). Consistent with these 
findings, low HO-1 expression is associated with failed implantation, abnormal trophoblast 
invasion (McCaig and Lyall, 2009), recurrent miscarriage (Donnez et al., 2016), and 
endometriosis (Jamali et al., 2019). The upregulation of FOXO1 upon endometrial stromal cell 
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decidualisation is essential for the process of decidualisation and confers oxidative stress 
resistance in decidual cells (Kajihara et al., 2006). 
5.1.1. Aims and objectives 
 Previous studies reported that Foxo1 induces HO-1 expression in mouse muscle and 
hepatocytes through direct binding to the HO-1 promoter (Liu et al., 2013, Kang et al., 2014). 
This suggests that, during decidualisation, HO-1 may be upregulated by FOXO1 and play a 
protective role in reducing the level of reactive oxygen species. It was therefore hypothesised 
that decidualisation would upregulate HO-1 expression in hESC and that HO-1 induction may 
affect hESC function and stromal-trophoblast interactions. We aimed to elucidate the sensitivity 
of HTR-8 cells migration to hemin. 
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5.2. Results  
5.2.1. HO-1 is upregulated during hESC decidualisation  
Although HO-1 levels were reported to increase during the receptive phase of the estrus cycle 
in mice (Zenclussen et al., 2014), its expression in hESC during decidualisation has yet to be 
examined. To investigate this, St-T1b and primary hESC were seeded in 6-wells plates at a 
density of 3x105 cells/well. Cells were either maintained in E2 medium or induced to 
decidualise by treatment with MPC medium for 4 to 7 days. The results show for the first time, 
a significant increase in HO-1 mRNA expression in both St-T1b (Figure 5.1A) and primary 
hESC isolated from three different individuals (Figure 5.1C) following decidualisation at day 
4 in comparison with the proliferative cells. Western blotting confirmed the increased HO-1 
protein levels in the decidualised St-T1b cells (Figure 5.1B) and primary hESC (Figure 5.1D). 
5.2.2. cAMP promotes HO-1 expression in hESC 
In order to investigate the effect of either P or cAMP driven pathways on HO-1 expression in 
hESC, the effect of individual MPA and 8-Br-cAMP stimulation was examined over a 24 h 
period. Primary hESC and St-T1b cells were seeded in 6-well plates at a density of 3x105 
cells/well. The cells were maintained in E2 medium or induced with MPA (1 µM) or 8-Br-
cAMP (0.5 mM) alone or in combination in MMI medium for 24 h. The results showed that 
HO-1 mRNA expression significantly increased following stimulation with 8-Br-cAMP or 8-
Br-cAMP plus MPA compared with the untreated control (Figure 5.2A).    
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Figure 5.1: HO-1 is upregulated during hESC decidualisation. Confluent monolayers of St-T1b 
and primary hESC were incubated in E2 medium or MPC for 4 and 7 days. Relative HO-1 mRNA 
fold changes expression in (A) St-T1b cells and (C) primary hESC normalised to β-actin. 
Representative Western blots showing HO-1 protein expression in (B) St-T1b cells and (D) primary 
hESC with tubulin used as a loading control. Results are the mean (± SEM) of four (A) and three (B) 
independent experiments.  Statistically significant differences (*P<0.05**P<0.001). 
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Figure 5.2: cAMP driven pathways upregulate HO-1 expression. Confluent monolayers of 
primary hESC were incubated in a complete growth medium with E2 (1 nM), insulin (1 µ/ml) 
or in MMI medium with 8-Br-cAMP (0.5 mM) or MPA (1 µM) alone, or in combination for 24 
h. Relative mRNA fold changes (A) HO-1, (B) FOXO1, (C) PLZF, and (D) SOD2 expression 
normalised to β-actin. Results are means (± SEM) of three independent experiments. 
Statistically significant differences (*P<0.05). 
 
 
Chapter 5 – Investigating HO-1 expression and regulation in hESC decidualisation 
165 
 
To confirm the activation of relevant pathways in hESC following stimulation with cAMP or 
MPA, the expression of FOXO1 and PLZF were examined (Figure 5.2B & C). As expected, 8-
Br-cAMP led to a significant increase in FOXO1 mRNA, which appeared to be potentiated in 
the presence of MPA, whilst as expected there was no change in FOXO1 levels in the presence 
of MPA alone (Figure 5.2B). These findings were also supported by the examination of PLZF 
which is regulated by P. PLZF is very strongly upregulated by MPA (Figure 5.2C). SOD2 is 
recognised as FOXO1 mediated gene and also showed a significant increase in expression with 
cAMP (Figure 5.2D) 
5.2.3. FOXO1 is a positive regulator of HO-1 expression in hESC 
Although FOXO1 has been shown to directly regulate HO-1 expression in the liver, muscle, 
and pancreas (Kang et al., 2014, Cheng et al., 2009), to our knowledge, it has not been 
investigated in the regulation of HO-1 in hESC. To determine whether FOXO1 positively 
regulates HO-1 expression during decidualisation, hESC were plated at 2.2x105 cells/well in 6-
well plates to a 65%-85% confluency. The transfection of FOXO1 (siFOXO1) or universal 
control siRNA (siControl) was performed using Viromer Blue in 2 ml of E2 medium/well 24 h 
post transfection. The cells were either stimulated with MPC or maintained in E2 medium 24 h 
prior to the harvesting. The results showed a successful FOXO1 knockdown at an mRNA and 
protein level in both St-T1b and primary hESC. In St-T1b cells, qPCR revealed a six-fold 
reduction in FOXO1 mRNA expression in comparison with the control (Figure 5.3A). Western 
blotting revealed a dramatic decrease in FOXO1 protein (Figure 5.3B) confirming the 
successful FOXO1 knockdown. HO-1 mRNA was significantly reduced following FOXO1 
knockdown than in the control cells (Figure 5.3C). This result was confirmed by Western blot 
as shown in Figure 5.3D. 
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Figure 5.3: FOXO1 knockdown inhibits HO-1 expression in hESC. Confluent monolayers of 
St-T1b cells were transfected with siRNA targeting FOXO1 (siFOXO1) or control (siControl) 
siRNA for 24 h followed by incubation in E2 medium or in MPC medium for 24 h. Relative 
mRNA fold changes of (A) FOXO1 (C) HO-1 and (E) PLZF expression normalised to β-actin. 
Representative Western blot showing (B) FOXO1 and (D) HO-1 protein expression. Tubulin used 
as a loading control. Results are the mean (± SEM) of three independent experiments. Statistically 
significant differences (*P<0.05).   
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The decidual marker PLZF, which is not directly regulated by FOXO1 (Kommagani et al., 
2016, Vasquez et al., 2015) was also investigated in FOXO1 knockdown cells. As expected, 
PLZF was not significantly affected by the loss of FOXO1 (Figure 5.3E). Collectively, these 
results show that HO-1 is upregulated by the cAMP – PKA – FOXO1 pathway during hESC 
decidualisation.  
5.2.4. HO-1 induction reduced the migration of primary hESC. 
HO-1 is reported to be involved in aortic smooth muscle cell migration (Chen et al., 2012, 
Rodriguez et al., 2010) and endometrial repair following menstruation (Maybin and Critchley, 
2012). However, to our knowledge, the evaluation of the effect of HO-1 expression on the 
motility of hESC has not been demonstrated yet. To investigate the effect of HO-1 on the 
functional behavior of hESC, an in vitro scratch assay was performed. Primary hESC were 
stimulated to decidualise with MPC medium or maintained in E2 medium in T75 flasks for 3 
days. Cells were harvested, plated on 6-well dishes and stimulated under the same conditions 
for a further 24 h. The cell monolayers were then scratch-wounded and washed with PBS. Two 
ml of DMEM/Ham F12 medium supplemented with 1 % FBS was then added with either hemin 
(10 µM), or PDGF-BB (10 ng/ml). Cell migration into the scratch was assessed at 18 h and the 
% of migration calculated using the following equation: 
% of migration =
scratch area (0 h) − scratch area (18 h)
scratch area (0 h)
 x 100 
The proliferative primary hESC treated with hemin showed significantly reduced migration 
compared with the untreated cells, indicating that HO-1 may be acting as a negative regulator 
of their migration. In contrast, PDGF-BB significantly induced hESC migration (Figure 5.5A 
& B).  
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Figure 5.4: FOXO1 is a positive regulator of HO-1 expression in primary hESC. Confluent 
monolayers of primary hESC were transfected with siRNA targeting FOXO1 (siFOXO1) or control 
(siControl) siRNA for 24 h followed by incubation in E2 medium or in MPC medium for 24 h. 
Relative mRNA fold changes of (A) FOXO1 and (C) HO-1 expression normalised to β-actin. 
Representative Western blots showing (B) FOXO1 and (D) HO-1 protein expression. Tubulin used 
as a loading control. Results are the means (± SEM) of three independent experiments. Statistically 
significant differences (*P<0.05). 
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Figure 5.5: HO-1 induction diminished migration in primary hESC. Confluent 
monolayers of primary hESC were scratch-wounded and stimulated with PDGF-BB (10 
ng/ml or hemin (10 μM). Cell migration was assessed after 18 h at 10 points /treatment 
condition in 2 wells and calculated as migration % = (Scratch area at 0 h-scratch area at 18 
h/scratch area at 0 h)*100. (A) Representative bright field images (4 x objective) showing the 
scratch areas at 0 and 18 h.  (B) Results are means (± SEM) of the migration percentage at 
18 h relative to zero time point of three independent experiments.  Statistically significant 
differences (*P<0.05).  Scale bar = 400 µm. 
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5.2.5. HO-1 has no effect on St-T1b cell in vitro migration  
An in-vitro scratch assay was performed in St-T1b cells with PDGF-BB stimulation used as a 
positive control. The St-T1b cells were seeded in 6-well plates at a density of 2.8x105cells/well. 
The next day the cells were scratched and treated with PDGF-BB (10 ng/ml) or hemin (10 µM) 
(See HO-1 induction confirmed by Western blot in Figure 5.6C). The degree of migration was 
assessed at 18 h. The results showed that the hemin mediated-induction of HO-1 had no 
significant effect on the migration of the control cells (Figure 5.6A & B). As observed 
previously, PDGF-BB treatment of cells caused a significant increase in migration. Although, 
hemin treatment alone had no effect on St-T1b migration compared with the untreated control, 
it significantly reduced the level of PDGF-BB-induced St-T1b migration (Figure 5.6A & B). 
5.2.6. Growth Factor treatment increases the migration of HTR-8 cells. 
It was reported that the invasive and migratory ability of trophoblasts was affected by different 
growth factors and cytokines activity (Bischoff et al., 2000). To achieve this, the HTR-8 cells 
were plated at a density of 3x105 cells/well in 6-well plates. Once confluent, the cell monolayers 
were scratch-wounded and hemin (10 µM), EGF (200 ng/ml) or PDGF-BB (10 ng/ml) were 
added. The reduction of the denuded scratch area was assessed at 18 h as mentioned before. 
Hemin had no effect on HTR-8 migration compared to untreated controls (Figure 5.7A & B). 
As expected, EGF significantly increased HTR-8 migration, which was inhibited with hemin 
treatment. PDGF-BB treatment alone or in combination with hemin did not affect HTR-8 
migration (Figure 5.7A & B). 
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Figure 5.6: HO-1 induction diminished migration in St-T1b hESC. Confluent monolayers of 
St-T1b hESC were scratch-wounded and stimulated with PDGF-BB (10 ng/ml or hemin (10 μM). 
Cell migration was assessed after 18 h at 10 points /treatment condition in 2 wells and calculated 
as migration % = (Scratch area at 0 h-scratch area at 18 h/scratch area at 0 h)*100. (A) 
Representative bright field images (4 x objective) showing the scratch areas at 0 and 18 h. (B) 
Migration percentage at 18 h relative to zero time point. (C) Western blot of HO-1 induction. 
Results are means (± SEM) of three independent experiments. Statistically significant differences 
(*P<0.05). Scale bar = 400 µm. 
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Figure 5.7: Hemin treatment has no effect on HTR-8 migration. Confluent HTR-8 cell 
monolayers were scratch-wounded and treated with EGF (200 ng/ml), PDGF-BB (10 ng/ml), and 
hemin (10 μM) in 2 ml of 1% FBS medium. Cell migration was assessed after 18 h at 10 points 
/treatment condition in 2 wells and calculated as migration %=(Scratch area at 0 h-scratch  area 
at 18 h/scratch area at 0 h)*100. (A) Representative bright field images (4 x objective) showing 
the scratch areas at 0 and 18 h.  (B) Results are means (± SEM) of three independent experiments.  
Statistically significant differences (*P<0.05).  Scale bar = 400 µm. 
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5.2.7. Hemin-mediated HO-1 induction inhibits trophoblast spheroid expansion 
The spheroid expansion co-culture model was employed to mimic a blastocyst spreading during 
embryo implantation to evaluate the effect of HO-1 induction using hemin in hESC on 
trophoblast-stromal cell interactions. These experiments were performed either in the presence 
of hemin (continuous hemin treatment) or with hemin added only for 4 h prior to co-culture of 
the spheroid. Hemin was added to the E2 medium for 4 h and then the hemin reapplied only to 
the “continuous hemin” treated cells in 1% FBS medium. The results showed that 4 h treatment 
for hESC monolayer has no effect on HTR-8 spheroid expansion. Continuous hemin treatment 
of the co-culture had no significant effect on HTR-8 spheroid expansion at 48 h (Figure 5.8A 
& B). While, continuous hemin treatment reduced spheroid expansion at 72 h (Figure 5.8A & 
B). Although EGF significantly increased the expansion rate at 72 h, a significant reduction of 
EGF-stimulated HTR-8 spheroid expansion was observed with continuous hemin treatment in 
the EGF in comparison with the control cells.  
3.2.8. HO-1 has no direct effect on HTR-8 spheroid invasion in the absence of 
stromal cells 
To further evaluate the effect of HO-1 on the invasive capacity of trophoblasts directly or 
through its activity in hESC, the HTR-8 spheroid invasion assay was used. HTR-8 spheroids 
were embedded in a fibrin gel. EGF (200 ng/ml) and PDGF-BB (10 ng/ml) were added alone 
or in a combination with hemin (10 µM) in 1% FBS ham F12 DMEM medium. The spheroid 
sprouting density was calculated by trainable weka plugin in ImageJ. The sprout length was 
calculated as the mean of the longest sprout in four quarters of the spheroid measured using 
ImageJ.  
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Figure 5.8: Hemin stimulation reduces trophoblast spheroid expansion. Labelled 
HTR-8 spheroids with Vybrant Green dye were seeded onto proliferating monolayers of 
St-T1b cells. The co-cultures were then treated with EGF (200 ng/ml) and hemin (10 μm) 
continuously or hemin applied only for 4 h (hemin 4 h) before spheroid embedding.  HTR-
8 spheroid expansion was calculated as spheroid size at 48 h or 72 h /spheroid size at 0 h 
using ImageJ. Ten spheroid/treatment conditions were measured in 4 wells. (A) 
Representative fluorescent images using Vybrant green dye (4x objective) showing 
spheroid expansion areas at 48 and 72 h.  (B) Results are the means (± SEM) of three 
independent experiments.  Statistically significant differences (*P<0.05). Scale bar = 200 
µm.    
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The results revealed that EGF and PDGF-BB increased the HTR-8 spheroid sprout length 
significantly at 48 h and 72 h respectively (p<0.05). At 72 h of the experiment, hemin treatment 
made no difference in the length or the density of the sprouts except on 72 h of treatment when 
it upregulated upon combined treatment with PDGF-BB (Figure 5.9A & B). 
5.2.9. Hemin treatment promotes trophoblast invasion in the presence of stromal 
cells 
 The HTR-8 spheroid co-culture model was used to determine whether hemin treatment of 
hESC affected the invasion of co-cultured trophoblast spheroids. For this purpose, HTR-8 
spheroids were labelled with Vybrant Green dye and set in fibrin gels over a proliferative St-
T1b cell monolayer. The co-culture then treated with hemin (10 µM), PDGF-BB (10 ng/ml), 
and EGF (200 ng/ml) in 1% FBS medium. The hemin added on two periods. First treatment for 
4 h to the monolayer in E2 medium. The second treatment was applied for the co-culture. The 
HTR-8 spheroids were monitored with a fluorescent microscope at 48 h and 72 h. As previously 
observed, both trophoblast sprout density and length were enhanced with EGF and PDGF-BB 
treatment at 48 h and 72 h ( 
Figure 5.10A & B). Hemin treatment caused a significant increase in sprout density and length 
in the control group. In the EGF and PDGF-BB treated group, HO-1 induction made no 
difference in sprouting density and length. 
5.2.10. Upregulation of HO-1 mRNA in PDGF-BB treated St-T1b cells. 
PDGF is reported as one of the HO-1 antioxidant inducer (Ryter and Choi, 2002).To further 
investigate the effect of PDGF on HO-1 as well cMYC, which is cell proliferation regulating 
gene reported to be expressed during hESC decidualisation (Popovici et al., 2000), the cells 
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were plated in 6-well plates then treated with PDGF-AA (100 ng/ml) and PDGF-BB (10 ng/ml) 
for 24 h. qPCR analyses were performed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 5 – Investigating HO-1 expression and regulation in hESC decidualisation 
181 
 
 
 
 
A 
Chapter 5 – Investigating HO-1 expression and regulation in hESC decidualisation 
182 
 
S
p
ro
u
t 
d
en
si
ty
  
(
m
2
)
         Control             EGF                    PDGF-BB 
0
1000
2000
3000
4000
5000
✱
S
p
ro
u
t 
d
en
si
ty
  
(
m
2
)
         Control             EGF                        PDGF-BB 
0
1000
2000
3000
4000
5000
- Hemin
+ Hemin
✱
S
p
ro
u
t 
le
n
g
th
 (

m
)
         Control             EGF                    PDGF-BB 
0
20
40
60
80
✱
✱✱
S
p
ro
u
t 
le
n
g
th
 (

m
)
         Control             EGF                    PDGF-BB 
0
20
40
60
80
✱✱
✱✱
48 h 72 h
48 h 72 h
Sprout density
Sprout length
 
B 
Figure 5.9: Hemin treatment has no effect on trophoblast spheroid invasion. HTR-8 
spheroids were labelled with Vybrant Green dye and set in a fibrin gel with hemin (10 µM), 
PDGF-BB (10 ng/ml), and EGF (200 ng/ml) in 1% FBS medium. The sprout density and sprout 
length were calculated for 10 spheroids/conditions in 4 wells from 3 independent experiments 
using ImageJ (A) Representative fluorescent images of HTR-8 spheroid invasion into fibrin gel 
at 48 h and 72 h (4x objective). (B) Results are means (± SEM) of 3 independent experiments. 
Statistically significant differences (*P<0.05). Scale bar = 200 µm.     
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Figure 5.10: Hemin promotes trophoblast spheroid invasion in the presence of hESC. HTR-8 
spheroids were labelled with Vybrant Green dye, embedded in fibrin gel set over a layer of St-T1b 
cells and treated with hemin (10 µM) for 4 h in E2 medium then treated with PDGF-BB (10 ng/ml), 
EGF (200 ng/ml), and hemin (10 µM) in 1% FBS medium. The sprout density and sprout length 
were calculated for 10 spheroids / condition in 4 wells from 3 independent experiments using 
ImageJ (A) Representative fluorescent images of HTR-8 spheroid invasion into fibrin gel at 48 h 
and 72 h (4x objective) (B). Results are means (± SEM) of 3 independent experiments. Statistically 
significant differences (*P<0.05, **P<0.001). Scale bar = 200 µm. 
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These results revealed that C-MYC mRNA was non-significantly changed with PDGF-
treatment (Figure 5.11A). In the case of HO-1 mRNA expression, PDGF-BB treatment 
significantly induced its expression in comparison with the untreated cells, while PDGF-AA 
treatment did not induce a significant change (Figure 5.11B & C). 
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Figure 5.11: The Effect of PDGF treatment on HO-1 expression in St-T1b cells. A confluent 
monolayer of hESC treated for 24 h with PDGF-BB (10 ng/ml) or PDGF-AA (100 ng/ml) in 
1% FBS DMEM/HAM F12 medium. Relative mRNA of (A) HO-1 and (B) cMYC mRNA 
normalised to β-actin. Representative Western blot of (C) HO-1 protein expression. Tubulin 
used as a loading control. Results are the mean (± SEM) of three independent experiments.  
Statistically significant differences (*P<0.05). 
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5.3. Discussion 
5.3.1. HO-1 is upregulated during hESC decidualisation 
Decidualisation is a reprogramming of the endometrium to enhance embryo implantation and 
protection against oxidative stress (Kajihara et al., 2006). HO-1 has various roles in pregnancy 
as a tissue-protective, anti-inflammatory, and antioxidant enzyme (Bainbridge and Smith, 
2005). Our results demonstrate, for the first time, the up-regulation of HO-1 expression in both 
primary hESC and St-T1b cells at mRNA and protein levels during in vitro decidualisation. 
Oxidative stress might be one of the reasons that induce HO-1 as the decasualised tissue is more 
resistant to oxidative stress (Kajihara et al., 2006, Jamali et al., 2019, Clark et al., 2000). 
Moreover, this upregulation may be attributed to different expression during the phases of the 
menstrual cycle. This agrees with the finding of Zenclussen et al (2014) who found, with qPCR, 
increased uterine HO-1 mRNA expression during the estrus phase of mice cycles. However, 
Yoshiki et al (2001) found that HO-1 is constitutively expressed throughout the menstrual cycle 
in the uterus generally, but its main localisation was in the endometrial epithelia and 
macrophages and not in the endometrial stromal cells. 
5.3.2. cAMP promotes HO-1 expression in hESC 
In order to dissect the contribution of 8-Br-cAMP and MPA on HO-1 expression, hESC were 
stimulated with them individually or in combination for 24 h. The activation of the individual 
pathways with 8-Br-cAMP and MPA was confirmed using FOXO1 and PLZF as markers. As 
expected, FOXO1 was induced with cAMP and this supports the earlier finding of Brosens and 
Gellersen (2006), who indicated that FOXO1 is cAMP-inducible. As expected, PLZF was 
induced with MPA and this supports the finding of Kommagani et al (2016), who demonstrated 
that PLZF is a direct target of P by RNA expression analysis and chromatin 
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immunoprecipitation (ChIP) assay which identified several P response elements in the PLZF 
gene. We identified that HO-1 upregulation during decidualisation is dependent on the cAMP 
stimulated pathways.   
cAMP causes nuclear accumulation of FOXO1 and the upregulation of pro-apoptotic anti-
proliferative P53 protein. This means the enhancement of transcription of factors that induce 
cell cycle arrest and apoptosis, which occurs during P withdrawal before menstruation (Labied 
et al., 2006, Chatzaki et al., 2001). The active fraction of FOXO1 results in the transcription of 
differentiation-promoting genes such as PRL and IGFBP-1 (Brosens and Gellersen, 2006). This 
indicates the important role of P in reducing the active amount of FOXO1 during 
decidualisation to prevent decidual cell death (Labied et al., 2006). PLZF is considered as a 
pro-survival anti-apoptotic factor that is highly expressed in decidualised hESC and suppresses 
decidual marker transcription. PLZF is rapidly induced by P, but not with cAMP in hESC 
(Fahnenstich et al., 2003). PLZF balances the apoptotic action of P53 (Brosens and Gellersen, 
2006, Maybin and Critchley, 2009, Szwarc et al., 2017). FOXO1 is an important factor in cell 
cycle regulation and this activity depends on its cellular localisation. Inactivation and 
phosphorylation of FOXO1 occurs with its release from the nucleus into the cytoplasm resulting 
in promoting  cell survival and proliferation (Brunet et al., 1999). 
Towards the end of luteal phase, P levels drop resulting in a reduction in PLZF expression. This 
again activates FOXO1 (The level of active FOXO1 will change, but there will always be some 
active), which coordinates with P53 toward upregulating the transcription of apoptotic factors 
such as BCL2 L11 (BIM). BIM is a target gene of FOXO1 activated by cAMP and inhibited by 
P. With P withdrawal, BIM expression increases, cell death occurs, and menstruation ensues 
(Brosens and Gellersen, 2006). The identification of FOXO1-mediated upregulation of HO-1 
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in hESC during the menstrual cycle would indicate that levels should be increased towards the 
end of the luteal phase prior to menstruation. This would be consistent with the involvement of 
HO-1 in limiting the haemorrhagic endometrial damage following menstruation (Maybin and 
Critchley, 2012).  
5.3.3. FOXO1 is a positive regulator of HO-1 expression in hESC 
The results indicated that the upregulation of FOXO1 during decidualisation was, at least in 
part, responsible for HO-1 upregulation. HO-1 maintains the oxidative and antioxdative 
balance, and regulates the apoptotic and anti-inflamatory mechanisms. The finding of HO-1 
upregulation in decidual hESC and its regulation by cAMP led us to look further at the 
involvement of FOXO1 by applying FOXO1 knockdown. A successful FOXO1 knockdown 
was achieved in primary hESC and St-T1b cells. A significant reduction of HO-1 expression 
was observed following FOXO1 knockdown in primary hESC and St-T1b cells under both 
proliferative and decidual conditions. To our knowledge, this is the first time that Foxo1 has 
been identified as a positive regulator of HO-1 expression in hESC. Our findings agree with 
studies in other tissues/cell types in the mouse that showed that FOXO1 can positively regulate 
HO-1 expression (Cheng et al., 2009, Kang et al., 2014). Kang et al (2014) found that Foxo1 
regulates HO-1 expression in mouse muscle atrophy through direct binding to DNA binding 
sites in the HO-1 promoter using ChIP analysis. Cheng et al., (2009) found that when double 
knockout of insulin receptors 1 and 2 in mice hepatic cells, Foxo1 has an HO-1 regulation 
activity and deletion of Foxo1 resulted in HO-1 expression reduction. However, Vasquez et al 
(2015), has not listed HO-1 as one of the direct targets of FOXO1 identified by DNA-Seq and 
ChIP seq analysis during hESC decidualisation. Further research might be suggested through 
FOXO1 over-expression in hESC followed by ChIP seq to elucidate any regulatory FOXO1 
role in HO-1 expression.  
Chapter 5 – Investigating HO-1 expression and regulation in hESC decidualisation 
190 
 
5.3.4. HO-1 negatively affects the migration of hESC. 
The migratory capacity of hESC is increasingly highlighted as an active contributor in the 
prominent uterine remodeling that occurs during embryo implantation (Petrie et al., 2009)  and 
endometrial regeneration following menstruation (Gentilini et al., 2007). Dysregulated hESC 
migration can be seen in cases of implantation failure and pathological uterine conditions, such 
as endometriosis (Weimar et al., 2013). HO-1 is involved in embryo implantation and in 
limiting the hemorrhagic endometrial damage following menstruation (Maybin and Critchley, 
2012). The current findings revealed that hemin has an inhibitory effect on the basal migration 
of primary hESC and PDGF-BB combined migration in St-T1b cells. There is only minimal 
information available on the direct effect of HO-1 in hESC migration. Rodriguez et al (2010) 
found that both HO-1 and CO can inhibit PDGF-BB-stimulated migration via the inhibition of 
nicotinamide adenine dinucleotide phosphate oxidase (NOX1) pathway in rat aortic smooth 
muscle cells. HO-1 knockdown in human leukemic cell line increases their motility 
(Abdelbaset-Ismail et al., 2017, Abdelbaset-Ismail et al., 2019). Additionally, HO-1 silencing 
in human retinal epithelial cells resulted in a reduced migration of co-cultured HUVEC cells 
(Zhang et al., 2013a) 
5.3.5. Hemin treatment inhibits EGF-stimulated migration of HTR-8 cells 
Using the in vitro scratch assay of HTR-8 cells, it was found that hemin significantly reduced 
the migration of EGF-stimulated HTR-8 cells. This agrees with the findings of Bilban et al 
(2009), who demonstrated reduced HTR-8 migration in transmigration assays following HO-1 
over-expression. The authors used retroviral transduction of a doxycycline-inducible HO-1 and 
showed that HO-1 over-expression inhibits migration through an increase in peroxisome 
proliferator activated receptor-γ (PPARγ). PPARγ is a member of a large nuclear receptor 
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superfamily that is expressed in the placenta and regulates the expression of various genes 
(Zhao et al., 2019). Chen et al., (2012) also found that HO-1 induction in rat vascular smooth 
muscle cells inhibited their migration.  
The result also showed that EGF has a stimulatory effect and this is in agreement with Haslinger 
et al (2013), who used primary trophoblasts, JEG-3, and HTR-8/SVneo. Interestingly, PDGF-
BB treatment of HTR-8 cells made no difference to their in vitro scratch migration, although 
we showed that PDGF-BB stimulates trophoblast cell invasion in sprouting assays in the 
presence and absence of hESC. This led to a suggestion that the increased invasion by PDGF-
BB is not related directly to the stimulation of their migration. Therefore, further study of 
changes in the stromal-trophoblast interaction, such as metalloprotease levels quantification 
using specific enzyme-linked immunosorbent assays, is required.  
5.3.6. HO-1 reduces HTR-8 spheroid expansion but increases the invasion in the 
presence of St-T1b cells 
We investigated the role of HO-1 on the interaction between trophoblasts and endometrial 
stroma. To achieve this, we employed our spheroid expansion and sprouting (invasion) co-
culture models mimicking blastocyst spreading and invasion during embryo implantation. The 
results showed that HO-1 treatment reduced the expansion of HTR-8 spheroids on hESC and 
this effect was more pronounced with continuous hemin treatment for 72 h the than initial 4 h 
treatment.  
HTR-8 spheroid invasion into the fibrin gel in the absence of stromal cells was not as 
pronounced as in the presence of hESC. This suggests that stromal cells act as an enhancer of 
trophoblast invasion. This may be explained by the secretion of factors from hESC that promote 
trophoblast invasion. In one study, trophoblasts were found to secrete integrins (Knöfler and 
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Pollheimer, 2012) and CXCL12 chemokines that in turn stimulate stromal cells to secrete 
CXCR4, which promotes their invasion (Ren et al., 2011). The enhancement of HTR-8 invasion 
by hESC adds further evidence to support the prevailing hypothesis that decidual cells are 
important contributors to the highly coordinated embryo-uterine interactions which are 
essential for embryo implantation. 
Hemin treatment caused increased sprout density and length under basal conditions at 72 h only 
in the presence of hESC. A study performed by Ha et al (2015) found that HO-1 products as 
CO and biliverdin increase HTR-8 and HUVEC invasion using trans-well migration assay, 
which investigates the invasion of each cell type individually and not as a co-culture. Li et al 
(2019) found that HO-1 increases invasion of HTR-8 and HUVEC under oxidative stress 
conditions by regulating the tight junction zonula occludens-1 (ZO-1) protein. This indicates 
the role of HO-1 in protecting pregnancy against oxidative stress. However, McCaig and Lyall 
(2009) found that using an HO-1 neutralising antibody has no effect on term cytotrophoblasts 
while the use of HO-2 inhibitors reduced the cell invasion into a Matrigel. Hence, we can further 
expand the HTR-8 spheroid sprouting assay by applying selective inhibitors of constitutive HO-
2 as oxypentyl derivatives 29, 31, 48, 50 and the thiobutyl derivative 39 as a pharmacological 
tool suitable for investigating the biological roles of HO-1 by its own (Salerno et al., 2015). 
Additionally, as the application of HO-1 inducer was to the co-culture, so that the observed 
resulted affect can be due to its effect on each type of cells separately, or due to the factors 
released from both cells. To further dissect this effect, HO-1 knockdown in each types of cells 
can be investigated separately to understand what influential cells are involved in the effect of 
HO-1 on the invasion assay. Further study can be performed in vivo through HO-1 induction 
using cobalt protoporphyrin to investigate the migration and invasion of trophoblasts in 
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pregnant rats. The present finding can add a new affirmation to support the finding that HO-1 
enhances embryo invasion  
5.3.7. Upregulation of HO-1 mRNA in PDGF-BB treated St-T1b 
HO-1 is the cellular sensor of oxidative stress which act as a cytoprotective through directly 
preventing cell damage. HO-1 is found to be reduced in pre-eclamptic pregnancy and 
intrauterine growth restriction. The result revealed that HO-1 mRNA level increased upon 
PDGF-BB treatment. This finding is in agreement with Ryter and Choi (2002), who recognised 
cytokines and growth factor such as PDGF as HO-1 induce through their effects on the cell 
surface receptor. The binding to the PDGF receptor leads to the alteration in the intracellular 
reactive oxygen species level and the activation of redox-signalling system and nuclear 
transcription factors as mitogen activated protein kinase (MAPK). This signalling pathway 
initiates the HO-1 inducing system. Chien et al (2015) found that the inhibition of PDGFR-α in 
human cardiomyocytes can inhibit HO-1 release. 
The result also showed that exogenous PDGF did not change the C-MYC mRNA level. This 
agrees with Kelly et al. (1984), who recognised that c-sis, which is a putative structural 
oncogene of PDGF-BB, regulates the production of C-MYC. However, C-MYC is unstable 
genes which increases to a high level within three hours of fibroblast treatment with PDGF then 
return to quiescent level after that. Here, RNA harvesting was performed following 24 h of 
PDGF treatment. However, Goustin et al (1985) indicated a colocalisation of cMYC and 
PDGF-B in cytotrophoblast cells in the placenta that leads to the assumption that the 
proliferation of the placenta can shape an autocrine loop. 
In conclusion, HO-1 mRNA and protein expression are upregulated during hESC 
decidualisation and cAMP is necessary for this upregulation. In addition, FOXO1 is a positive 
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regulator in this upregulation. HO-1 has a pronounced inhibitory effect on the primary hESC 
cell migration, and HTR-8 spheroid expansion, whereas it increases the invasion of HTR-8 
spheroids over an endometrial stromal monolayer. These findings support our hypothesis that 
HO-1 can influence the function of interacting cells at the endometrial-trophoblast interface. 
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6.1. Introduction 
Flt-1 undergoes alternative mRNA splicing producing sFlt-1, which works as a potent anti-
VEGF factor through the sequestration of free VEGF and the formation of a complex that 
competes negatively with its receptors in endothelial cells (Kendall et al., 1996). VEGF and its 
receptors play an important role in the endometrial decidualisation, embryo implantation, 
trophoblastic invasion, and the maintenance of healthy pregnancy (Plaisier, 2011, Goldman-
Wohl and Yagel, 2002). An imbalance in VEGF and sFlt-1 expression can be seen in different 
reproductive problems such as abnormal trophoblast invasion (McMahon et al., 2014), early 
recurrent spontaneous  abortion (Pang et al., 2013), porcine peri-implantation fetal death 
(Tayade et al., 2007), endometriosis (Cho et al., 2012), and later in pregnancy in pre-eclampsia 
and IUGR (McKeeman et al., 2004). With  RT-PCR, Krüssel et al (1999) found that sFlt-1 is 
highly expressed in the proliferative rather than the secretory phase of human endometrial 
tissues. Lockwood et al (2007) found that sFlt-1 mRNA expression is enhanced by thrombin in 
the first trimester decidua. The pre-eclamptic decidua shows thrombophilia and haemorrhage 
as thrombin is produced from decidual cells expressing tissue factor. A negative correlation 
between HO-1 expression and sFlt-1 expression was found in endothelial cells and placental 
explants (Cudmore et al., 2007); however, the relation between HO-1 and sFlt-1 expression in 
hESC has not yet been demonstrated. 
sFlt-e15a and sFlt-i13 are two Flt-1 splice variants, which have been implicated in reproductive 
problems. sFlt-e15a is a recently discovered primate-specific variant (Thomas et al., 2009) 
produced in non-endothelial cell types, such as vascular smooth muscle cells (Sela et al., 2008) 
and trophoblasts. sFlt-i13 is produced in the placenta, kidney, brain, heart, and endothelium 
(Palmer et al., 2015). sFlt-1 isoforms have antiangiogenic properties as they inhibit endothelial 
cell invasion, sprout formation, and migration (Jebbink et al., 2011). 
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6.1.1. Aim and objectives. 
In this chapter, the effect of HO-1 on the expression of sFlt-1 variants (sFlt-e15a and sFlt-i13), 
and VEGF during hESC decidualisation was investigated. sFlt-1 and VEGF expression were 
measured by qPCR and ELISA, in hESC stimulated to decidualise following HO-1 induction 
or inhibition. 
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6.2. Results 
6.2.1. Decidualisation causes a significant reduction of sFlt-1 production in hESC 
 To evaluate the effect of decidualisation on sFlt-1 and VEGF release from hESC, an ELISA 
was used to measure the levels of sFlt-1 and VEGF in ST-T1b cell supernatants collected at day 
4 and day 7 of decidualisation. The results revealed a significant reduction of sFlt-1 protein 
secretion on day 4 and day 7 compared with control cells maintained in E2 medium (Figure 
6.1).  In contrast VEGF secretion increased significantly (p<0.001) on day 7 (Figure 6.2). 
6.2.2. Downregulation of sFlt-1 protein expression on 24 h decidualisation 
stimulation in St-T1b hESC 
To delineate the pathways involved in the downregulation of sFlt-1 during decidualisation, 
hESC were stimulated with 8-Br-cAMP and/or MPA. St-T1b cells and primary hESC were 
seeded in 6-well plates at a density of 3 x105 cells/well. The cells either maintained in E2 
medium or treated with MMI medium containing MPA (1 µM) or 8-Br-cAMP (0.5 mM) alone 
or in combination for 24 h. Supernatants were collected and sFlt-1 measured by ELISA. The 
results showed a significant reduction of sFlt-1 protein release in all decidualised St-T1b groups 
in comparison to the controls (Figure 6.3A).   
In the primary hESC, sFlt-1 protein expression was found to be lower in controls (~350 pg/ml) 
in comparison with the St-T1b cells controls (~3500 pg/ml). MPA and cAMP stimulation for 
24 h was not found to significantly affect sFlt-1 production in primary hESC. 
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Figure 6.1: Reduction of sFlt-1 secretion in hESC during decidualisation. Confluent 
monolayers of St-T1b cells were incubated in E2 medium or MPC medium for 4 and 7 days. 
sFlt-1 was measured in the cell supernatants by ELISA. Results are mean (± SEM) of three 
independent experiments performed in duplicate. Statistically significant differences 
(*p<0.05, **p<0.001).  
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Figure 6.2: VEGF secretion increases in hESC during decidualisation. Confluent 
monolayers of St-T1b cells were incubated in E2 or MPC medium for 4 and 7 days. 
Measurement of sFlt-1 protein concentration was performed by ELISA. Results are mean (± 
SEM) in three independent experiments. Statistically significant differences (*p<0.05). 
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Figure 6.3: Effect of MPA and 8-Br-cAMP on sFlt-1 protein secretion in hESC. 
Confluent monolayers of St-T1b cells (A) and primary hESC (B) were incubated in a complete 
E2 or in MMI medium containing either 8-Br-cAMP (0.5 mM) or MPA (1 µM) alone or in 
combination for 24 h. sFlt-1 measured in the cell supernatants by ELISA. Results are the mean 
(± SEM) of three independent experiments performed in duplicate. Statistically significant 
differences (*p<0.05). 
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6.2.3. Reduction of FOXO1and Flt-1 mRNA expression in HO-1 induced hESC 
St-T1b and increased FOXO1 expression in primary hESC 
A negative correlation between HO-1 expression and sFlt-1 expression was reported in human 
endothelial cells and placental explants (Cudmore et al., 2007). Here, we investigated the effect 
of HO-1 induction on hESC, focusing on changes of FOXO1 and Flt-1 mRNA splice variant 
expression. In St-T1b cells and hESC, hemin (10 µM) resulted in a 70% increase HO-1 mRNA 
induction accompanied by a marked increase in protein expression as revealed by Western 
blotting (Figure 6.4A & B). In primary hESC, the same hemin concentration induced a marked 
(5-fold) increase in HO-1 mRNA in comparison with the controls. This mRNA upregulation 
was also confirmed by Western blotting (Figure 6.5A & B). Following confirmation of HO-1 
induction with hemin, the associated changes in FOXO1, sFlt-1 variants, and SOD2 expression 
were investigated. The results showed a significant reduction in the full-length Flt-1 and sFlt-
i13 mRNA in St-T1b cells and sFlt-1 protein was only detected weakly in the hemin treated 
cells (Figure 6.4D, E & G). 
 In primary hESC, the changes in Flt-1, sFlt-i13a, and sFlt-e15a variants were not significantly 
upregulated (Figure 6.5E, F, & G). In Western blots, a faint signal (sFlt-i13) was observed in 
the hemin treated cells (Figure 6.5H) of the same size as recombinant sFlt-1, which was used 
as a positive marker.    
FOXO1, SOD2, and OGG1 were used to determine if there was an increase in oxidative stress 
induced using hemin. St-T1b cells showed a significant down-regulation of FOXO1 mRNA and 
no difference in SOD2 mRNA levels (Figure 6.4C & H). In contrast, primary hESC showed a 
significant upregulation of FOXO1 and SOD2 mRNA (Figure 6.5C & I).   
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Figure 6.4: FOXO1 and Flt-1 mRNA expression reduced in HO-1 induced hESC. 
Confluent monolayers of St-T1b cells were treated for 24 h with hemin (10 µM) in E2 medium. 
Relative mRNA fold changes of (A) HO-1, (C) FOXO1, (D) full length Flt-1, (E) sFlt-i13, (F) 
sFlt-e15a, (H) SOD2 and (I) OGG1 normalised to β-actin. Representative Western blots 
showing (B) HO-1 and (G) sFlt-1 protein expression with recombinant sFlt-1 (R-sFlt-1) as a 
positive marker. Tubulin was used as a loading control. Results are the mean (± SEM) of four 
independent experiments. Statistically significant differences (*p<0.05). 
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Figure 6.5: HO-1 induction upregulates FOXO1 in the primary hESC. Confluent 
monolayers of primary hESC were treated for 24 h with hemin (10 µM) in E2 medium. 
Relative mRNA fold changes of (A) HO-1, (C) FOXO1, (E) Flt-1, (F) sFlt-i13, (G) sFlt-
e15a, (I) SOD2, and (J) OGG1 normalised to β-actin. Representative Western blots 
showing (B) HO-1, (D) FOXO1, and (H) sFlt-1 protein expression with recombinant sFlt-
1 (R-sFlt-1). Tubulin was used as a loading control. Results are the means (± SEM) of three 
independent experiments. Statistically significant differences (*p<0.05). 
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The upregulation of FOXO1 was also seen at the protein level expression in primary hESC, 
whilst FOXO1 protein was undetected in St-T1b cells. OGG1 mRNA levels did not change in 
either St-T1b cells or primary hESC (Figure 6.4I; Figure 6.5D & J). 
6.2.4. Reduction of sFlt-e15a mRNA in hemin induced HUVEC 
 As HO-1 was previously reported to down-regulate the sFlt-1 production in endothelial cells 
(Cudmore et al., 2007), HUVEC were used to investigate the effect of hemin treatment on 
sFlt-1 variant expression and to compare with the results seen in hESC. HUVEC were seeded 
at 2.8x105cells/well in a 6-well plate. Confluent monolayers of HUVEC were treated with 
hemin (10 µM) for 24 h and HO-1 mRNA and protein levels analysed. A 2.5-fold induction 
of HO-1 mRNA was detected upon hemin treatment (Figure 6.6A). HO-1 protein expression 
was strongly induced. Following confirmation of HO-1 induction, we investigated Flt-1, sFlt-
1 mRNA expression levels. The results showed a non-significant reduction of sFlt-i13 mRNA 
and a significant reduction in sFlt-e15a expression (Figure 6.6E, C & D). In Western blots, 
three bands were detected (Figure 6.6F). The lower band is sFlt-i13, a less prominent band of 
approximately 100 kDa, sFlt-e15a is <135kDa, and the upper band of ~170 kDa was the full-
length Flt-1 receptor. The intensity of all the bands increased following hemin treatment. 
The sFlt-1 protein concentration in the hESC supernatants was analysed by ELISA. The 
results revealed a significant elevation of sFlt-1 expression in the hemin treated group (Figure 
6.7). 
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Figure 6.6: sFlt variant expression in endothelial cells following hemin treatment. Confluent 
monolayers of HUVEC were treated with hemin (10 µM) in for 24 h. Relative mRNA fold 
changes (A) HO-1, (B) Flt-1, (C) sFlt-e15, and (D) sFlt-i13 mRNA expression measured by 
qPCR and normalised to β-actin. Representative Western blots showing (E) HO-1 and (F) sFlt-
1 protein. Tubulin used as a loading control. Results are the mean (± SEM) of four independent 
experiments. Statistically significant differences (*p<0.05). 
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Figure 6.7: HO-1 induction increased sFlt-1 release in endothelial cells. Confluent 
monolayers of HUVECs were treated with hemin (10 µM) for 24 h. Supernatants were 
harvested, and sFlt-1 protein secretion determined by ELISA. Results are the mean (± SEM) 
of sFlt-1 protein relative to untreated control of three independent experiments performed in 
duplicate. Statistically significant differences (*p<0.05). 
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6.2.5. Up-regulation of HO-1 increases sFlt-1 and VEGF expression in hESC 
HO-1 regulates both VEGF and sFlt-1 expression in various cell types (Cudmore et al., 2007). 
Here, we assessed the role of HO-1 using pharmacological stimulators and inhibitors; namely, 
hemin and OB24 hydrochloride (OB24 h) and tin protoporphyrin IX dichloride (SnPP) on sFlt-
1 and VEGF release in hESC. hESC were plated at 1x105 cells/well in a 24-well plate and 
incubated until they reached confluence. The cells were then treated with hemin (10 µM) for 4 
h to ensure that HO-1 was induced. Then, OB24 (10 µM) and SnPP (10 µM) were added into 
E2 medium with hemin (10 µM) for a further 24 h. Hemin treatment caused an elevated 
expression of sFlt-1 in St-T1b cells and primary hESC (Figure 6.8). The up-regulation of HO-
1 in these cells was confirmed by Western blotting (Figure 6.4B). A significant elevation of 
sFlt-1 expression was observed following hemin treatment, which was also observed in cells 
treated with OB24. However, sFlt-1 expression did not change in the SnPP treated hESC 
(Figure 6.8A). 
In primary hESC, sFlt-1 secretion was significantly upregulated following hemin treatment and 
increased in HO-1 expression confirmed by Western blotting (Figure 6.5B). This response was 
not affected by the presence of the HO-1 inhibitors (Figure 6.8A, Figure 6.8B).  
Interestingly, VEGF expression in St-T1b cells was found to be significantly upregulated 
following SnPP treatment in the absence of hemin induction (Figure 6.9A). Hemin caused a 
significant increase of VEGF expression in the OB24 treated group. In primary hESC, VEGF 
expression did not increase significantly following hemin treatment in hESC (Figure 6.9B). 
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Figure 6.8: HO-1 induction increased sFlt-1 protein secretion in hESC. Confluent monolayers of 
St-T1b cells and primary hESC were incubated with hemin (10 µM) 4 h prior to or in combination with 
OB24 (10 µM) or SnPP (10 µM) for 24 h in E2 medium. ELISA measurements of sFlt-1 protein release 
were performed in (A) St-T1b cells and (B) primary hESC supernatants. Results are the mean (± SEM) 
of % sFlt-1 protein release relative to untreated control of three independent experiments performed in 
duplicates. Statistically significant differences (*p<0.05, **p<0.001). 
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Figure 6.9: HO-1 induction affects VEGF protein expression in hESC. Confluent 
monolayers of St-T1b cells and primary hESC were incubated with hemin (10 µM) 4 h prior 
to and in combination with OB24 (10 µM) or SnPP (10 µM) in E2 medium for a further 24 
h. ELISA measurements for VEGF protein release were performed in (A) St-T1b cells and 
(B) primary hESC supernatants. Results are the mean % VEGF release (± SEM) relative to 
untreated control of three independent experiments performed in duplicate. Statistically 
significant differences (*p<0.05, **p<0.001). 
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6.2.6. HO-1 knockdown in primary hESC 
To further investigate whether the hESC HO-1 activity can affect sFlt-1 release, HO-1 was 
knocked down in primary hESC with the same protocol used for FOXO1 knockdown. mRNA, 
western blot protein expression, and ELISA analyses were performed. Unfortunately, the results 
showed only a partial knockdown of HO-1 in both mRNA and protein levels. Therefore, the 
results could not be inferred to a conclusion (Figure 6.10).  
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Figure 6.10: HO-1 knockdown in primary hESC. Confluent monolayers of primary hESC were 
transfected with siRNAs targeting HO-1 (siHO-1) or control (siControl) siRNA for 24 h followed by 
incubation in E2 medium in combination with hemin (10 µM) in for 24 h. Relative mRNA fold 
changes of  (A) HO-1, (C) FOXO1, (E) sFlt-i13 and (F) sFlt-e15a normalised to β-actin. (G) ELISA 
analysis of sFlt-1 protein expression following HO-1 knockdown in primary hESC. Representative 
Western blots showing (B) HO-1, (D) FOXO1 protein expression. Tubulin was used as a loading 
control. Results are the means (± SEM) of three independent experiments. (G) ELISA measurements 
of sFlt-1 protein release. Statistically significant differences (*p<0.05). 
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6.3. Discussion 
6.3.1. Elevated VEGF and reduced sFlt-1 release in hESC during decidualisation. 
Here, we aimed to describe the control of sFlt-1 and VEGF in hESC during in vitro 
decidualisation, and the impact of HO-1 expression on them. Our results reveal the upregulation 
of VEGF and down-regulation of sFlt-1 in St-T1b cells following decidualisation. These 
findings are consistent with the recent report by Cottrell et al (2017), which was published 
during this study. They induced human endometrial cells from the proliferative stage to 
decidualise with a cocktail of E2, P, and cAMP at the initial stage of the experiment. Then, they 
maintained decidualisation with cAMP alone. They found an up-regulation of VEGF protein 
by ELISA with a reduced level of sFlt-1 by qPCR, western blot, and ELISA assay in 
decidualised cells with cAMP versus the control group.  The findings show a reduction of sFlt-
1 protein release over 24 h in hESC stimulated with cAMP or MPA alone or in combination. 
This may be related to a combined effect of FOXO1 (which depends on cAMP activity) and P 
activity, which induced decidualisation. Further in vitro studies by overexpressing FOXO1 in 
hESC can identify the role of FOXO1 in sFlt-1 release. Krüssel et al (1999) reported a constant 
mRNA expression of full length Flt-1 in the menstrual cycle, whilst sFlt-1 reduced in the 
secretory phase using endometrial biopsies from women at different stages of the menstrual 
cycle. These findings agree with our results in hESC decidualisation, which naturally occurs 
during the secretory phase of the menstrual cycle and could be explained on the basis of steroid 
hormone regulation of sFlt-1 expression. Furuyama et al (2000) found that Foxo deletion in 
mice can result in the reduction of Full length Flt-1in angiogenic cells. The reduction of sFlt-1 
gives much-updated evidence to confirm the importance of decidualisation in protection against 
sFlt-1 related problems. 
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 Our finding of the upregulation of VEGF during hESC decidualtion supports the previous 
finding of others (Matsui et al., 2004, Lockwood et al., 2009). Studies by Vasquez et al (2015) 
and Mazur et al (2015) found that FOXO1 and P regulate VEGF upregulation during 
decidualisation. Vasquez et al (2015) found by ChIP sequencing of decidualised hESC that 
VEGF and Flt-1 are among the genes regulated with stromal decidualisation and FOXO1 
transcription. Mazur et al (2015) found that decidual VEGF expression is regulated with the 
PGR. Schatz et al (2003) also found an increase in  VEGF mRNA and protein in hESC decidual 
production. In contrast to our finding of increased VEGF release on P and cAMP treatment, 
Okada et al (2010) found that E2 stimulation of hESC increases VEGF and reduces sFlt-1 
release. In our study, we found that E2 in E2 medium does not increase the VEGF level, whilst 
MPC medium increases its release, which might be due to the activation of PI3/AKT signaling 
during decidualisation (Fabi et al., 2017).   
6.3.2. HO-1 induction increases sFlt-1 protein expression in hESC  
The ELISA results of sFlt-1 release following hemin treatment in hESC show that it is 
upregulated even in the presence of pharmacological HO-1 inhibitors. This upregulation was 
combined with a significant rise in VEGF levels produced by St-T1b cells. Fan et al (2014) 
reported that in women with pre-eclampsia, the overexpression of VEGF by placental 
trophoblasts is associated with sFlt-1 over-expression in endometrial cells. In cultured murine 
trophoblasts, VEGF was found to increase the expression of sFlt1 mRNA. 
 OB24 is a new small molecule HO-1 inhibitor. It is an imidazole derivative that works as a 
potent selective HO-1 inhibitor with 50 % inhibitory activity of HO-1 when used at 10 µM in 
the prostate cell line (PC3M) (Alaoui-Jamali et al., 2009). SnPP is a competitive substrate 
inhibitor of HO-1 enzyme activity. It was reported that SnPP, at a level of 10 µM, can result in 
Chapter 6 – Investigation the role of HO-1 in the regulation of sFlt-1 expression in hESC 
decidualisation 
215 
 
>50 % inhibition of HO-1 activity (Drummond and Kappas, 1981, Grundemar and Ny, 1997). 
Cudmore et al (2007) found that the adenoviral HO-1 overexpression in HUVEC results in sFlt-
1 down-regulation, and when HO-1 is  inhibited with SnPP in the presence of VEGF, the sFlt-
1 reduces. This may be attributed to the difference between endothelial cells and hESC or may 
be due to more complicated causes as this study was performed on a pre-eclamptic condition, 
which occurs later in pregnancy (after 20th week of gestation). Furthermore, we induced HO-1 
in HUVEC with hemin; therefore, the induction of sFlt-1 may be either due to HO-1 induction 
itself or due to another effect of hemin on the hESC. Other approaches could be adopted using 
alternative HO-1 inducers such as Zinc protoporphyrin (ZnPP), Statins, Resveratrol, or 
adenoviral overexpression of HO-1 constructs.  
Our findings may not be linked directly to the regulatory relation between VEGF and a sFlt-1 
release in hESC as VEGF increases during decidualisation while sFlt-1 decreases. Hence, we 
need to indicate that there might be an autocrine function of endogenous VEGF in hESC as in 
the endothelial cells to maintain survival (Lee et al., 2007a, Domigan et al., 2015). Further 
experiments to measure sFlt-1 release following treatment with VEGF might be indicated. HO-
1 knockdown was not successful, and due to time constraints, ordering of new siRNA to check 
what made the knockdown failed was not achievable. However, sFlt-1 was also elevated in the 
presence of hemin in the HO-1 knockdown trial.  
6.3.3. Reduction of FOXO1 and Flt-1 mRNA expression in HO-1 induced hESC 
St-T1b. 
The findings revealed that FOXO1 is a positive regulator of HO-1 in hESC and that HO-1 can 
affect levels of cellular oxidative stress, which is a known regulator of FOXO1. Accordingly, 
we planned to determine whether HO-1 activity might affect FOXO1 expression (i.e. can HO-
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1 affect FOXO1 levels). Interestingly, HO-1 induction led to up-regulation of FOXO1 in 
primary hESC. To find an explanation, we looked to connect FOXO1 expression with an 
oxidative stress environment (Kuang et al., 2014), which might be induced by hemin itself 
through measuring the levels of SOD2 and OGG1. OGG1 is upregulated in conditions of severe 
oxidative stress when DNA damage has occurred (Ruchko et al., 2005). The results showed that 
the OGG1 level was unchanged, and this may exclude the possibility of a severe oxidative stress 
environment in the induction of HO-1 with hemin. However, the rise in Foxo1 in primary cells 
was associated with raised SOD2. This may suggest that hemin treatment may be associated 
with a mild stressful environment (Souza et al., 1997) in the primary hESC that was not seen 
in the St-T1b cell line. It could be that St-T1b cells are immortalized and more resistant, with a 
higher threshold of coping with hemin than primary cells. Kang et al (2014) found that HO-1 
induction using hemin in differentiated mouse myoblasts resulted in the induction of Foxo1 
leading to elevated muscle degradation factors known as atrogenes and hemin administration 
to mice for 7 days caused mice muscle atrophy. Muscle atrophy and protein degradation were 
found to be caused by increased oxidative stress (Sacheck et al., 2007). 
The second focus of hemin treatment was to check its effect on sFlt-1 expression. The results 
indicate the down-regulation of sFlit-i13 mRNA expression in St-T1b cells with hemin 
treatment, whilst the difference in primary hESC was non-significant. Very recent research by 
Palmer et al (2017) introduced a discriminatory tool to differentiate between early and late 
onsets pre-eclampsia. In the early onset, they found an increased protein expression of the 
placental predominate sFlt-1splice variant (sFlt-e15a), whilst the late onset, pre-eclampsia is 
mainly endothelial in origin and associated with endothelial cell production of their 
predominant sFlt-i13 isoform. In Western blots, the band was faint in comparison with the 
recombinant sFlt-1 band, which was used to indicate the right position of sFlt-1 band. 
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Therefore, an ELISA assay was used to investigate the sFlt-1 protein release, especially by 
hemin-treated hESC.  
In conclusion, decidualisation reduces the sFlt-1 protein expression in both St-T1b cells and 
primary hESC with increases VEGF protein. 24 h decidualisation stimulation, whether by 
cAMP or MPA causes a reduction in sFlt-1 protein expression in St-T1b without any significant 
difference following treatment with them separately. hESC hemin treatment over 24 h increases 
sFlt-1 protein expression. 
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Embryo implantation is an essential stage in mammalian reproduction and cyclical hESC 
decidualisation, coordinated by ovarian steroids is a key component of this process (Nie and 
Dimitriadis, 2019). Aberrant decidualisation can lead to failed implantation (De Carolis et al., 
2019, Berkhout et al., 2019), poor embryo selection (Teklenburg et al., 2010a, Weimar et al., 
2012),  pregnancy complications such as recurrent miscarriage (Medicine, 2012a), IUGR and 
pre-eclampsia (Leeman and Fontaine, 2008). Exploring the molecular events regulating 
decidualisation may identify pathways and factors that underlie endometrial-related infertility 
and pregnancy complications and provide novel targets for therapy.  
7.1. Establishment of in vitro models of human embryo implantation 
The study of human implantation is limited by a number of ethical and practical factors.  
Although both these issues obviously restrict the direct investigation of human implantation in 
vivo, the use of animal models has undoubtedly provided invaluable information but is often 
hampered by cost and the inherent physiological differences between species. Higher primates 
most closely represent the human situation, but their use has now largely been phased out on 
ethical grounds and due to the prohibitive costs involved. Rodent models are most frequently 
used with their advantage of short generation times and convenience of use. However, they 
cannot fully recapitulate the process of human implantation. For example, the short estrous 
cycle in comparison with the 28 day human menstrual cycle. Cell lines established using 
retroviral transduction human telomerase (Samalecos et al., 2009c, Yuhki et al., 2011) seem to 
retain more phenotypic features of the parent cells than those immortalised with SV40 large T 
antigen (Chapdelaine et al., 2006) and hESC lines produced by both methods appear to yield 
lines with an appropriate progestational response (Yuhki et al., 2011). In this project, the 
comparison of the St-T1b cells and primary hESC demonstrated that the St-T1b cell 
decidualisation response is very similar to primary hESC. Therefore, they represent a 
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convenient and viable alternative to the use of primary cells to establish in vitro models to 
investigate embryo implantation and the effects of hESC decidualisation. The use of cell lines 
offers an advantage in terms of consistency of response within an assay over time and the 
potential to adopt techniques such as CRISPR for the generation of mutant lines to examine 
particular aspects of gene regulation and function in the implantation process (Wyvekens et al., 
2015, Kinnear et al., 2019, Marx, 2019) 
Several in vitro implantation models have reported previously. The first co-culture implantation 
model was reported around 60 years ago (Glenister, 1961). Many models have been 
subsequently developed to mimic various aspects of embryo implantation (Rogers et al., 1986, 
Ho et al., 2012, Bischof and Campana, 1996, Mardon et al., 2007, Berneau et al., 2019). 
Although similar models were developed previously (Gonzalez et al., 2011), significant 
refining modifications were introduced during this project. The result was the development of 
convenient, robust, and reproducible models that can be applied to study the improvement of 
embryo implantation. The use of fluorescent cell tracer dyes allows the opportunity to 
continuously monitor various aspects of implantation over 72 h and improved analysis.  
To better mimic the effect of decidualisation on the invasion of HTR-8 spheroids, hESC could 
be seeded into the matrix to provide direct cell contact. This proved problematic when using 
fibrin gels because it was hard to control the initial cell distribution and prevent cell clumping 
and deformation of the fibrin gel with culture.  Fibrin gels were used to embed spheroids for 
these studies as they are thought to be broadly representative of the matrix present in the decidua 
during trophoblast invasion (Bischof and Campana, 1996). However, they are easily degraded, 
which requires the addition of plasmin inhibitors, such as tranexamic acid, and limits their use 
in long-term culture (Cholewinski et al., 2009). Recently, there has been much interest in the 
development of 3D cell culture using new hydrogel matrices with controlled setting properties 
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based on materials such as modified alginate. These are more durable matrices overcoming the 
problems encountered with traditional gels.  
The introduction of an epithelial cell monolayer would extend these models to enable 
examination of the initial interactions of the epithelium with ESC and trophoblasts using the 
HTR-8 spheroids. A model of attachment and invasion, including all three types with an 
epithelial monolayer overlying hESC embedded within a gel, has been reported (Wang et al., 
2011). Recently, a new model of trophoblast invasion using a bioprinting technique has been 
reported (Ding et al., 2019). We can incorporate the idea of this model in our co-culture through 
adding a 2D multi-ring model, which will form the front of HTR-8 trophoblast and can be used 
as an indicator of invasion and migration potential. Further expansion of our model could be 
made through the use of rabbit or mouse embryos instead of HTR-8 spheroids, as in the study 
performed by Grewal et al (2010) and Fischer et al (2012). Additionally, the effect of follicular 
fluid on trophoblast invasion could be examined. 
7.2. Fluorescent image analysis protocols 
Different analysis protocols have been previously reported to analyse images of the scratch-
wound migration assay. Some depend on the manual measurement of the area between two 
points in the scratch or the distance between multiple points along the scratch (Abdulkareem, 
2017). Manual measurement is very time consuming and can be subjective. The use of the 
ImageJ trainable weka plugin allows the measurement of the total scratch area rather than the 
measurement of the distance between multiple points along the scratch. It also carries the 
advantage of automated assessment of multiple fields along the scratch. Automated analysis 
was also possible with a fluorescently labelled spheroid expansion area without the need for 
manual demarcation of the trophoblast/spheroid boundaries.  
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To overcome the possibility of multiple-line representation of a thick trophoblast sprout in the 
analysis of spheroid invasion assay, the trainable weka plugin was applied as an alternative to 
the skeleton analysis method (Blacher et al., 2014, Salisbury, 2017). Automated subtraction of 
the spheroid core was performed, followed by thresholding and measurement of the total 
sprouting area. The three analytic protocols are computer-based processes performed via freely 
accessible ImageJ software. The protocols can be applied to image stacks saving investigator 
time and effort spent while analysing multiple single images. This protocol can be adopted by 
researchers and overcomes the difficulty of using new macros and maintaining the functionality 
of such macros.   
7.3. The role of decidualisation on endometrial and trophoblast cell functions 
The endometrium displays cyclical changes in its receptivity and these changes are the hallmark 
of decidualisation (Vergaro et al., 2019). However, the role of decidualisation in embryo 
invasion into the endometrium is not fully understood. Several studies have reported that 
decidualisation controls trophoblast invasion during implantation through different 
mechanisms (Sharma et al., 2016). They are proposed to present a physical or chemical barrier 
to the invading trophoblasts through the modulation of factor secretion, such as adhesion 
molecules and MMPs (Menkhorst et al., 2019). Our results indicate a reduced trophoblast 
sprout invasion into fibrin gel in the presence of decidualised stromal cells. Furthermore, we 
found an increase in the expansion of trophoblast spheroids over decidualised hESC 
monolayers. This may be interpreted as decidualisation first enhances the spreading of the 
embryo to offer more nutritional supply by simple diffusion, then restricts its further invasion. 
This controlled invasion may be a protective mechanism to prevent tumour-like embryo 
invasion, and subsequent harm to the mother, which can result from placenta accreta (Jauniaux 
et al., 2018, Miller et al., 1997). Although IGFBP-1, dPRL, and PDGF enhance trophoblast 
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invasion (Chakraborty et al., 2002, Stefanoska et al., 2013), reduced invasion was seen during 
decidualisation. This reduced invasion may be attributed to fibrinoid deposition by EVT during 
invasion (Pijnenborg et al., 2006, Pijnenborg and Brosens, 2010). Further measurement of 
factor, which might counteract the effect of IGFBP-1, can be performed, such as the 
investigation of α5β1, the fibronectin receptor, which binds to IGFBP-1 (Irwin and Giudice, 
1998, Gu et al., 2019). My results showed  reduced hESC migration during decidualisation, 
which might be attributed to inhibition of the PI3K/AKT pathway (Fabi et al., 2017).  
7.4. The role of decidualisation on PDGF family expression 
Various functions have been reported for PDGF family in the female reproductive system such 
as ovarian function (Carson et al., 1989), embryo implantation (Nie and Dimitriadis, 2019), 
decidualisation, trophoblast invasion, angiogenesis and infertility problems including 
endometriosis (Kobayashi et al., 2014, Simopoulou et al., 2019). The expression of the PDGFs 
and their receptors by the HTR-8 trophoblast cell line and hESC was characterised using 
endothelial cells as a positive control. This confirmed the expression of PDGF-AA, PDGF-CC, 
PDGFR-α, and PDGFR-β and the absence of PDGF-BB in hESC. HTR-8 cells expressed 
PDGF-AA, PDGF-BB, PDGF-CC, PDGFR-α, and PDGFR-β. As expected, both PDGFR-α and 
PDGFR-β were not detected in endothelial cells. These findings were in broad agreement with 
Lash et al (2011) and further support a protein array study performed previously in our lab 
(Ting & Hewett – unpublished results). Decidualisation with MPA and cAMP differentially 
effect of PDGR-α and PDGF-AA expression in hESC. Further investigation is needed to dissect 
which decidualisation stimulus was responsible for this change. PDGF-BB enhanced the 
migration of stromal cells, expansion and invasion of HTR-8 spheroids. Furthermore, this study 
revealed, for the first time, the upregulation of endosialin during primary hESC decidualisation. 
Endosialin has been shown to promote PDGF activity in pericyte cells and may enhance 
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PDGFR internalisation and signalling (Tomkowicz et al., 2010). Further studies are required to 
investigate the function of endosialin in decidualisation. Endosialin knockdown experiments 
could be used to determine its effect in hESC in the scratch-wound migration assay in response 
to PDGF-BB and HTR-8 spheroid expansion assay and signalling studies. If successful,  
endosialin knock-out mice could be used to determine its effect following induction of 
decidualisation (Halhali et al., 1991, Liu et al., 2016). 
7.5. HO-1 expression and function in hESC decidualisation and embryo 
trophoblast interaction 
HO-1 plays a vital role in successful pregnancy (Bainbridge and Smith, 2005). Zenclussen and 
colleagues (2014) reported that HO-1 was upregulated in the receptive period of the estrus phase 
in mouse estrous cycle. In agreement with these studies we show that HO-1 expression is 
upregulated in hESC decidualisation in vitro. This may contribute in part to the oxidative stress 
resistance state of decidual and placental tissue (Kajihara et al., 2006, Peng et al., 2019) due to 
the steroid regulation and cAMP induction of decidualisation as confirmed on hESC treatment 
with cAMP and MPA individually. Hence, we showed that HO-1 upregulation during 
decidualisation is dependent on cAMP stimulated pathways. Here, we show that FOXO1 
silencing is associated with a significant reduction of HO-1 expression. The demonstration of 
FOXO1-mediated up-regulation of HO-1 in hESC indicates that HO-1 should increase towards 
the end of the luteal phase before menstruation and therefore, may be involved in limiting the 
haemorrhagic endometrial damage following menstruation (Maybin and Critchley, 2012). 
Further research might be suggested through the use of endometrial-specific FOXO1 knockout 
in mice followed by an examination of putative FOXO1 transcription factor binding sites in the 
HO-1 promoter to further elucidate the regulatory FOXO1 role in HO-1 expression. 
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HO-1 is involved in embryo implantation and in limiting the hemorrhagic endometrial damage 
following menstruation (Maybin and Critchley, 2012). Rodriguez et al (2010) found that HO-1 
inhibits migration in rat aortic smooth muscle cells via the inhibition of the nicotinamide 
adenine dinucleotide phosphate oxidase (NOX1) pathway. In agreement with these studies, we 
showed that hemin has an inhibitory effect on the migration of primary hESC. Bilban et al 
(2009) demonstrated a reduced HTR-8 migration in transmigration assays following HO-1 
over-expression. Our results show a reduction of PDGF-BB stimulated HTR-8 cell migration 
on treatment with hemin. Further studies can be suggested to explore any effect of PPARγ, 
which is expressed in the placenta and can affect migration (Zhao et al., 2019).  
In a study by Knöfler and Pollheimer (2012) study, trophoblasts were found to produce integrin 
and CXCL12 chemokines that in turn stimulate stromal cells to secrete CXCR4, which 
promotes trophoblast invasion (Ren et al., 2011). We showed that HTR-8 spheroid invasion 
into fibrin gels in the absence of stromal cells was not as pronounced as in the presence of 
hESC. Therefore, stromal cells may act as an enhancer of trophoblast invasion by the secretion 
of factors from hESC that promote trophoblast invasion. Ha et al (2015) found that HO-1 
products increase HTR-8 and HUVEC invasion using a trans-well migration assay. The assay 
investigates the invasion of individual cell types and not as a co-culture model. However, our 
co-culture method showed that hemin treatment caused increased sprouting in the presence of 
hESC. McCaig and Lyall (2009) showed that HO-1 and HO-2 have different roles in cell 
invasion. Hence, we can further expand the HTR-8 spheroid sprouting assay by applying 
selective inhibitors of constitutive HO-2 such as analogues of 1-(4-chlorobenzyl)-2-(pyrrolidin-
1-ylmethyl)-1H-benzimidazole (clemizole) (Vlahakis et al., 2013), for investigating the 
biological roles of HO-1 by its own or by in vitro or in vivo knockdown trials. Further study 
can be performed in vivo through HO-1 overexpression or knockdown to investigate the 
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migration and invasion of trophoblast in mice or rats, such as the study performed by 
Zenclussen et al (2003).  
7.6. Regulation of VEGF and sFlt-1 by decidualisation 
VEGF and its receptors play an important role in endometrial decidualisation and embryo 
implantation, driving the vascular and trophoblast responses (Plaisier, 2011, Goldman-Wohl 
and Yagel, 2002). Dysregulated VEGF and sFlt-1 expression can be seen in different 
reproductive problems such as the early recurrent spontaneous abortion (Pang et al., 2013), 
endometriosis (Cho et al., 2012), pre-eclampsia and IUGR (McKeeman et al., 2004). sFlt-e15a 
and sFlt-i13 are the two major Flt-1 splice variants that have been implicated in reproductive 
problems. As the decidual cells are a significant source of VEGF in the endometrium (Fan et 
al., 2014, Matsui et al., 2004), the regulation of its activity by sFlt-1 is likely to be critical for 
a healthy pregnancy. Cottrell et al (2017) found an upregulation of VEGF protein with a 
reduced level of sFlt-1 in decidualised hESC. Their findings agree with our findings of 
increased VEGF and reduced sFlt-1 release upon decidualisation of hESC. A study by Vasquez 
et al (2015) recently found that FOXO1 regulates VEGF in agreement with findings from our 
laboratory. Mazur et al (2015), who found that VEGF and Flt-1 are differently expressed with 
decidualisation in hESC. We found that the induction of decidualisation with both cAMP and 
MPA resulted in a significant reduction of sFlt-1 level.  
 7.7. HO-1 effect on sFlt-1 and VEGF expression 
Hemin treatment of hESC shows that sFlt-1 is upregulated with treatment by HO-1 
pharmacological inhibitors. The increased level of sFlt-1 may be due to the effect of HO-1 
induction itself or due to the other effects of hemin on the hESC. To investigate this further, 
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another approach could be adopted using alternative HO-1 inducers such as Zinc 
protoporphyrin (ZnPP), Statins, Resveratrol, or adenoviral overexpression of HO-1 constructs. 
7.8. Conclusion 
The results of this PhD study contribute to our knowledge of human embryo implantation 
mechanisms through the establishment of in vitro models to evaluate the critical role of 
decidualisation in this limiting step of human reproduction. Essentially, the findings recognise 
the role of decidualisation in the expression of growth factors implicated with implantation and 
how the growth factor and decidualisation affect the stromal-trophoblast interaction. They 
identify for the first time that decidualisation increases the expression of PDGF receptors, HO-
1, and endosialin in hESC. Furthermore, they confirm the concurrent findings of increased 
expression of VEGF and reduced sFlt-1 expression during hESC decidualisation. 
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Appendix 1: The image analytic protocol used for the migration assay. (A) A flow chart 
shows the processes used to measure the area of migration using ImageJ. (B) A macro developed 
in ImageJ to simplify and standardise image processing each time. 
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Appendix 2: The image analytic protocol used for the expansion assay. (A) A flow chart 
shows the processes used to measure the area of migration using ImageJ. (B) A macro 
developed in ImageJ to simplify and standardise image processing each time. 
 
 
Appendices 
231 
 
 
 
 
 
 
 
 
 
 
 
  
Appendices 
232 
 
 
 
 
 
 
Appendix 3: The image analytic protocol used for the sprouting assay. (A) A flow chart shows 
the processes used to measure the area of migration using ImageJ. (B) A macro developed in 
ImageJ to simplify and standardise image processing each time. 
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